{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Preferred medications for opioid agonist therapy and associated\n",
    "\n",
    "factors among people who regularly use opioids in Australia\n",
    "\n",
    "MJ Stowe [![](data:image/png;base64,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)](https://orcid.org/0000-0002-0760-5497) (The Kirby Institute, UNSW Syndey, Sydney Australia)  \n",
    "Anna Conway [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (The Kirby Institute, UNSW Syndey, Sydney Australia)  \n",
    "Frederick Altice [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (Yale School of Medicine, Yale University, New Haven, Connecticut, United States)  \n",
    "Tom Hassett [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (Yale School of Medicine, Yale University, New Haven, Connecticut, United States)  \n",
    "Marianne Byrne [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (The National Drug and Alcohol Research Centre, UNSW Syndey, Sydney, Australia, The Kirby Institute, UNSW Syndey, Sydney Australia)  \n",
    "Samantha Colledge [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (The National Drug and Alcohol Research Centre, UNSW Syndey, Sydney, Australia)  \n",
    "Phillip Read [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (Kirketon Road Centre, Sydney, New South Wales, Australia, Drug and Alcohol Services, Northern Sydney Local Health District, Sydney, New South Wales, Australia)  \n",
    "Mark Montebello [![](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABAAAAAQCAYAAAAf8/9hAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAA2ZpVFh0WE1MOmNvbS5hZG9iZS54bXAAAAAAADw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8+IDx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iIHg6eG1wdGs9IkFkb2JlIFhNUCBDb3JlIDUuMC1jMDYwIDYxLjEzNDc3NywgMjAxMC8wMi8xMi0xNzozMjowMCAgICAgICAgIj4gPHJkZjpSREYgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj4gPHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9IiIgeG1sbnM6eG1wTU09Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC9tbS8iIHhtbG5zOnN0UmVmPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvc1R5cGUvUmVzb3VyY2VSZWYjIiB4bWxuczp4bXA9Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8iIHhtcE1NOk9yaWdpbmFsRG9jdW1lbnRJRD0ieG1wLmRpZDo1N0NEMjA4MDI1MjA2ODExOTk0QzkzNTEzRjZEQTg1NyIgeG1wTU06RG9jdW1lbnRJRD0ieG1wLmRpZDozM0NDOEJGNEZGNTcxMUUxODdBOEVCODg2RjdCQ0QwOSIgeG1wTU06SW5zdGFuY2VJRD0ieG1wLmlpZDozM0NDOEJGM0ZGNTcxMUUxODdBOEVCODg2RjdCQ0QwOSIgeG1wOkNyZWF0b3JUb29sPSJBZG9iZSBQaG90b3Nob3AgQ1M1IE1hY2ludG9zaCI+IDx4bXBNTTpEZXJpdmVkRnJvbSBzdFJlZjppbnN0YW5jZUlEPSJ4bXAuaWlkOkZDN0YxMTc0MDcyMDY4MTE5NUZFRDc5MUM2MUUwNEREIiBzdFJlZjpkb2N1bWVudElEPSJ4bXAuZGlkOjU3Q0QyMDgwMjUyMDY4MTE5OTRDOTM1MTNGNkRBODU3Ii8+IDwvcmRmOkRlc2NyaXB0aW9uPiA8L3JkZjpSREY+IDwveDp4bXBtZXRhPiA8P3hwYWNrZXQgZW5kPSJyIj8+84NovQAAAR1JREFUeNpiZEADy85ZJgCpeCB2QJM6AMQLo4yOL0AWZETSqACk1gOxAQN+cAGIA4EGPQBxmJA0nwdpjjQ8xqArmczw5tMHXAaALDgP1QMxAGqzAAPxQACqh4ER6uf5MBlkm0X4EGayMfMw/Pr7Bd2gRBZogMFBrv01hisv5jLsv9nLAPIOMnjy8RDDyYctyAbFM2EJbRQw+aAWw/LzVgx7b+cwCHKqMhjJFCBLOzAR6+lXX84xnHjYyqAo5IUizkRCwIENQQckGSDGY4TVgAPEaraQr2a4/24bSuoExcJCfAEJihXkWDj3ZAKy9EJGaEo8T0QSxkjSwORsCAuDQCD+QILmD1A9kECEZgxDaEZhICIzGcIyEyOl2RkgwAAhkmC+eAm0TAAAAABJRU5ErkJggg==)](https://orcid.org/0000-0002-7859-8394) (The National Drug and Alcohol Research Centre, UNSW Sydney, UNSW, Australia, Drug and Alcohol Services, Northern Sydney Local Health District, Sydney, New South Wales, Australia, University of Sydney, Sydney, New South Wales, Australia)  \n",
    "Jeremy Hayllar [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (Drug Health Service, South West Sydney Local Health District, New South Wales, Australia)  \n",
    "Sione Crawford [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (Harm Reduction Victoria, Victoria, Australia)  \n",
    "Charles Henderson [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (New South Wales Users and AIDS Association (NUAA), Sydney, Australia)  \n",
    "Michael Farrell [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (The National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia)  \n",
    "Chris Gough [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (CAHMA)  \n",
    "Louisa Degenhardt [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (The National Drug and Alcohol Research Centre, UNSW Syndey, Sydney, Australia)  \n",
    "Amy Peacock [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (The National Drug and Alcohol Research Centre, UNSW Syndey, Sydney, Australia)  \n",
    "Gregory J. Dore [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (The Kirby Institute, UNSW Syndey, Sydney Australia)  \n",
    "Jason Grebely [![](data:image/png;base64,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)](https://orcid.org/0000-0002-7859-8394) (The Kirby Institute, UNSW Syndey, Sydney Australia)  \n",
    "November 14, 2023\n",
    "\n",
    "**Background:** People who use opioids from an unregulated drug supply are increasingly exposed to related adverse social and health outcomes. Opioid agonist therapy (OAT) is effective in mitigating adverse outcomes, with individual preference identified as key to enhancing treatment. We examined OAT preferences and associated factors in a national sample of people who regularly use opioids. **Methods:** In this cross-sectional study, 400 people were enrolled between October 2020-April 2021. Participants completed an interviewer-administered questionnaire with questions on sociodemographic, behavioural, drug use- and treatment-related characteristics. Multivariable logistic regression was used to evaluate factors associated with treatment preferences. **Results:** Among all participants (mean age 45, 42% female), X% preferred OAT, with X% and X% reporting a preference for methadone and buprenorphine respectively. Among those who reported a preference for OAT, X% (n=X) preferred metahdone, while X% (n=X) preferred buprenorphine. participants who preferred methadone were more likely to have ever received OAT with methadone, and had used heroin (aOR X.XX, 95%CI:X.XX, X.XX) and other pharmaceutical opioids in the past month(aOR X.XX, 95%CI:X.XX, X.XX). Participants who preferred buprenorphine were more likely to have ever received OAT with burpenorphine (aOR X.XX, 95%CI:X.XX, X.XX). Among participants currently on OAT (n=317), X% in receipt of methadone and X% of buprenorphine were prescribed their preferred medication. Participants who preferred methadone were more likely to be receiving OAT with the same medication (aOR X.XX, 95%CI:X.XX, X.XX), had used and heroin (aOR X.XX, 95%CI:X.XX, X.XX) and other pharmaceutical opioids in the prior month (aOR X.XX, 95%CI:X.XX, X.XX). Participants who preferred buprenorphine were more likely to be currently receiving burpenorphine (aOR X.XX, 95%CI:X.XX, X.XX). **Conclusions:** Among people who regularly used opioids, most preferred to receive OAT with methadone and those currently receiving OAT were prescribed their preferred medication. Providers that do not offer a range of OAT and restrict choice of preferred medication risk negatively impacting treatment outcomes.\n",
    "\n",
    "## Introduction\n",
    "\n",
    "People who use opioids from the unregulated market are increasingly exposed to related social and health harms \\[@milaneyscoping2022; @cheethamimpact2022\\], including fatal and non-fatal opioid-involved overdose \\[@santo2021; @åstrøm2023\\], incarceration \\[@gisev2019; @fazel2017\\], stigma \\[@treloar2022\\] and structural violence \\[@lancaster2023\\]. Use via injection is associated is several health risks \\[@brener2022; @colledge2019; @degenhardt2019\\] such as increased risk of HIV and HCV infection \\[@Grebely2022; @Martinello2017a; @hajarizadeh\\], skin and soft tissue infection \\[@wheeler2022\\] and endocarditis \\[@wurcel2016; @see2020\\]. Opioid agonist therapy (OAT) with methadone and buprenorphine is effective in reducing associated harms \\[@degenhardt2023; @Nielsen2016; @Nielsen2022; @Jones2022\\], with retention associated with improved social and health outcomes , and reduced quality-adjusted life-years lost compared to no treatment or non-pharmacological interventions \\[@martin2022\\]. Despite the efficacy of these medications \\[@degenhardt2023\\], treatment acceptability, satisfaction, and retention is sub-optimal, globally. Individual preferences for these medications play a pivotal role in determining positive treatment outcomes \\[@joosten2008\\]. With similar outcomes for a range of measures among particular subgroups between medications \\[@degenhardt2023\\], the choice between methadone and buprenorphine should be informed by consultation with each person after consideration of preferences and the relative risks and benefits of each medication to the indivudal. While a number of studies explore the role of treatment preferences generally \\[@uebelacker2016; @kenney2018\\], relatively fewer number of studies focus specifically on factors associated with preferences for medication types and formulations.\n",
    "\n",
    "Preferences around OAT and individual choice are identified as key to improving treatment outcomes and reducing potential harms associated with use of unregulated opioids \\[@muthulingam2023\\]. Preferences are comprised of attitudes, beliefs, expectations, values, and processes used to evaluate the costs and benefits of treatment options \\[@montori2013\\], with the decision for one formulation over another being largely preference sensitive \\[@keirns2009\\]. Understanding treatment preference could inform shared decision-making and help to overcome barriers to effective, person-centered healthcare and support \\[@maddensatisfaction2008\\]. However, about how opioid-dependent patients’ preferences and previous experiences influence treatment decisions. Preferences, perceptions and acceptability of medication formulations vary widely based on each participant’s individual experiences, goals, and values \\[@neale2018; @nealequalitative2023; @nealedepot2019\\]. Previous studies exploring preferences for methadone and buprenorphine have beenStudies have compared patients’ views of methadone with buprenorphine \\[@hillcomparison2015\\]. However, findings have been inconsistent and variable \\[@whitepatients2007\\]. Previous studies into treatment preferences carried out in the United Kingdom \\[@neale2018; @tompkinsopioid2019\\], France \\[@rolland2021\\], North America \\[@saunders2020; @muthulingam2023; @kaplowitztreatment2022\\], Iran \\[@amini-rarani2023\\] and Australia \\[@larance2020\\] suggest that preferences for OAT is influenced by a range of physical, psychological and social factors. Additional studies have explored preferences generally, however, understanding of factors that influence and contribute to stated preference are limited. Limitations of previous studies include limited geographic scope with samples from single clinics (e.g.\\[@bailey2013\\]) or cities (e.g.\\[@luty2004\\]), and relatively small samples and lack of power to investigate factors associated with OAT preferences (e.g. \\[@ridge2009\\]).\n",
    "\n",
    "In Australia, there are several formulations of buprenorphine currently available, including a monobuprenorphine formulation (Subutex) and buprenorphine– naloxone formulations in a tablet or film and administered orally or sublingually (Suboxone), and, more recently, long-acting injectable formulations that are administered once-weekly or once-monthly, depending on the product (Buivdal and Sublocade). Most people received methadone (58%), the median age was 44 years. ODT medicines were mostly prescribed by a private health practitioner, dosing was mainly dispensed in pharmacies, and the primary drug of concern for the majority was heroin. In 2021, approximately 47,000 people were receiving OAT (median age 44; over two-thirds male), with most (58%) receiving methadone. The median age was 44 years and two-thirds were male. There are variations in OAT provision between jurisdictions due to decentralized funding of health services and the varied historical contexts across the country \\[@hall2023\\]. In some jurisdictions, OAT is dispensed exclusively at community pharmacies, while others have a mix of community pharmacy and public clinics. Community pharmacies offer longer opening hours and more accessible locations than public clinics, yet the out-of-pocket dispensing fees at pharmacy can make OAT prohibitively expensive \\[@tran2022; @zahra2022\\]. Historically, provision of OAT has been considered complex given its strict regulatory oversight and varied interpretation of guidelines among OAT prescribers. Despite providers differing in their interpretation of guidelines, OAT provision in Australia has been criticised for its rigidity in not adapting to the needs of people engaged in treatment \\[@crawford2013\\]. Many aspects of OAT provision also lack flexibility, and are often not person-centered, with limited access to unsupervised dosing and restrictive dosing times, which cumulatively decrease treatment adhearance \\[@hall2023\\]. It is important to understand preferences for the available medications to inform person-centered OAT provision and enhance treatment outcomes.\n",
    "\n",
    "Accessibility and diversity of OAT need to be enhanced to ensure that all people can receive their preferred OAT. Improved understanding of preference and factors associated with a preference for OAT preference is needed to inform policy and service provision. information on preference for different OAT options has shown to enhance patient acceptability, leading to increased OAT treatment uptake, adherence, and retention to improve clinical utility and facilitate planning, prioritization and investment in national strategies and guidelines. Extensive literature on patient participation in medication decision-making emphasizes that incorporating patient treatment preference leads to higher rates of retention and the desired outcomes \\[@friedrichs2016; @joosten2008\\]. Providers incorporating client preferences into treatment is linked to increased satisfaction, with individual choice, with alignment with preferred therapy leading to improved outcomes \\[@fallah2015; @joosten2008\\]. To better understand treatment preferences and develop an evidence-base to inform policy and treatment service design and delivery, we examined OAT preferences and associated factors among a national sample of people who regularly use opioids in Australia.\n",
    "\n",
    "## Data & Methods\n",
    "\n",
    "### Study design and participants\n",
    "\n",
    "In this cross-sectional study, participants were enrolled from 59 sites including drug and alcohol treatment clinics (n=28), needle and syringe programmes (n=13), pharmacies and organisations advocating for (n=6) and providing support and services to people who use drugs (n=7), There was national representation of sites across all states and territories in Australia (except Tasmania), including Australian Capital Territory (n=3), New South Wales (n=37), the Northern Territory (n=1), Queensland (n=9), South Australia (n=6), Victoria (n=2), and Western Australia (n=1). Study enrolment took place between October 2020 and April 2021, and continued throughout periods of COVID-19-related restrictions. To be eligible for this study, participants had to be aged 18 years or older, provide voluntary and informed consent, use opioids regularly. In this study, regular opioid use was defined as use of any opioid (including heroin, methadone, burpenorphine use and other opioids or the extramedical use of pharmaceutical opioids) on at least 21 of the past 28 days. The content within this article is presented following the ‘Strengthening the reporting of observational studies in epidemiology’ (STROBE) guidelines \\[@von2007; @Vandenbroucke2007\\]. A completed checklist of the STROBE requirements is available in the @sec-supp-material.\n",
    "\n",
    "### Procedures\n",
    "\n",
    "Participants were recruited from a range of settings (including drug and alcohol treatment services, needle and syringe programmes, organisations providing support and services for people who use drugs, community-based and -led advocacy organisations, and pharmacies), via snowballing (where eligible participants promote the study via their personal networks), and word-of-mouth. The study was advertised at services using posters and fliers, but service staff were not directly involved in recruitment. Participants who were interested in the study contacted the study team directly and were screened for eligibility over the telephone.\n",
    "\n",
    "Interviewers contacted the person over the phone or video conference (Microsoft Teams or Zoom) to obtain consent and conduct the interview. Interviews were semi-structured were conducted by trained interviewers. Participants completed an interviewer-administered questionnaire focused on patient preferences for OAT that included information on participant demographics, drug use characteristics, and drug treatment. The interviews took approximately 30-45 minutes to complete, and participants were reimbursed AUD\\$40 for their time and out-of-pocket expenses.\n",
    "\n",
    "### Outcomes\n",
    "\n",
    "The primary outcome was a preference for opioid agonist therapy with methadone, which was assessed by asking the question “*Of all the following types of medications used for opioid agonist therapy, if you could choose today, which one would you prefer?*” Options included methadone, monobuprenorphine (Subutex), buprenorphine-naloxone (Suboxone) taken orally as a film or tablet, long acting injectable buprenorphine (Buvidal or Sublocade), any treatment (i.e. no preference for any medication), and no treatment.\n",
    "\n",
    "Demographic, behavioural, and clinically significant factors hypothesised to be associated with preference to receive OAT with methadone were determined a priori, comprising the following: 1) age at survey (18 - 35; 36 – 45; \\> 45 years old) ), 2) gender (female; male; transgender), 3) education (\\< year 10; \\> year 10), 4) employment (paid; other), 5) homelessness (no; yes), 6) chronic pain (no; yes), 7) incarceration history (never, \\>6 months ago, \\6 months ago), 8) Drugs used and injected in the last 28 days (heroin, non-prescribed methadone, non-prescribed buprenorphine, other pharmaceutical opioids, methamphetamine, cocaine and benzodiazepines), 9) Frequency of injection drug use (\\>1 year ago, within 1–12 months ago, within the last month less than daily, and daily or more), 10) OAT (history and current), with methadone (history and current) and buprenorphine (history and current). Among the sub-group of participants currently receiving OAT, factors hypothesized to be associated with a preference for OAT with methadone included 11) current OAT medication (methadone; buprenorphine; buprenorphine-naloxone; long-acting injectable buprenorphine; none), 12) Drugs used while on OAT (no, heroin, non-prescribed methadone, non-prescribed buprenorphine, other pharmaceutical opioids, methamphetamine, cocaine and benzodiazepines); 13) Pay out of pocket for oat treatment (no; yes); 14) Amount paid out of pocket for OAT (xx; xx), 15) Site last prescribed OAT medication was collected (pharmacy; public clinic; private clinic; at home; other), 16) Frequency of OAT dose collection (daily or several times per week; weekly or less frequently), 17) Distance traveled to OAT collection site, 18) Time traveled to OAT collection site (less than 30 minutes; more than 30 minutes).\n",
    "\n",
    "### Statistical analysis\n",
    "\n",
    "The proportion of people who reported preference for methadone and factors associated with this preference was assessed. Quantitative parameters are presented as the median and interquartile range \\[IQR\\]. Categorical parameters are presented as the number and percentage (n; %). The association between the response to each variable and the binarized category of preference for methadone was explored using logistic regression modeling through unadjusted bivariate analysis, providing an odds ratio and the 95 % confidence interval (OR \\[95% CI\\]), and comparisons adjusted for age category and gender, providing an adjusted OR (aOR) and the 95 % CI. A sample of those who would choose treatment and who had a preference for methadone or any buprenorphine forumation was selected for analysis (n=352) . Multivariable logistic regression was used assess factors associated with preferred medication for OAT. Unadjusted and adjusted odds ratios were derived using logistic regression and 95% confidence intervals calculated for all variables. For the final model, all the explanatory variables significantly associated with the outcome in the bivariate models were included in the multivariable model, whilst also adjusting for age and gender. The final model was assessed through examining which contributed significantly to model fit through backwards selection using decreasing values of Akaike Information Criterion. The variance inflation factor was used to assess collinearity in the final model \\[@obrien2007\\]. Individuals with missing values were not integrated in the models. A subset of the sample comprising of participants currently receiving OAT with methadone and buprenorphine (including sublingual-monobuprenorphine, buprenorphine-naloxone and long-acting injectable buprenorphine) was selected for analysis. There was no formal sample size calculation, however, based of similar previous surveys (e.g. \\[@larance2020; @rolland2021\\]) we aimed to recruit 300 - 400 people.\n",
    "\n",
    "The analytical approach received input from and was reviewed by people who use opioids with lived-experience of injecting drug use and opioid agonist therapy with various formulations of methadone and buprenorphine. Advice and perspectives were provided on the inclusion of explanatory variables and the clinical and practical significance of identified factors.\n",
    "\n",
    "The analysis was undertaken in using `R` version 4.2.2 using the following packages: gtsummary v. 1.7.2 \\[@gtsummary\\], finalfit v. 1.0.6 \\[@finalfit\\], quarto v. 1.3 \\[@quarto\\] and rmarkdown v. 2.25 \\[@rmarkdown\\]. The code for this analysis is available on request from the corresponding author. The data supporting the findings of this study are available within the article and its Supporting information. The analysis was not pre-registered and the results should be considered exploratory.\n",
    "\n",
    "### Study oversight\n",
    "\n",
    "All participants provided written informed consent before study procedures. The study protocol were approved by the Human Research Ethics Committees at St Vincent’s Hospital, Sydney (HREC Ref: HREC/17/SVH/113) and the Aboriginal Health and Medical Research Council (HREC Ref: 1279/17). This study was conducted according to the Declaration of Helsinki and International Conference on Harmonization Good Clinical Practice (ICH/GCP) guidelines.\n",
    "\n",
    "### Role of the Funding source\n",
    "\n",
    "The study was funded by a research grant from X. The funders had no role in the study design, data collection, analysis, interpretation of the results, writing or the decision to submit the study for publication. JG, AC, LD, and MJS had access to the raw data. The National Drug and Alcohol Research Centre and the Kirby Institute, UNSW Sydney collaborated to design the study, monitor study conduct, and perform the statistical analysis. X, X and X were responsible for the decision to submit the study for publication.\n",
    "\n",
    "## Results"
   ],
   "id": "3df40d6c-ec6b-4fd4-8e07-d51dea3ccea4"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "knitr::opts_chunk$set(echo=FALSE, include = FALSE, fig.align = \"center\")"
   ],
   "id": "56b1fa68-2661-48bf-9832-d730b84d6687"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "# Load the packages required for the analysis. If packages haven't been installed yet, use install.packages() followed by the library() function.\n",
    "# \n",
    "# Another way to load packages is through the pacman package using the p_load() function.\n",
    "\n",
    "pacman::p_load(\n",
    "   pacman, \n",
    "   ggplot2,    # plotting and graphing results\n",
    "   rlang,      # read in excel files\n",
    "   forcats,    # read in excel files\n",
    "   broom,      # tidy code\n",
    "   readxl,     # read in excel files\n",
    "   pacman,     # loading and reading in packages\n",
    "   rio,        # importing data  \n",
    "   here,       # relative file pathways  \n",
    "   janitor,    # data cleaning and tables\n",
    "   lubridate,  # working with dates\n",
    "   matchmaker, # dictionary-based cleaning\n",
    "   epikit,     # age_categories() function\n",
    "   tidyverse,  # data management and visualization\n",
    "   gtsummary,  # logistic regression and plotting results\n",
    "   gt,         # for gtsummary \n",
    "   flextable,  # table creation and manipulating\n",
    "   car,        # data management and visualization\n",
    "   readstata13,# read in Stata files\n",
    "   finalfit,   # logistic regression and plotting results\n",
    "   survminer,  # forest plots\n",
    "   easystats, \n",
    "   BiocManager, \n",
    "   survival, \n",
    "   forestplot, \n",
    "   rticles,     # templates for scientific journal articles in RMarkdown\n",
    "   jtools, \n",
    "   corrplot, \n",
    "   # bstfun, \n",
    "   # ggforestplot, \n",
    "   codebookr,\n",
    "   codebook,\n",
    "   sjlabelled, \n",
    "   likert, \n",
    "   kableExtra, \n",
    "   haven,\n",
    "   here,\n",
    "   flexdashboard, # dashboard versions of R Markdown reports\n",
    "   plotly, # interactive plots\n",
    "   shiny, \n",
    "   webshot, \n",
    "   webshot2, \n",
    "   grateful, \n",
    "   spelling\n",
    "   )\n",
    "\n",
    "# install.packages(\"webshot\")\n",
    "# webshot::install_phantomjs(force = TRUE)"
   ],
   "id": "c43f9617-418e-4844-b22f-6f51560f28d0"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "  load(here::here(\"data_processed\", \"prefer_tables_working.rda\"))"
   ],
   "id": "d0ee73ef-fffe-44de-a5eb-4504805100e1"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "load(\n",
    "  here::here(\"data_processed\", \"prefer_tables_working.rda\"))"
   ],
   "id": "3b7386c7-71eb-4f72-8272-4481c9273f5b"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "load(\n",
    "  here::here(\"data_processed\", \"prefer_logistic_working.rda\"))"
   ],
   "id": "b5cbea22-2af0-4fe8-9631-0841793e8789"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "load(\n",
    "  here::here(\"data_processed\", \"prefer_subset_working.rda\"))"
   ],
   "id": "5de25cb7-d2a8-4cd3-b64b-a4ae7535e704"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "load(\n",
    "  here::here(\"data_processed\", \"prefer_working.rda\"))"
   ],
   "id": "dc5d3372-4c84-4135-9179-d208bb6c9737"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "p <- p %>%\n",
    "mutate(prefer.factor = fct_relevel(prefer.factor,\"Methadone\", \"Buprenorphine\"))"
   ],
   "id": "fe31ffed-e05b-4fda-9fcb-8b4968b4369f"
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Participant Characteristics\n",
    "\n",
    "Overall, 400 participants were enrolled (@fig-profile). The median age was 45 years, 41% (n=162) were female, 48% (n=193) incarcerated in the last six months and 42% (n=169) were currently living with chronic pain (Table 1).\n",
    "\n",
    "At enrollment, 78% (n=310) had injected drugs in the month prior, with 45% (n=141 of 310) having injected drugs \\>daily. Most participants were treatment experienced (n = 344; 87%), with 91% (n=X) with most having received methadone (n = 319; 91%) compared to buprenorphine (n = 344; 87%) (@tbl-s1). Among those who injected, commonly injected drugs in the prior month included heroin (90%), non-prescribed methadone (13%%), non-prescribed buprenorphine (10%), other non-prescribed pharmaceutical opioids (X%), methamphetamine (X%), cocaine (X%) and benzodiazepines (X%)\n",
    "\n",
    "Of the participants currently receiving OAT, 77% (n=243) were prescribed methadone, 15% (n=47) buprenorphine-naloxone (Suboxone), 6% (n=18) long-acting injectable buprenorphine (Buivdal or Sublocade) 3% (n=9), buprenorphine (Subutex) and X% (n=X) were not in treatment. Among those receving treatment, most collected their last dose at pharmacies (n=150; 47%) or public clinics (n=111; 35%), with just over half (n=177; 56%) travelling less than five kilometers (@tbl-s2)."
   ],
   "id": "86f69a6f-dd8c-439c-bcef-d90feaa5800b"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  -----------------------------------------------------------------------------\n",
       "  Characteristic                                         Enrolled\\\n",
       "                                                         (n = 400)\n",
       "  ----------------------------------------- -----------------------------------\n",
       "  [Age, Median                                         45 (39 - 53)\n",
       "  (IQR)]{style=\" font-weight: bold;    \"}   \n",
       "\n",
       "  [Age group, n                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  \\>55 years                                             72 (18%)\n",
       "\n",
       "  18 - 35 years                                          53 (13%)\n",
       "\n",
       "  36 - 45 years                                          150 (38%)\n",
       "\n",
       "  46 - 55 years                                          125 (31%)\n",
       "\n",
       "  [Formal education, n                      \n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  Completed less than 10 years school                    206 (52%)\n",
       "  education                                 \n",
       "\n",
       "  Completed more than 10 years school                    194 (49%)\n",
       "  education                                 \n",
       "\n",
       "  [Gender, n                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  Female                                                 162 (41%)\n",
       "\n",
       "  Male                                                   237 (59%)\n",
       "\n",
       "  [Currently employed, n                    \n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  Other                                                  349 (87%)\n",
       "\n",
       "  Paid                                                   51 (13%)\n",
       "\n",
       "  [Currently homeless, n                                 32 (8.0%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Ever incarcerated, n                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  No                                                     166 (42%)\n",
       "\n",
       "  Yes \\< 6 months                                        193 (48%)\n",
       "\n",
       "  Yes \\> 6 months                                        41 (10%)\n",
       "\n",
       "  [Chronic pain, n                                       169 (42%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Heroin use, n                                         281 (89%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Non-prescribed methadone use, n                       70 (78%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Non-prescribed buprenorphoine use, n                  21 (66%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Non-prescribed pharmaceutical opioid                  58 (64%)\n",
       "  use,, n                                   \n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Cocaine use, n                                        35 (52%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Methamphetamine use, n                                152 (78%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Non-prescribed benzodiazepine use, n                  193 (87%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Currently receiving OAT, n                            317 (79%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Ever received OAT with methadone, n                   348 (87%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "\n",
       "  [Ever received OAT with methadone, n                   262 (66%)\n",
       "  (%)]{style=\" font-weight: bold;    \"}     \n",
       "  -----------------------------------------------------------------------------\n",
       "\n",
       "  : Table 1. Demographic and behavioural characteristics of all\n",
       "  participants enrolled in this study (n=400)\n"
      ]
     }
    }
   ],
   "source": [
    "#| label: tbl-participants\n",
    "\n",
    "p.relevel <- p %>%\n",
    "mutate(agegroup = case_when(\n",
    "    # criteria            # new value if TRUE\n",
    "    age < 36              ~ \"18 - 35 years\",\n",
    "    age >= 36 & age < 46  ~ \"36 - 45 years\",\n",
    "    age >= 46   ~ \">45 years\"\n",
    "    )%>%\n",
    "         fct_relevel(\"18 - 35 years\",\n",
    "                      \"36 - 45 years\",\n",
    "                      \">45 years\" )%>%\n",
    "          ff_label(\"Age group\"))\n",
    "\n",
    "tbl.pts.subset <-  \n",
    "p.relevel %>% \n",
    "  tbl_summary(include = c(age, age.group, edu.factor, gender.mf, income.yn,\n",
    "                          homeless.factor, prison.yn, chronicpain.yn, heroin.month, nonmethadone.month,\n",
    "                           nonsuboxone.month, \n",
    "                          otheropi.month, \n",
    "                          cocaine.month, meth.month, benzo.month, oat.yn, methadoneever.yn, bupeever.yn \n",
    "                          ),\n",
    "              label = list(age ~ \"Age\",\n",
    "                           age.group ~ \"Age group\",\n",
    "                           edu.factor ~ \"Formal education\",\n",
    "                           gender.mf ~ \"Gender\",\n",
    "                           prison.yn ~ \"Ever incarcerated\", \n",
    "                           homeless.factor ~ \"Currently homeless\",\n",
    "                           income.yn ~ \"Currently employed\",\n",
    "                           chronicpain.yn ~ \"Chronic pain\",\n",
    "                           heroin.month ~ \"Heroin use\",\n",
    "                           nonmethadone.month ~ \"Non-prescribed methadone use\", \n",
    "                           nonsuboxone.month ~ \"Non-prescribed buprenorphoine use\",\n",
    "                          \n",
    "                           otheropi.month ~ \"Non-prescribed pharmaceutical opioid use,\", \n",
    "                           cocaine.month ~ \"Cocaine use\", \n",
    "                           meth.month ~ \"Methamphetamine use\", \n",
    "                           benzo.month ~ \"Non-prescribed benzodiazepine use\",\n",
    "                           oat.yn ~ \"Currently receiving OAT\", \n",
    "                           methadoneever.yn ~ \"Ever received OAT with methadone\",\n",
    "                           bupeever.yn ~ \"Ever received OAT with methadone\"\n",
    "                          ),missing = \"no\",\n",
    "              statistic = all_continuous() ~ (\"{median} ({p25} - {p75})\")) %>%\n",
    "  add_stat_label()%>%\n",
    "  modify_footnote(update = everything() ~ NA, abbreviation = FALSE) %>%\n",
    "  modify_header(\n",
    "    stat_0 = \"**Enrolled** \\n **(n = {N})**\",\n",
    "    )%>%\n",
    " bold_labels()\n",
    "\n",
    "\n",
    "tbl.pts.subset.kable <- tbl.pts.subset %>% \n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\",\n",
    "    caption=\"Table 1. Demographic and behavioural characteristics of all participants enrolled in this study (n=400)\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )\n",
    "\n",
    "tbl.pts.subset.kable"
   ],
   "id": "611c86e2-844b-4964-9746-79295498925c"
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Preferences for OAT\n",
    "\n",
    "Among all participants (n=400), 91% (n=366) would prefer to receive OAT, with X% (n=352) preferring either methadone or any formulation of buprenorphine and 4% (n=14) choosing treatment, but having no preferred medication. Methadone was preferred by 54% (n=216) and buprenorphine by 34% (n=136).Among those who preferred buprenorphine, sublingual buprenorphine-naloxone was preferred by 50% (n=68) and long-acting injectable buprenorphine by 50% (n=68). A summary of sociodemographic characteristics stratified by preference is presented in @tbl-s1. Among participants currently receiving OAT (n=313), 95% (n=296) preferred either oral methadone or any formulation of buprenorphine, 2% (n=5) would choose treatment, but had no preferred medications and 4% (n=12) would prefer not to receive treatment. Methadone was preferred by 60% (n=185), oral and sublingual by 18% (n=56) and long-acting injectable buprenorphine by 18% (n=55). A summary of sociodemographic characteristics of people currently receiving OAT stratified by preference is presented in @tbl-s2.\n",
    "\n",
    "![Study profile](attachment:figures/study_profile01.png){#fig-profile }"
   ],
   "attachments": {
    "figures/study_profile01.png": {
     "image/png": "iVBORw0KGgoAAAANSUhEUgAABE8AAAICCAYAAAA+tOOfAAAAAXNSR0IArs4c6QAAAARnQU1BAACx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\nAAAAAIACFE8AAAAAAACClPr/Ada8JAgdnFDNAAAAAElFTkSuQmCC\n"
    }
   },
   "id": "38dc0d3b-e00c-46dd-8ad0-20d1c5191c50"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stderr",
     "text": [
      "48 observations missing `prefer.factor` have been removed. To include these observations, use `forcats::fct_na_value_to_level()` on `prefer.factor` column before passing to `tbl_summary()`."
     ]
    },
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  -----------------------------------------------------------------------------------------------\n",
       "  Characteristic                                Enrolled\\        Methadone\\      Buprenorphine\\\n",
       "                                                (n = 352)         (n = 216)         (n = 136)\n",
       "  ----------------------------------------- ----------------- ----------------- -----------------\n",
       "  [Age, Median                                45 (40 - 52)      46 (40 - 53)      44 (39 - 50)\n",
       "  (IQR)]{style=\" font-weight: bold;    \"}                                       \n",
       "\n",
       "  [Age group, n                                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  18 - 35 years                                    43             22 (51%)          21 (49%)\n",
       "\n",
       "  36 - 45 years                                    137            82 (60%)          55 (40%)\n",
       "\n",
       "  \\>45 years                                       172            112 (65%)         60 (35%)\n",
       "\n",
       "  [Gender, n                                                                    \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  Female                                           142            87 (61%)          55 (39%)\n",
       "\n",
       "  Male                                             209            128 (61%)         81 (39%)\n",
       "\n",
       "  [Level of education, n                                                        \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  Completed less than 10 years school              188            118 (63%)         70 (37%)\n",
       "  education                                                                     \n",
       "\n",
       "  Completed more than 10 years school              164            98 (60%)          66 (40%)\n",
       "  education                                                                     \n",
       "\n",
       "  [Income, n                                                                    \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  Other                                            309            188 (61%)         121 (39%)\n",
       "\n",
       "  Paid                                             43             28 (65%)          15 (35%)\n",
       "\n",
       "  [Currently in stale housing, n                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               20             15 (75%)           5 (25%)\n",
       "\n",
       "  Yes                                              332            201 (61%)         131 (39%)\n",
       "\n",
       "  [Incarceration, n                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               145            87 (60%)          58 (40%)\n",
       "\n",
       "  Yes \\> 6 months                                  35             21 (60%)          14 (40%)\n",
       "\n",
       "  Yes \\< 6 months                                  172            108 (63%)         64 (37%)\n",
       "\n",
       "  [Chronic pain, n                                                              \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               206            123 (60%)         83 (40%)\n",
       "\n",
       "  Yes                                              146            93 (64%)          53 (36%)\n",
       "\n",
       "  [Heroin use, n                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               110            57 (52%)          53 (48%)\n",
       "\n",
       "  Yes                                              242            159 (66%)         83 (34%)\n",
       "\n",
       "  [Non-prescribed methadone use, n                                              \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               296            175 (59%)         121 (41%)\n",
       "\n",
       "  Yes                                              56             41 (73%)          15 (27%)\n",
       "\n",
       "  [Non-prescribed buprenorphine use, n                                          \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               333            209 (63%)         124 (37%)\n",
       "\n",
       "  Yes                                              19              7 (37%)          12 (63%)\n",
       "\n",
       "  [Cocaine use, n                                                               \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               323            198 (61%)         125 (39%)\n",
       "\n",
       "  Yes                                              29             18 (62%)          11 (38%)\n",
       "\n",
       "  [Methamphetamine use, n                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               198            125 (63%)         73 (37%)\n",
       "\n",
       "  Yes                                              154            91 (59%)          63 (41%)\n",
       "\n",
       "  [Recent benzodiazepine use, n                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               179            108 (60%)         71 (40%)\n",
       "\n",
       "  Yes                                              173            108 (62%)         65 (38%)\n",
       "\n",
       "  [Non-prescribed pharmaceutical opioid                                         \n",
       "  use, n                                                                        \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               295            174 (59%)         121 (41%)\n",
       "\n",
       "  Yes                                              57             42 (74%)          15 (26%)\n",
       "\n",
       "  [Currently receiving OAT, n                                                   \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               52             31 (60%)          21 (40%)\n",
       "\n",
       "  Yes                                              300            185 (62%)         115 (38%)\n",
       "\n",
       "  [Ever received OAT with methadone, n                                          \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               33              8 (24%)          25 (76%)\n",
       "\n",
       "  Yes                                              319            208 (65%)         111 (35%)\n",
       "\n",
       "  [Ever received OAT with buprenorphine, n                                      \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                         \n",
       "\n",
       "  No                                               117            97 (83%)          20 (17%)\n",
       "\n",
       "  Yes                                              235            119 (51%)         116 (49%)\n",
       "  -----------------------------------------------------------------------------------------------\n",
       "\n",
       "  : Demographic and behavioural characteristics of all participants\n",
       "  stratified by preference for methadone or buprenorphine (n=352)\n"
      ]
     }
    }
   ],
   "source": [
    "p <- p %>%\n",
    "  mutate(prefer.factor = fct_relevel(prefer.factor, \"Methadone\", \"Buprenorphine\"))\n",
    "\n",
    "stratified.model <-  \n",
    "  p %>% \n",
    "  tbl_summary(by = prefer.factor, \n",
    "              include = c(age, agegroup, \n",
    "                          gender.mf, edu.factor,\n",
    "                          income.factor.yn, homeless.factor.yn,         \n",
    "                          prison.factor, chronicpain.factor.yn,\n",
    "                          heroin.month.factor,  \n",
    "                          nonmethadone.month.factor,\n",
    "                          nonbupe.month.factor, \n",
    "                          cocaine.month.factor, meth.month.factor, \n",
    "                          benzo.month.factor,otheropi.month.factor,\n",
    "                          oat.yn.f, methadoneever.yn, bupeever.factor\n",
    "              ),\n",
    "              label = c(age ~ \"Age\",\n",
    "                        agegroup ~ \"Age group\",\n",
    "                        gender.mf ~ \"Gender\",\n",
    "                        homeless.factor.yn ~ \"Currently in stale housing\",\n",
    "                        otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n",
    "                        methadoneever.yn ~ \"Ever received OAT with methadone\",\n",
    "                           bupeever.factor ~ \"Ever received OAT with buprenorphine\"\n",
    "                          ),\n",
    "              type = all_categorical()~\"categorical\",\n",
    "              missing = \"no\",\n",
    "              percent = \"row\",\n",
    "              statistic = all_continuous() ~ (\"{median} ({p25} - {p75})\")) %>%\n",
    "  add_stat_label()%>%\n",
    "  add_overall(statistic = list(all_continuous()  ~ \"{median} ({p25} - {p75})\",\n",
    "                               all_categorical() ~ \"{n}\")) %>% \n",
    "  modify_footnote(update = everything() ~ NA, abbreviation = FALSE) %>%\n",
    "  modify_header(\n",
    "    stat_0 = '**Enrolled** \\n **(n = {n})**',\n",
    "    stat_1 = '**Methadone** \\n **(n = {n})**',\n",
    "    stat_2 = '**Buprenorphine** \\n **(n = {n})**'\n",
    "  ) %>% \n",
    "  bold_labels()"
   ],
   "id": "d3b0bb29-45f7-41cb-a36b-f8648606c71b"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "p <- p %>%\n",
    "mutate(prefer.factor = fct_relevel(prefer.factor, \"Buprenorphine\", \"Methadone\"))"
   ],
   "id": "b277e64d-446c-4ae2-87c2-f063a947d459"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  Variable                                                                          cOR (95% CI)      p-value\n",
       "  ----------------------------------------------------------------------------- -------------------- ---------\n",
       "  [Age]{style=\" font-weight: bold;    \"}                                         1.02 (1.0 - 1.04)     0.130\n",
       "  [Gender]{style=\" font-weight: bold;    \"}                                                          \n",
       "  Female                                                                                ---          \n",
       "  Male                                                                           1.00 (0.64 - 1.55)    0.996\n",
       "  [Level of education]{style=\" font-weight: bold;    \"}                                              \n",
       "  Completed less than 10 years school education                                         ---          \n",
       "  Completed more than 10 years school education                                  0.88 (0.57 - 1.35)    0.563\n",
       "  [Income]{style=\" font-weight: bold;    \"}                                                          \n",
       "  Other                                                                                 ---          \n",
       "  Paid                                                                           1.20 (0.62 - 2.39)    0.590\n",
       "  [Currently in stale housing]{style=\" font-weight: bold;    \"}                                      \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            0.51 (0.16 - 1.36)    0.205\n",
       "  [Incarceration]{style=\" font-weight: bold;    \"}                                                   \n",
       "  No                                                                                    ---          \n",
       "  Yes \\> 6 months                                                                1.00 (0.47 - 2.16)   \\>0.999\n",
       "  Yes \\< 6 months                                                                1.13 (0.71 - 1.77)    0.611\n",
       "  [Chronic pain]{style=\" font-weight: bold;    \"}                                                    \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            1.18 (0.77 - 1.84)    0.449\n",
       "  [Heroin use]{style=\" font-weight: bold;    \"}                                                      \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            1.78 (1.13 - 2.82)    0.014\n",
       "  [Non-prescribed methadone use]{style=\" font-weight: bold;    \"}                                    \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            1.89 (1.02 - 3.67)    0.050\n",
       "  [Non-prescribed buprenorphine use]{style=\" font-weight: bold;    \"}                                \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            0.35 (0.13 - 0.88)    0.030\n",
       "  [Non-prescribed pharmaceutical opioid use]{style=\" font-weight: bold;    \"}                        \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            1.95 (1.05 - 3.77)    0.039\n",
       "  [Cocaine use]{style=\" font-weight: bold;    \"}                                                     \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            1.03 (0.48 - 2.33)    0.935\n",
       "  [Methamphetamine use]{style=\" font-weight: bold;    \"}                                             \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            0.84 (0.55 - 1.30)    0.440\n",
       "  [Recent benzodiazepine use]{style=\" font-weight: bold;    \"}                                       \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            1.09 (0.71 - 1.68)    0.687\n",
       "  [Currently receiving OAT]{style=\" font-weight: bold;    \"}                                         \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            1.09 (0.59 - 1.98)    0.779\n",
       "  [Ever received OAT with methadone]{style=\" font-weight: bold;    \"}                                \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            5.86 (2.66 - 14.3)   \\<0.001\n",
       "  [Ever received OAT with buprenorphine]{style=\" font-weight: bold;    \"}                            \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            0.21 (0.12 - 0.36)   \\<0.001\n",
       "\n",
       "  : Results of a univariate logistic regression with crude odds ratios\n",
       "  and 95% confidence intervals\n"
      ]
     }
    }
   ],
   "source": [
    "subset_cor <-\n",
    "  p %>%\n",
    "  dplyr::select(age, gender.mf,edu.factor, income.factor.yn, homeless.factor.yn,  \n",
    "                prison.factor, chronicpain.factor.yn, heroin.month.factor, \n",
    "                nonmethadone.month.factor,\n",
    "                nonbupe.month.factor, otheropi.month.factor, \n",
    "                cocaine.month.factor, meth.month.factor, benzo.month.factor, oat.yn.f, methadoneever.yn, bupeever.factor, prefer.factor) %>%\n",
    "  tbl_uvregression(\n",
    "    method = glm,\n",
    "    y = prefer.factor, \n",
    "    label = list(age ~ \"Age\",\n",
    "                 gender.mf ~ \"Gender\",\n",
    "                 otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n",
    "                 homeless.factor.yn ~ \"Currently in stale housing\",\n",
    "                 methadoneever.yn ~ \"Ever received OAT with methadone\",\n",
    "                 bupeever.factor ~ \"Ever received OAT with buprenorphine\"),\n",
    "    method.args = list(family = binomial),\n",
    "    exponentiate = TRUE,\n",
    "    hide_n = TRUE,\n",
    "    pvalue_fun = function(x) style_pvalue(x, digits = 3)\n",
    "  ) %>%\n",
    "  modify_header(\n",
    "    label = '**Variable**',\n",
    "    estimate = '**cOR**',\n",
    "    ci = '**95% CI**',\n",
    "    p.value = '**p-value**'\n",
    "  ) %>%\n",
    "  modify_footnote(update = everything() ~ NA, abbreviation = TRUE) %>%\n",
    "  modify_table_styling(\n",
    "    column = estimate,\n",
    "    rows = !is.na(estimate),\n",
    "    cols_merge_pattern = \"{estimate} ({conf.low} - {conf.high})\"\n",
    "  ) %>%\n",
    "  modify_header(estimate ~ \"**cOR (95% CI)**\") %>%\n",
    "  modify_table_styling(label = '**Enrolled** \\n **(n = {n})**') %>%\n",
    "  modify_column_hide(c(ci)) %>% \n",
    "  bold_labels()\n",
    "\n",
    "subset_cor.kable <- subset_cor %>%\n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\",\n",
    "    caption=\"Results of a univariate logistic regression with crude odds ratios and 95% confidence intervals\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )\n",
    "\n",
    "subset_cor.kable"
   ],
   "id": "b945d49c-c010-4a28-a461-5d0626cb8c6f"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  Variable                                                                          aOR (95% CI)      p-value\n",
       "  ----------------------------------------------------------------------------- -------------------- ---------\n",
       "  [Age]{style=\" font-weight: bold;    \"}                                         1.00 (0.98 - 1.03)    0.910\n",
       "  [Gender]{style=\" font-weight: bold;    \"}                                                          \n",
       "  Female                                                                                ---          \n",
       "  Male                                                                           1.25 (0.76 - 2.06)    0.372\n",
       "  [Heroin use]{style=\" font-weight: bold;    \"}                                                      \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            1.78 (1.06 - 3.00)    0.030\n",
       "  [Non-prescribed methadone use]{style=\" font-weight: bold;    \"}                                    \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            1.86 (0.92 - 3.93)    0.092\n",
       "  [Non-prescribed buprenorphine use]{style=\" font-weight: bold;    \"}                                \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            0.28 (0.09 - 0.84)    0.025\n",
       "  [Non-prescribed pharmaceutical opioid use]{style=\" font-weight: bold;    \"}                        \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            2.23 (1.07 - 4.95)    0.039\n",
       "  [Ever received OAT with methadone]{style=\" font-weight: bold;    \"}                                \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            6.54 (2.66 - 17.9)   \\<0.001\n",
       "  [Ever received OAT with buprenorphine]{style=\" font-weight: bold;    \"}                            \n",
       "  No                                                                                    ---          \n",
       "  Yes                                                                            0.19 (0.10 - 0.35)   \\<0.001\n",
       "\n",
       "  : Results of a multivariable logistic regression with adjusted odds\n",
       "  ratios and 95% confidence intervals\n"
      ]
     }
    }
   ],
   "source": [
    "subset_mod_final <- glm(prefer.factor ~ age + gender.mf +\n",
    "heroin.month.factor + nonmethadone.month.factor + nonbupe.month.factor +\n",
    "otheropi.month.factor + methadoneever.yn + bupeever.factor, data =\n",
    "p, family = binomial)\n",
    "\n",
    "\n",
    "model.final <- tbl_regression(subset_mod_final, exponentiate = TRUE,  \n",
    "                              label = \n",
    "                                list(age ~ \"Age\",\n",
    "                                    gender.mf ~ \"Gender\",\n",
    "                                    otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n",
    "                                    \n",
    "                                    methadoneever.yn ~ \"Ever received OAT with methadone\",\n",
    "                  bupeever.factor ~ \"Ever received OAT with buprenorphine\"\n",
    "                  ),\n",
    "pvalue_fun = function(x) style_pvalue(x, digits = 3))%>%\n",
    "# pvalue_fun = ~style_sigfig(., digits = 4)                              )%>%\n",
    "  modify_header(\n",
    "    label = '**Variable**',\n",
    "    estimate = '**aOR**',\n",
    "    ci = '**95% CI**',\n",
    "    p.value = '**p-value**'\n",
    "  ) %>%\n",
    "  modify_footnote(update = everything() ~ NA, abbreviation = TRUE) %>%\n",
    "  modify_table_styling(\n",
    "    column = estimate,\n",
    "    rows = !is.na(estimate),\n",
    "    cols_merge_pattern = \"{estimate} ({conf.low} - {conf.high})\"\n",
    "  ) %>%\n",
    "  modify_header(estimate ~ \"**aOR (95% CI)**\") %>%\n",
    "  modify_column_hide(c(ci)) %>% \n",
    "  bold_labels() %>%\n",
    "  modify_footnote(everything() ~ NA, abbreviation = TRUE)\n",
    "\n",
    "kable.final <- model.final %>% \n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\",\n",
    "    caption=\"Results of a multivariable logistic regression with adjusted odds ratios and 95% confidence intervals\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )\n",
    "\n",
    "kable.final"
   ],
   "id": "6f45bd95-1fa8-44bd-9b75-cdf3299de97d"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "|        |        |        |        | ::: {s |        | ::: {s |        |\n",
       "|        |        |        |        | tyle=\" |        | tyle=\" |        |\n",
       "|        |        |        |        | border |        | border |        |\n",
       "|        |        |        |        | -botto |        | -botto |        |\n",
       "|        |        |        |        | m: 1px |        | m: 1px |        |\n",
       "|        |        |        |        |  solid |        |  solid |        |\n",
       "|        |        |        |        |  #ddd; |        |  #ddd; |        |\n",
       "|        |        |        |        |  paddi |        |  paddi |        |\n",
       "|        |        |        |        | ng-bot |        | ng-bot |        |\n",
       "|        |        |        |        | tom: 5 |        | tom: 5 |        |\n",
       "|        |        |        |        | px; \"} |        | px; \"} |        |\n",
       "|        |        |        |        | Unad   |        | Ad     |        |\n",
       "|        |        |        |        | justed |        | justed |        |\n",
       "|        |        |        |        | model  |        | model  |        |\n",
       "|        |        |        |        | :::    |        | :::    |        |\n",
       "+:=======+:======:+:======:+:======:+:======:+:======:+:======:+:======:+\n",
       "| Va     | Enr    | Meth   | Bu     | cOR    | p      | aOR    | p      |\n",
       "| riable | olled\\ | adone\\ | prenor | (95%   | -value | (95%   | -value |\n",
       "|        | (n =   | (n =   | phine\\ | CI)    |        | CI)    |        |\n",
       "|        | 352)   | 216)   | (n =   |        |        |        |        |\n",
       "|        |        |        | 136)   |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Age,  | 45     | 46     | 44     | 1.02   | 0.130  | 1.00   | 0.910  |\n",
       "| Median | (40 -  | (40 -  | (39 -  | (1.0 - |        | (      |        |\n",
       "| (IQ    | 52)    | 53)    | 50)    | 1.04)  |        | 0.98 - |        |\n",
       "| R)]{st |        |        |        |        |        | 1.03)  |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Age   |        |        |        |        |        |        |        |\n",
       "| group, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| 18 -   | 43     | 22     | 21     |        |        |        |        |\n",
       "| 35     |        | (51%)  | (49%)  |        |        |        |        |\n",
       "| years  |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| 36 -   | 137    | 82     | 55     |        |        |        |        |\n",
       "| 45     |        | (60%)  | (40%)  |        |        |        |        |\n",
       "| years  |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| \\>45   | 172    | 112    | 60     |        |        |        |        |\n",
       "| years  |        | (65%)  | (35%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [G     |        |        |        |        |        |        |        |\n",
       "| ender, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Female | 142    | 87     | 55     | ---    |        | ---    |        |\n",
       "|        |        | (61%)  | (39%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Male   | 209    | 128    | 81     | 1.00   | 0.996  | 1.25   | 0.372  |\n",
       "|        |        | (61%)  | (39%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 0.64 - |        | 0.76 - |        |\n",
       "|        |        |        |        | 1.55)  |        | 2.06)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Level |        |        |        |        |        |        |        |\n",
       "| of     |        |        |        |        |        |        |        |\n",
       "| educ   |        |        |        |        |        |        |        |\n",
       "| ation, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Com    | 188    | 118    | 70     | ---    |        |        |        |\n",
       "| pleted |        | (63%)  | (37%)  |        |        |        |        |\n",
       "| less   |        |        |        |        |        |        |        |\n",
       "| than   |        |        |        |        |        |        |        |\n",
       "| 10     |        |        |        |        |        |        |        |\n",
       "| years  |        |        |        |        |        |        |        |\n",
       "| school |        |        |        |        |        |        |        |\n",
       "| edu    |        |        |        |        |        |        |        |\n",
       "| cation |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Com    | 164    | 98     | 66     | 0.88   | 0.563  |        |        |\n",
       "| pleted |        | (60%)  | (40%)  | (      |        |        |        |\n",
       "| more   |        |        |        | 0.57 - |        |        |        |\n",
       "| than   |        |        |        | 1.35)  |        |        |        |\n",
       "| 10     |        |        |        |        |        |        |        |\n",
       "| years  |        |        |        |        |        |        |        |\n",
       "| school |        |        |        |        |        |        |        |\n",
       "| edu    |        |        |        |        |        |        |        |\n",
       "| cation |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [I     |        |        |        |        |        |        |        |\n",
       "| ncome, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Other  | 309    | 188    | 121    | ---    |        |        |        |\n",
       "|        |        | (61%)  | (39%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Paid   | 43     | 28     | 15     | 1.20   | 0.590  |        |        |\n",
       "|        |        | (65%)  | (35%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.62 - |        |        |        |\n",
       "|        |        |        |        | 2.39)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Cur   |        |        |        |        |        |        |        |\n",
       "| rently |        |        |        |        |        |        |        |\n",
       "| in     |        |        |        |        |        |        |        |\n",
       "| stale  |        |        |        |        |        |        |        |\n",
       "| ho     |        |        |        |        |        |        |        |\n",
       "| using, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 20     | 15     | 5      | ---    |        |        |        |\n",
       "|        |        | (75%)  | (25%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 332    | 201    | 131    | 0.51   | 0.205  |        |        |\n",
       "|        |        | (61%)  | (39%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.16 - |        |        |        |\n",
       "|        |        |        |        | 1.36)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [In    |        |        |        |        |        |        |        |\n",
       "| carcer |        |        |        |        |        |        |        |\n",
       "| ation, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 145    | 87     | 58     | ---    |        |        |        |\n",
       "|        |        | (60%)  | (40%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes \\> | 35     | 21     | 14     | 1.00   | \\      |        |        |\n",
       "| 6      |        | (60%)  | (40%)  | (      | >0.999 |        |        |\n",
       "| months |        |        |        | 0.47 - |        |        |        |\n",
       "|        |        |        |        | 2.16)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes \\< | 172    | 108    | 64     | 1.13   | 0.611  |        |        |\n",
       "| 6      |        | (63%)  | (37%)  | (      |        |        |        |\n",
       "| months |        |        |        | 0.71 - |        |        |        |\n",
       "|        |        |        |        | 1.77)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [C     |        |        |        |        |        |        |        |\n",
       "| hronic |        |        |        |        |        |        |        |\n",
       "| pain,  |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 206    | 123    | 83     | ---    |        |        |        |\n",
       "|        |        | (60%)  | (40%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 146    | 93     | 53     | 1.18   | 0.449  |        |        |\n",
       "|        |        | (64%)  | (36%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.77 - |        |        |        |\n",
       "|        |        |        |        | 1.84)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [      |        |        |        |        |        |        |        |\n",
       "| Heroin |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 110    | 57     | 53     | ---    |        | ---    |        |\n",
       "|        |        | (52%)  | (48%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 242    | 159    | 83     | 1.78   | 0.014  | 1.78   | 0.030  |\n",
       "|        |        | (66%)  | (34%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 1.13 - |        | 1.06 - |        |\n",
       "|        |        |        |        | 2.82)  |        | 3.00)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [No    |        |        |        |        |        |        |        |\n",
       "| n-pres |        |        |        |        |        |        |        |\n",
       "| cribed |        |        |        |        |        |        |        |\n",
       "| met    |        |        |        |        |        |        |        |\n",
       "| hadone |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 296    | 175    | 121    | ---    |        | ---    |        |\n",
       "|        |        | (59%)  | (41%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 56     | 41     | 15     | 1.89   | 0.050  | 1.86   | 0.092  |\n",
       "|        |        | (73%)  | (27%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 1.02 - |        | 0.92 - |        |\n",
       "|        |        |        |        | 3.67)  |        | 3.93)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [No    |        |        |        |        |        |        |        |\n",
       "| n-pres |        |        |        |        |        |        |        |\n",
       "| cribed |        |        |        |        |        |        |        |\n",
       "| b      |        |        |        |        |        |        |        |\n",
       "| upreno |        |        |        |        |        |        |        |\n",
       "| rphine |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 333    | 209    | 124    | ---    |        | ---    |        |\n",
       "|        |        | (63%)  | (37%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 19     | 7      | 12     | 0.35   | 0.030  | 0.28   | 0.025  |\n",
       "|        |        | (37%)  | (63%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 0.13 - |        | 0.09 - |        |\n",
       "|        |        |        |        | 0.88)  |        | 0.84)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [C     |        |        |        |        |        |        |        |\n",
       "| ocaine |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 323    | 198    | 125    | ---    |        |        |        |\n",
       "|        |        | (61%)  | (39%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 29     | 18     | 11     | 1.03   | 0.935  |        |        |\n",
       "|        |        | (62%)  | (38%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.48 - |        |        |        |\n",
       "|        |        |        |        | 2.33)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Met   |        |        |        |        |        |        |        |\n",
       "| hamphe |        |        |        |        |        |        |        |\n",
       "| tamine |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 198    | 125    | 73     | ---    |        |        |        |\n",
       "|        |        | (63%)  | (37%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 154    | 91     | 63     | 0.84   | 0.440  |        |        |\n",
       "|        |        | (59%)  | (41%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.55 - |        |        |        |\n",
       "|        |        |        |        | 1.30)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [      |        |        |        |        |        |        |        |\n",
       "| Recent |        |        |        |        |        |        |        |\n",
       "| be     |        |        |        |        |        |        |        |\n",
       "| nzodia |        |        |        |        |        |        |        |\n",
       "| zepine |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 179    | 108    | 71     | ---    |        |        |        |\n",
       "|        |        | (60%)  | (40%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 173    | 108    | 65     | 1.09   | 0.687  |        |        |\n",
       "|        |        | (62%)  | (38%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.71 - |        |        |        |\n",
       "|        |        |        |        | 1.68)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [No    |        |        |        |        |        |        |        |\n",
       "| n-pres |        |        |        |        |        |        |        |\n",
       "| cribed |        |        |        |        |        |        |        |\n",
       "| ph     |        |        |        |        |        |        |        |\n",
       "| armace |        |        |        |        |        |        |        |\n",
       "| utical |        |        |        |        |        |        |        |\n",
       "| opioid |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 295    | 174    | 121    | ---    |        | ---    |        |\n",
       "|        |        | (59%)  | (41%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 57     | 42     | 15     | 1.95   | 0.039  | 2.23   | 0.039  |\n",
       "|        |        | (74%)  | (26%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 1.05 - |        | 1.07 - |        |\n",
       "|        |        |        |        | 3.77)  |        | 4.95)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Cur   |        |        |        |        |        |        |        |\n",
       "| rently |        |        |        |        |        |        |        |\n",
       "| rec    |        |        |        |        |        |        |        |\n",
       "| eiving |        |        |        |        |        |        |        |\n",
       "| OAT, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 52     | 31     | 21     | ---    |        |        |        |\n",
       "|        |        | (60%)  | (40%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 300    | 185    | 115    | 1.09   | 0.779  |        |        |\n",
       "|        |        | (62%)  | (38%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.59 - |        |        |        |\n",
       "|        |        |        |        | 1.98)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Ever  |        |        |        |        |        |        |        |\n",
       "| re     |        |        |        |        |        |        |        |\n",
       "| ceived |        |        |        |        |        |        |        |\n",
       "| OAT    |        |        |        |        |        |        |        |\n",
       "| with   |        |        |        |        |        |        |        |\n",
       "| meth   |        |        |        |        |        |        |        |\n",
       "| adone, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 33     | 8      | 25     | ---    |        | ---    |        |\n",
       "|        |        | (24%)  | (76%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 319    | 208    | 111    | 5.86   | \\      | 6.54   | \\      |\n",
       "|        |        | (65%)  | (35%)  | (      | <0.001 | (      | <0.001 |\n",
       "|        |        |        |        | 2.66 - |        | 2.66 - |        |\n",
       "|        |        |        |        | 14.3)  |        | 17.9)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Ever  |        |        |        |        |        |        |        |\n",
       "| re     |        |        |        |        |        |        |        |\n",
       "| ceived |        |        |        |        |        |        |        |\n",
       "| OAT    |        |        |        |        |        |        |        |\n",
       "| with   |        |        |        |        |        |        |        |\n",
       "| bu     |        |        |        |        |        |        |        |\n",
       "| prenor |        |        |        |        |        |        |        |\n",
       "| phine, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 117    | 97     | 20     | ---    |        | ---    |        |\n",
       "|        |        | (83%)  | (17%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 235    | 119    | 116    | 0.21   | \\      | 0.19   | \\      |\n",
       "|        |        | (51%)  | (49%)  | (      | <0.001 | (      | <0.001 |\n",
       "|        |        |        |        | 0.12 - |        | 0.10 - |        |\n",
       "|        |        |        |        | 0.36)  |        | 0.35)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "\n",
       ": Final model including crude odds ratios (cOR) and adjusted odds ratios\n",
       "(aOR)\n"
      ]
     }
    }
   ],
   "source": [
    "table_merged <-\n",
    "  tbl_merge(\n",
    "    tbls = list(stratified.model, subset_cor, model.final),\n",
    "    tab_spanner = c(\"** **\", \"**Unadjusted model**\", \"**Adjusted model**\")) %>%\n",
    "  modify_header(label = \"**Variable**\") %>% # update the column header\n",
    "  modify_footnote(everything() ~ NA)\n",
    "\n",
    "table_merged.kable <- table_merged %>%\n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\", \n",
    "    caption=\"Final model including crude odds ratios (cOR) and adjusted odds ratios (aOR)\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )\n",
    "#     scroll_box(\n",
    "#   height = \"50%\",\n",
    "#   # width = \"100%\",\n",
    "#   box_css = \"border: 1px solid #ddd; padding: 5px; \",\n",
    "#   extra_css = NULL,\n",
    "#   fixed_thead = TRUE\n",
    "# )\n",
    "\n",
    "table_merged.kable"
   ],
   "id": "bf3fde06-fcbe-47f2-8733-289a7f3b5fc0"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "|        |        |        |        | ::: {s |        | ::: {s |        |\n",
       "|        |        |        |        | tyle=\" |        | tyle=\" |        |\n",
       "|        |        |        |        | border |        | border |        |\n",
       "|        |        |        |        | -botto |        | -botto |        |\n",
       "|        |        |        |        | m: 1px |        | m: 1px |        |\n",
       "|        |        |        |        |  solid |        |  solid |        |\n",
       "|        |        |        |        |  #ddd; |        |  #ddd; |        |\n",
       "|        |        |        |        |  paddi |        |  paddi |        |\n",
       "|        |        |        |        | ng-bot |        | ng-bot |        |\n",
       "|        |        |        |        | tom: 5 |        | tom: 5 |        |\n",
       "|        |        |        |        | px; \"} |        | px; \"} |        |\n",
       "|        |        |        |        | Unad   |        | Ad     |        |\n",
       "|        |        |        |        | justed |        | justed |        |\n",
       "|        |        |        |        | model  |        | model  |        |\n",
       "|        |        |        |        | :::    |        | :::    |        |\n",
       "+:=======+:======:+:======:+:======:+:======:+:======:+:======:+:======:+\n",
       "| Va     | Enr    | Meth   | Bu     | cOR    | p      | aOR    | p      |\n",
       "| riable | olled\\ | adone\\ | prenor | (95%   | -value | (95%   | -value |\n",
       "|        | (n =   | (n =   | phine\\ | CI)    |        | CI)    |        |\n",
       "|        | 352)   | 216)   | (n =   |        |        |        |        |\n",
       "|        |        |        | 136)   |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Age,  | 45     | 46     | 44     | 1.02   | 0.130  | 1.00   | 0.910  |\n",
       "| Median | (40 -  | (40 -  | (39 -  | (1.0 - |        | (      |        |\n",
       "| (IQ    | 52)    | 53)    | 50)    | 1.04)  |        | 0.98 - |        |\n",
       "| R)]{st |        |        |        |        |        | 1.03)  |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Age   |        |        |        |        |        |        |        |\n",
       "| group, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| 18 -   | 43     | 22     | 21     |        |        |        |        |\n",
       "| 35     |        | (51%)  | (49%)  |        |        |        |        |\n",
       "| years  |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| 36 -   | 137    | 82     | 55     |        |        |        |        |\n",
       "| 45     |        | (60%)  | (40%)  |        |        |        |        |\n",
       "| years  |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| \\>45   | 172    | 112    | 60     |        |        |        |        |\n",
       "| years  |        | (65%)  | (35%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [G     |        |        |        |        |        |        |        |\n",
       "| ender, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Female | 142    | 87     | 55     | ---    |        | ---    |        |\n",
       "|        |        | (61%)  | (39%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Male   | 209    | 128    | 81     | 1.00   | 0.996  | 1.25   | 0.372  |\n",
       "|        |        | (61%)  | (39%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 0.64 - |        | 0.76 - |        |\n",
       "|        |        |        |        | 1.55)  |        | 2.06)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Level |        |        |        |        |        |        |        |\n",
       "| of     |        |        |        |        |        |        |        |\n",
       "| educ   |        |        |        |        |        |        |        |\n",
       "| ation, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Com    | 188    | 118    | 70     | ---    |        |        |        |\n",
       "| pleted |        | (63%)  | (37%)  |        |        |        |        |\n",
       "| less   |        |        |        |        |        |        |        |\n",
       "| than   |        |        |        |        |        |        |        |\n",
       "| 10     |        |        |        |        |        |        |        |\n",
       "| years  |        |        |        |        |        |        |        |\n",
       "| school |        |        |        |        |        |        |        |\n",
       "| edu    |        |        |        |        |        |        |        |\n",
       "| cation |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Com    | 164    | 98     | 66     | 0.88   | 0.563  |        |        |\n",
       "| pleted |        | (60%)  | (40%)  | (      |        |        |        |\n",
       "| more   |        |        |        | 0.57 - |        |        |        |\n",
       "| than   |        |        |        | 1.35)  |        |        |        |\n",
       "| 10     |        |        |        |        |        |        |        |\n",
       "| years  |        |        |        |        |        |        |        |\n",
       "| school |        |        |        |        |        |        |        |\n",
       "| edu    |        |        |        |        |        |        |        |\n",
       "| cation |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [I     |        |        |        |        |        |        |        |\n",
       "| ncome, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Other  | 309    | 188    | 121    | ---    |        |        |        |\n",
       "|        |        | (61%)  | (39%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Paid   | 43     | 28     | 15     | 1.20   | 0.590  |        |        |\n",
       "|        |        | (65%)  | (35%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.62 - |        |        |        |\n",
       "|        |        |        |        | 2.39)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Cur   |        |        |        |        |        |        |        |\n",
       "| rently |        |        |        |        |        |        |        |\n",
       "| in     |        |        |        |        |        |        |        |\n",
       "| stale  |        |        |        |        |        |        |        |\n",
       "| ho     |        |        |        |        |        |        |        |\n",
       "| using, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 20     | 15     | 5      | ---    |        |        |        |\n",
       "|        |        | (75%)  | (25%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 332    | 201    | 131    | 0.51   | 0.205  |        |        |\n",
       "|        |        | (61%)  | (39%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.16 - |        |        |        |\n",
       "|        |        |        |        | 1.36)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [In    |        |        |        |        |        |        |        |\n",
       "| carcer |        |        |        |        |        |        |        |\n",
       "| ation, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 145    | 87     | 58     | ---    |        |        |        |\n",
       "|        |        | (60%)  | (40%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes \\> | 35     | 21     | 14     | 1.00   | \\      |        |        |\n",
       "| 6      |        | (60%)  | (40%)  | (      | >0.999 |        |        |\n",
       "| months |        |        |        | 0.47 - |        |        |        |\n",
       "|        |        |        |        | 2.16)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes \\< | 172    | 108    | 64     | 1.13   | 0.611  |        |        |\n",
       "| 6      |        | (63%)  | (37%)  | (      |        |        |        |\n",
       "| months |        |        |        | 0.71 - |        |        |        |\n",
       "|        |        |        |        | 1.77)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [C     |        |        |        |        |        |        |        |\n",
       "| hronic |        |        |        |        |        |        |        |\n",
       "| pain,  |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 206    | 123    | 83     | ---    |        |        |        |\n",
       "|        |        | (60%)  | (40%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 146    | 93     | 53     | 1.18   | 0.449  |        |        |\n",
       "|        |        | (64%)  | (36%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.77 - |        |        |        |\n",
       "|        |        |        |        | 1.84)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [      |        |        |        |        |        |        |        |\n",
       "| Heroin |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 110    | 57     | 53     | ---    |        | ---    |        |\n",
       "|        |        | (52%)  | (48%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 242    | 159    | 83     | 1.78   | 0.014  | 1.78   | 0.030  |\n",
       "|        |        | (66%)  | (34%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 1.13 - |        | 1.06 - |        |\n",
       "|        |        |        |        | 2.82)  |        | 3.00)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [No    |        |        |        |        |        |        |        |\n",
       "| n-pres |        |        |        |        |        |        |        |\n",
       "| cribed |        |        |        |        |        |        |        |\n",
       "| met    |        |        |        |        |        |        |        |\n",
       "| hadone |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 296    | 175    | 121    | ---    |        | ---    |        |\n",
       "|        |        | (59%)  | (41%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 56     | 41     | 15     | 1.89   | 0.050  | 1.86   | 0.092  |\n",
       "|        |        | (73%)  | (27%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 1.02 - |        | 0.92 - |        |\n",
       "|        |        |        |        | 3.67)  |        | 3.93)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [No    |        |        |        |        |        |        |        |\n",
       "| n-pres |        |        |        |        |        |        |        |\n",
       "| cribed |        |        |        |        |        |        |        |\n",
       "| b      |        |        |        |        |        |        |        |\n",
       "| upreno |        |        |        |        |        |        |        |\n",
       "| rphine |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 333    | 209    | 124    | ---    |        | ---    |        |\n",
       "|        |        | (63%)  | (37%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 19     | 7      | 12     | 0.35   | 0.030  | 0.28   | 0.025  |\n",
       "|        |        | (37%)  | (63%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 0.13 - |        | 0.09 - |        |\n",
       "|        |        |        |        | 0.88)  |        | 0.84)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [C     |        |        |        |        |        |        |        |\n",
       "| ocaine |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 323    | 198    | 125    | ---    |        |        |        |\n",
       "|        |        | (61%)  | (39%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 29     | 18     | 11     | 1.03   | 0.935  |        |        |\n",
       "|        |        | (62%)  | (38%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.48 - |        |        |        |\n",
       "|        |        |        |        | 2.33)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Met   |        |        |        |        |        |        |        |\n",
       "| hamphe |        |        |        |        |        |        |        |\n",
       "| tamine |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 198    | 125    | 73     | ---    |        |        |        |\n",
       "|        |        | (63%)  | (37%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 154    | 91     | 63     | 0.84   | 0.440  |        |        |\n",
       "|        |        | (59%)  | (41%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.55 - |        |        |        |\n",
       "|        |        |        |        | 1.30)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [      |        |        |        |        |        |        |        |\n",
       "| Recent |        |        |        |        |        |        |        |\n",
       "| be     |        |        |        |        |        |        |        |\n",
       "| nzodia |        |        |        |        |        |        |        |\n",
       "| zepine |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 179    | 108    | 71     | ---    |        |        |        |\n",
       "|        |        | (60%)  | (40%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 173    | 108    | 65     | 1.09   | 0.687  |        |        |\n",
       "|        |        | (62%)  | (38%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.71 - |        |        |        |\n",
       "|        |        |        |        | 1.68)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [No    |        |        |        |        |        |        |        |\n",
       "| n-pres |        |        |        |        |        |        |        |\n",
       "| cribed |        |        |        |        |        |        |        |\n",
       "| ph     |        |        |        |        |        |        |        |\n",
       "| armace |        |        |        |        |        |        |        |\n",
       "| utical |        |        |        |        |        |        |        |\n",
       "| opioid |        |        |        |        |        |        |        |\n",
       "| use, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 295    | 174    | 121    | ---    |        | ---    |        |\n",
       "|        |        | (59%)  | (41%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 57     | 42     | 15     | 1.95   | 0.039  | 2.23   | 0.039  |\n",
       "|        |        | (74%)  | (26%)  | (      |        | (      |        |\n",
       "|        |        |        |        | 1.05 - |        | 1.07 - |        |\n",
       "|        |        |        |        | 3.77)  |        | 4.95)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Cur   |        |        |        |        |        |        |        |\n",
       "| rently |        |        |        |        |        |        |        |\n",
       "| rec    |        |        |        |        |        |        |        |\n",
       "| eiving |        |        |        |        |        |        |        |\n",
       "| OAT, n |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 52     | 31     | 21     | ---    |        |        |        |\n",
       "|        |        | (60%)  | (40%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 300    | 185    | 115    | 1.09   | 0.779  |        |        |\n",
       "|        |        | (62%)  | (38%)  | (      |        |        |        |\n",
       "|        |        |        |        | 0.59 - |        |        |        |\n",
       "|        |        |        |        | 1.98)  |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Ever  |        |        |        |        |        |        |        |\n",
       "| re     |        |        |        |        |        |        |        |\n",
       "| ceived |        |        |        |        |        |        |        |\n",
       "| OAT    |        |        |        |        |        |        |        |\n",
       "| with   |        |        |        |        |        |        |        |\n",
       "| meth   |        |        |        |        |        |        |        |\n",
       "| adone, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 33     | 8      | 25     | ---    |        | ---    |        |\n",
       "|        |        | (24%)  | (76%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 319    | 208    | 111    | 5.86   | \\      | 6.54   | \\      |\n",
       "|        |        | (65%)  | (35%)  | (      | <0.001 | (      | <0.001 |\n",
       "|        |        |        |        | 2.66 - |        | 2.66 - |        |\n",
       "|        |        |        |        | 14.3)  |        | 17.9)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| [Ever  |        |        |        |        |        |        |        |\n",
       "| re     |        |        |        |        |        |        |        |\n",
       "| ceived |        |        |        |        |        |        |        |\n",
       "| OAT    |        |        |        |        |        |        |        |\n",
       "| with   |        |        |        |        |        |        |        |\n",
       "| bu     |        |        |        |        |        |        |        |\n",
       "| prenor |        |        |        |        |        |        |        |\n",
       "| phine, |        |        |        |        |        |        |        |\n",
       "| n      |        |        |        |        |        |        |        |\n",
       "| (      |        |        |        |        |        |        |        |\n",
       "| %)]{st |        |        |        |        |        |        |        |\n",
       "| yle=\"  |        |        |        |        |        |        |        |\n",
       "| font-w |        |        |        |        |        |        |        |\n",
       "| eight: |        |        |        |        |        |        |        |\n",
       "|  bold; |        |        |        |        |        |        |        |\n",
       "|     \"} |        |        |        |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| No     | 117    | 97     | 20     | ---    |        | ---    |        |\n",
       "|        |        | (83%)  | (17%)  |        |        |        |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "| Yes    | 235    | 119    | 116    | 0.21   | \\      | 0.19   | \\      |\n",
       "|        |        | (51%)  | (49%)  | (      | <0.001 | (      | <0.001 |\n",
       "|        |        |        |        | 0.12 - |        | 0.10 - |        |\n",
       "|        |        |        |        | 0.36)  |        | 0.35)  |        |\n",
       "+--------+--------+--------+--------+--------+--------+--------+--------+\n",
       "\n",
       ": Final model including crude odds ratios (cOR) and adjusted odds ratios\n",
       "(aOR)\n"
      ]
     }
    }
   ],
   "source": [
    "table_merged.kable"
   ],
   "id": "c6c8e16a-f623-4a4a-97b0-331587fff770"
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Factors associated with OAT preference\n",
    "\n",
    "Overall, participants who preferred methadone were more likely to have ever received OAT with methadone, and had used heroin (aOR X.XX, 95%CI:X.XX, X.XX) and other pharmaceutical opioids in the month prior (aOR X.XX, 95%CI:X.XX, X.XX) (@fig-forest). Participants who preferred buprenorphine were more likely to have ever received OAT with burpenorphine (aOR X.XX, 95%CI:X.XX, X.XX).\n",
    "\n",
    "![Forest plot of sociodemographic and drug use-related factors associations with a preference for methadone](attachment:figures/forest_plot_all.png){#fig-forest }\n",
    "\n",
    "Participants who were currently receiving OAT and who preferred methadone were more likely to have ever received OAT with methadone, and had used heroin (aOR X.XX, 95%CI:X.XX, X.XX) and other pharmaceutical opioids in the past month (aOR X.XX, 95%CI:X.XX, X.XX) (@fig-forest). Participants who preferred buprenorphine were more likely to have ever received OAT with burpenorphine (aOR X.XX, 95%CI:X.XX, X.XX).\n",
    "\n",
    "![Forest plot of sociodemographic and drug use-related factors associations with a preference for methadone among participants currently receiving OAT](attachment:figures/forest_plot_oat.png){#fig-forest_oat }\n",
    "\n",
    "## Discussion\n",
    "\n",
    "Both short- and long-acting formulations have been rigorously studied (Mattick et al., 2014; Nielsen et al., 2016; Sordo et al., 2017), the decision for one formulation over another is largely preference sensitive, a choice that depends on patients’ preferences and their individual values (Keirns & Goold, 2009). In this study, we offer additional insight into preferences for OATAlthough previous studies have explored OAT preferences using small samples from single cities or recruitment sites \\[@bailey2013; @ridge2009; @pinto2010\\], within specific populations \\[@kaplowitz2022\\] and investigate specific factors \\[@muthulingam2023\\] this study builds on this previous work by examining sociodemographic, behavioural and clinical factors associated with preferences for OAT in a national sample of people who regularly use opioids. Most preferred OAT, whereas among those who had a stated preference for one type of medication, two thirds preferred methadone, with an equal number of the remaining participants preferring oral and sublingual buprenorphine (i.e. monobuprenorphine and buprenorphine-naloxone) or long-acting injectable buprenorphine, respectively. Those who preferred methadone were significantly more likely to have ever received treatment with methadone, and recently used heroin and non-pharmaceutical opioids. Among participants currently in treatment, almost all were receiving their preferred therapies. Despite limitations on the statistical power to investigate preferences for short-acting versus long-acting injectable buprenorphine, this study provides important insights into the factors associated with preferred OAT and offers guidance in clinical decision making for the management and mitigation of drug-related risks among people who regularly use opioids.\n",
    "\n",
    "Most participants preferred OAT. This is consistent with other studies \\[@bailey2013; @uebelacker2016\\] who found that among people in opioid withdrawal management, 63% - 78% would choose OAT following withdrawal. The 9% (n=34) who had a preference for no treatment in this study is less than other studies, such as Bailey \\[@bailey2013\\], who in a survey of 372 opioid-dependent people undergoing inpatient detox found that 22% (n=82) would choose not to receive OAT. In addition, \\[@saunders2020\\]’s qualitative study of 40 people who used opioids that one-third had a preference for not receiving OAT. The choice of whether to choose OAT is based on several individual and structural-level factors. In Australia, treatment programs in the public sector are characterised by daily supervised dosing, out-of-pocket cost and small windows in which doses of daily medication can be dispensed \\[@hall2023; @komalasari2021\\]. Those choosing to not receive OAT often list the onerous requirements of daily supervised dosing as too demanding \\[@crawford2013\\], experiences of stigma, discrimination and structural violence associated with treatment \\[@treloar2022\\], perceptions of replacing one drug for another \\[@frank2020\\], distrust in the the motives of pharmaceutical companies and prescribers \\[@saunders2020\\], and misalignment with personal pursuits of well-being, bodily autonomy and positive treatment outcomes \\[@mayock2021; @carlisle2023\\] as reasons for not choosing to enroll on or discontinue treatment \\[@clay2023\\].\n",
    "\n",
    "A larger proportion of participants preferred methadone over formulations of buprenorphine. This finding is consistent with other studies, including \\[@pinto2010\\] where among 361 opiod-dependent individuals, 63% (n=227) patients chose methadone and 37% (n=134) buprenorphine. However, in contrast, \\[@uebelacker2016\\], in a study of people in opioid withdrawal management, found that more people preferred buprenorphine over methadone following withdrawal, with 18% (n=68) stating a preference for methadone, 28% (n=104) buprenorphine and 32% (n=118) extended-release naltrexone - which is currently not registered for the management of opioid use in Australia. These inconsistent findings have been noted by others \\[@neale2018; @rolland2021; @neale2019\\]. Individual preferences for treatment with these medications are multifaceted and influenced by perceived effectiveness, privacy concerns, autonomy, convenience, previous treatment experiences, and side effect profiles.\n",
    "\n",
    "Among those with a preference for buprenorphine, an equal number of participants preferred short-acting buprenorphine (oral or sublingual monobuprenorphine and buprenorphine-naloxone) as long-acting injectable buprenorphine. Consistent with this study, \\[@uebelacker2016\\]found that among X people, 104 (28%) preferred oral or sublingual buprenorphine and 118 (32%) preferred XR-NTX. A previous study by \\[@kenney2018\\] in the United States found that in of X, 55% of people stated they preferred buprenorphine over other formulations and of these, 49% preferred daily oral formulations and 23% preferred a weekly or monthlybuprenorphine. dose of long-acting injectable injection. (Paragraph is incomplete - to be written).\n",
    "\n",
    "Participants who had previous experience with receiving methadone were more likely to prefer methadone, consistent with several studies that identify prior treatment experience are a strong predictor of treatment preference \\[@yarborough2016; @pinto2010; @gryczynski2013\\]. Findings from Yarborough \\[@yarborough2016\\]’s qualitative study provides insight into this result, with participants describing how negative experiences with methadone (including non-prescribed use) led them to consider buprenorphine. Likewise, patients described how experiences with buprenorphine influenced their decision to choose methadone experience with buprenorphine treatment was related to an increased likelihood of being prescribed buprenorphine. In Ridge \\[@ridge2009\\]’s findings, the odds of being prescribed buprenorphine during the current treatment episode were about 12 times greater for those patients who had previous experience of being treated with buprenorphine. In contrast, prior treatment with oral methadone was not related to any increased probability of receiving methadone treatment. Qualitative studies suggest that client preference for buprenorphine and methadone varies, and is influenced by peer attitudes, prior treatment experience and clinic dispensing practices. In a second study analyzing factors related to patient preference for buprenorphine or methadone among 190 opioid-dependent people seeking OAT, the odds of being prescribed buprenorphine were three times greater among those reporting a preference for it; similarly, the odds of receiving methadone were twice as great among those requesting methadone \\[@ridge2009\\].\n",
    "\n",
    "Among participants currently receiving OAT, most were receiving their preferred therapy, with X% in receipt of methadone and X% of prescribed buprenorphine having a preference for the same treatment. Limited studies have investigated treatment outcomes associated with receipt of preferred therapy, however, extensive literature on client participation in medication decision making demostrates that incorporating client preference leads to higher rates of retention and related positive outcomes \\[@fallah2015; @friedrichs2016; @gilman2018; @gryczynski2013; @joosten2008\\]. Currently, available formulations in Australia exclude several formulations and modes of devlivery that are available in other countries. For example, injectable opioid agonist therapy (iOAT) with hydromorphone or diamorphine has shown promise as a treatment for those who have not experienced the desired outcomes with traditional therapies treatments (reference). Despite not currently an option in Australia, a clinical trial investigating iOAT with hydromorphone is currently underway. Further, Nielsen \\[@nielsen2021\\] found that in a sample of people who regularly use opioids in Australia, 53% of participants (n = 182) stated that they would have a preferencefor iOAT if available. In addition to the existing evidence-base, further research into medication preferences is needed as the range of available treatments becomes established and up-scaled.\n",
    "\n",
    "### Limitations\n",
    "\n",
    "There are several limitations of the study to consider. Data comprising the study arise from cross sectional survey design and convenience sampling of harm reduction sites and voluntary participation of individuals within those sites, therefore these findings may not be generalizable to all people who use drugs. Study sites did not routinely collect information about numbers examined for eligibility, confirmed eligible and included in the study, and we are unable to report these details. However, the demographic characteristics of the current study’s sample are consistent with those of other large Australian studies of people who are regularly use opioids (i.e. the majority male, typically aged early 40s, with the majority of OAT clients receiving methadone) \\[e.g. \\[@brener2022; @larance2020; @maddensatisfaction2008\\]\\]. Most of the sample were treatment experienced having ever received treatment with methadone (n=) or buprenorphine (n=x), and therefore, there was limited input from participants who had never previously sought treatment. Despite this, there is still a need to ensure that those currently receiving OAT are prescribed their preferred medication, and to understand preferences of those interersted in OAT to enhance treatment and improve overall satisfaction. In addition, although most participants preferred treatment with a particular medication (n=366), the sample of participants preferring sublingual buprenorphine (n=68) and long-acting injectable bupenorphine (n=68) was relatively small, limiting the statistical power to detect differences and representativeness. A larger and more diverse sample would enhance the study’s reliability and enable more robust analysis. The survey’s self-report nature may introduce bias, as participants’ preferences might not fully align with their actual experiences with these medications.In addition, this study was conducted prior to the widespread implementation of long-acting injectable formulations of buprenorphine and participants were therefore largely unfamiliar to people receiving OAT. The lack of familiarity with these formulations is a potential source of bias as participants were reporting on hypothetical scenarios and anticipated preferences, benefits and disadvantages. Despite these limitations, this study provides important insights into preferred treatment and medications.\n",
    "\n",
    "## Conclusion\n",
    "\n",
    "In conclusion, this study provides valuable insight into opioid agonist therapy preferences among people who regularly use opioids. Methadone was preferred over any available formulation of buprenorphine by most participants, where a similar number of participants preferred oral or sublingual and long-acting injectable formulations of buprenorphine. Most those receiving treatment were prescribed their preferred medication, with previous and current treatment experience the strongest predictor of medication preference. Australian OAT guidelines recommend that client preferences are taken into account in choosing medications. These findings may act as a guide for those discussions that are had on an individual basis. Clinical decision making around treatment options must center individual preference and balance suitability and choice of treatment."
   ],
   "attachments": {
    "figures/forest_plot_all.png": {
     "image/png": "iVBORw0KGgoAAAANSUhEUgAABFcAAAOXCAYAAADhEa7HAAAAAXNSR0IArs4c6QAAAARnQU1BAACx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\nH0x5Be5vdKAiAAAAAElFTkSuQmCC\n"
    },
    "figures/forest_plot_oat.png": {
     "image/png": "iVBORw0KGgoAAAANSUhEUgAABDoAAAO5CAYAAAD4rkVBAAAAAXNSR0IArs4c6QAAAARnQU1BAACx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\nAElFTkSuQmCC\n"
    }
   },
   "id": "c386981c-160e-448e-91a6-63728c2a71d2"
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## References"
   ],
   "id": "00f2cf7c-2c1b-491e-965d-f6dc323ade34"
  },
  {
   "cell_type": "raw",
   "metadata": {
    "raw_mimetype": "tex"
   },
   "source": [
    "\\singlespacing"
   ],
   "id": "cc056125-d84a-4039-ae5d-96b52f6e95cc"
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [],
   "id": "05f59960-1288-4f83-b91d-c4b07c2f5c71"
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Supplementary Material\n",
    "\n",
    "### Table S1"
   ],
   "id": "2cd0a7d4-446f-4948-a7af-8a644fa53b65"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  -----------------------------------------------------------------------------------------------------------------------\n",
       "  Characteristic                             Overall\\   Methadone\\   Buprenorphine   Buprenorphine     Any\\      None\\\n",
       "                                            (n = 400)   (n = 216)        oral\\           LAIB\\       (n = 14)   (n = 34)\n",
       "                                                                       (n = 68)        (n = 68)                \n",
       "  ----------------------------------------- ---------- ------------ --------------- --------------- ---------- ----------\n",
       "  [Age, Median                               45 (39 -  46 (40 - 53)  43 (38 - 48)    46 (40 - 52)    39 (34 -   51 (41 -\n",
       "  (IQR)]{style=\" font-weight: bold;    \"}      53)                                                     49)        54)\n",
       "\n",
       "  [Age group, n                                                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  18 - 35 years                                 53       22 (42%)      12 (23%)         9 (17%)      4 (7.5%)   6 (11%)\n",
       "\n",
       "  36 - 45 years                                150       82 (55%)      31 (21%)        24 (16%)      6 (4.0%)   7 (4.7%)\n",
       "\n",
       "  \\>45 years                                   197      112 (57%)      25 (13%)        35 (18%)      4 (2.0%)   21 (11%)\n",
       "\n",
       "  [Gender, n                                                                                                   \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Male                                         237      128 (54%)      44 (19%)        37 (16%)      9 (3.8%)  19 (8.0%)\n",
       "\n",
       "  Female                                       162       87 (54%)      24 (15%)        31 (19%)      5 (3.1%)  15 (9.3%)\n",
       "\n",
       "  Transgender                                   1        1 (100%)       0 (0%)          0 (0%)        0 (0%)     0 (0%)\n",
       "\n",
       "  [Level of education, n                                                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Completed less than 10 years school          206      118 (57%)      31 (15%)        39 (19%)      7 (3.4%)  11 (5.3%)\n",
       "  education                                                                                                    \n",
       "\n",
       "  Completed more than 10 years school          194       98 (51%)      37 (19%)        29 (15%)      7 (3.6%)   23 (12%)\n",
       "  education                                                                                                    \n",
       "\n",
       "  [Income, n                                                                                                   \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Other                                        349      188 (54%)      59 (17%)        62 (18%)     13 (3.7%)  27 (7.7%)\n",
       "\n",
       "  Paid                                          51       28 (55%)       9 (18%)         6 (12%)      1 (2.0%)   7 (14%)\n",
       "\n",
       "  [Homelessness, n                                                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            26       15 (58%)      1 (3.8%)         4 (15%)      2 (7.7%)   4 (15%)\n",
       "\n",
       "  Yes                                          374      201 (54%)      67 (18%)        64 (17%)     12 (3.2%)  30 (8.0%)\n",
       "\n",
       "  [Incarceration, n                                                                                            \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           166       87 (52%)      30 (18%)        28 (17%)      4 (2.4%)   17 (10%)\n",
       "\n",
       "  Yes \\> 6 months                               41       21 (51%)       7 (17%)         7 (17%)      1 (2.4%)   5 (12%)\n",
       "\n",
       "  Yes \\< 6 months                              193      108 (56%)      31 (16%)        33 (17%)      9 (4.7%)  12 (6.2%)\n",
       "\n",
       "  [Chronic pain, n                                                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           231      123 (53%)      48 (21%)        35 (15%)     11 (4.8%)  14 (6.1%)\n",
       "\n",
       "  Yes                                          169       93 (55%)      20 (12%)        33 (20%)      3 (1.8%)   20 (12%)\n",
       "\n",
       "  [Heroin use, n                                                                                               \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           119       57 (48%)      31 (26%)        22 (18%)      3 (2.5%)   6 (5.0%)\n",
       "\n",
       "  Yes                                          281      159 (57%)      37 (13%)        46 (16%)     11 (3.9%)  28 (10.0%)\n",
       "\n",
       "  [Non-prescribed methadone use, n                                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           330      175 (53%)      62 (19%)        59 (18%)     10 (3.0%)  24 (7.3%)\n",
       "\n",
       "  Yes                                           70       41 (59%)      6 (8.6%)         9 (13%)      4 (5.7%)   10 (14%)\n",
       "\n",
       "  [Non-prescribed buprenorphine use, n                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           375      209 (56%)      61 (16%)        63 (17%)     12 (3.2%)  30 (8.0%)\n",
       "\n",
       "  Yes                                           25       7 (28%)        7 (28%)         5 (20%)      2 (8.0%)   4 (16%)\n",
       "\n",
       "  [Non-prescribed pharmaceutical opioid                                                                        \n",
       "  use, n                                                                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           333      174 (52%)      60 (18%)        61 (18%)     10 (3.0%)  28 (8.4%)\n",
       "\n",
       "  Yes                                           67       42 (63%)       8 (12%)         7 (10%)      4 (6.0%)   6 (9.0%)\n",
       "\n",
       "  [Cocaine use, n                                                                                              \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           365      198 (54%)      66 (18%)        59 (16%)     10 (2.7%)  32 (8.8%)\n",
       "\n",
       "  Yes                                           35       18 (51%)      2 (5.7%)         9 (26%)      4 (11%)    2 (5.7%)\n",
       "\n",
       "  [Methamphetamine use, n                                                                                      \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           219      125 (57%)      35 (16%)        38 (17%)      4 (1.8%)  17 (7.8%)\n",
       "\n",
       "  Yes                                          181       91 (50%)      33 (18%)        30 (17%)     10 (5.5%)  17 (9.4%)\n",
       "\n",
       "  [Recent benzodiazepine use, n                                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           207      108 (52%)      35 (17%)        36 (17%)      9 (4.3%)  19 (9.2%)\n",
       "\n",
       "  Yes                                          193      108 (56%)      33 (17%)        32 (17%)      5 (2.6%)  15 (7.8%)\n",
       "\n",
       "  [Drug injecting, n                                                                                           \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            90       40 (44%)      23 (26%)        19 (21%)      3 (3.3%)   5 (5.6%)\n",
       "\n",
       "  Yes                                          310      176 (57%)      45 (15%)        49 (16%)     11 (3.5%)  29 (9.4%)\n",
       "\n",
       "  [Drug injecting frequency, n                                                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Did not inject                                90       40 (44%)      23 (26%)        19 (21%)      3 (3.3%)   5 (5.6%)\n",
       "\n",
       "  Weekly or less                                64       36 (56%)      10 (16%)        12 (19%)      2 (3.1%)   4 (6.3%)\n",
       "\n",
       "  More than weekly, not daily                  105       64 (61%)      15 (14%)        13 (12%)      2 (1.9%)   11 (10%)\n",
       "\n",
       "  Once daily                                    64       40 (63%)      6 (9.4%)        11 (17%)      3 (4.7%)   4 (6.3%)\n",
       "\n",
       "  2 - 3 times a day                             54       24 (44%)       9 (17%)        13 (24%)      3 (5.6%)   5 (9.3%)\n",
       "\n",
       "  More than 3 times a day                       23       12 (52%)       5 (22%)         0 (0%)       1 (4.3%)   5 (22%)\n",
       "\n",
       "  [Heroin injecting, n                                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           131       62 (47%)      34 (26%)        26 (20%)      3 (2.3%)   6 (4.6%)\n",
       "\n",
       "  Yes                                          269      154 (57%)      34 (13%)        42 (16%)     11 (4.1%)   28 (10%)\n",
       "\n",
       "  [Non-prescribed methadone injecting, n                                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           359      185 (52%)      65 (18%)        65 (18%)     12 (3.3%)  32 (8.9%)\n",
       "\n",
       "  Yes                                           41       31 (76%)      3 (7.3%)        3 (7.3%)      2 (4.9%)   2 (4.9%)\n",
       "\n",
       "  [Recent non-prescribed suboxone                                                                              \n",
       "  injecting, n                                                                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           368      205 (56%)      59 (16%)        63 (17%)     13 (3.5%)  28 (7.6%)\n",
       "\n",
       "  Yes                                           32       11 (34%)       9 (28%)         5 (16%)      1 (3.1%)   6 (19%)\n",
       "\n",
       "  [Cocaine injecting, n                                                                                        \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           374      201 (54%)      67 (18%)        63 (17%)     10 (2.7%)  33 (8.8%)\n",
       "\n",
       "  Yes                                           26       15 (58%)      1 (3.8%)         5 (19%)      4 (15%)    1 (3.8%)\n",
       "\n",
       "  [Methamphetamine injecting, n                                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           256      139 (54%)      45 (18%)        45 (18%)      4 (1.6%)  23 (9.0%)\n",
       "\n",
       "  Yes                                          144       77 (53%)      23 (16%)        23 (16%)     10 (6.9%)  11 (7.6%)\n",
       "\n",
       "  [Ever received OAT with methadone, n                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            52       8 (15%)       17 (33%)         8 (15%)      6 (12%)    13 (25%)\n",
       "\n",
       "  Yes                                          348      208 (60%)      51 (15%)        60 (17%)      8 (2.3%)  21 (6.0%)\n",
       "\n",
       "  [Ever received OAT with buprenorphine, n                                                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           138       97 (70%)      5 (3.6%)        15 (11%)      5 (3.6%)   16 (12%)\n",
       "\n",
       "  Yes                                          262      119 (45%)      63 (24%)        53 (20%)      9 (3.4%)  18 (6.9%)\n",
       "  -----------------------------------------------------------------------------------------------------------------------\n",
       "\n",
       "  : Final model including crude odds ratios (cOR) and adjusted odds\n",
       "  ratios (aOR)\n"
      ]
     }
    }
   ],
   "source": [
    "pts_subset_stratified <-  \n",
    "  p %>% \n",
    "  tbl_summary(by = oatpref.all, include = c(age,agegroup, genderall.factor, edu.factor, \n",
    "                                              \n",
    "                                              income.factor.yn, homeless.factor.yn,         \n",
    "                                              prison.factor, chronicpain.factor.yn, \n",
    "                                              heroin.month.factor,  \n",
    "                                              nonmethadone.month.factor,\n",
    "                                              nonbupe.month.factor,  \n",
    "                                              otheropi.month.factor, \n",
    "                                              cocaine.month.factor, \n",
    "                                              meth.month.factor, benzo.month.factor,\n",
    "                                              anyinject.yn.f,\n",
    "                                              injfreq.factor, injectingheroin.month.f,\n",
    "                                              injectingnonmethadone.month.f, \n",
    "                                              injectingnonsuboxone.month.f,\n",
    "                                              injectjngcocaine.month.f,\n",
    "                                              injectingmeth.month.f,\n",
    "                                              methadoneever.yn, bupeever.factor\n",
    "                                              ),\n",
    "  # type = all_categorical() ~ \"categorical\",\n",
    "  label = \n",
    "    list(age ~ \"Age\",\n",
    "         agegroup ~ \"Age group\",\n",
    "         # usedrugs.oat ~ \"Drugs used while on OAT\",\n",
    "         methadoneever.yn ~ \"Ever received OAT with methadone\", \n",
    "         bupeever.factor ~ \"Ever received OAT with buprenorphine\",\n",
    "         injectingheroin.month.f ~ \"Heroin injecting\",\n",
    "         injectingnonmethadone.month.f ~ \"Non-prescribed methadone injecting\",\n",
    "         otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n",
    "         injectjngcocaine.month.f ~ \"Cocaine injecting\",\n",
    "         injectingmeth.month.f ~ \"Methamphetamine injecting\"\n",
    "         ), \n",
    "         # currentmed ~ \"Current OAT medication\"),\n",
    "  type = all_categorical()~\"categorical\",\n",
    "  missing = \"no\",\n",
    "  percent = \"row\",\n",
    "  statistic =(all_continuous()  ~ \"{median} ({p25} - {p75})\"))%>%\n",
    "  add_stat_label()%>%\n",
    "  add_overall(statistic = list(all_continuous()  ~ \"{median} ({p25} - {p75})\",\n",
    "                               all_categorical() ~ \"{n}\")) %>% \n",
    "  modify_footnote(update = everything() ~ NA, abbreviation = FALSE) %>%\n",
    "  modify_header(\n",
    "    stat_0 = '**Overall** \\n **(n = {n})**',\n",
    "    stat_1 = '**Methadone** \\n **(n = {n})**',\n",
    "    stat_2 = '**Buprenorphine oral** \\n **(n = {n})**', \n",
    "    stat_3 = '**Buprenorphine LAIB** \\n **(n = {n})**', \n",
    "    stat_4 = '**Any** \\n **(n = {n})**', \n",
    "    stat_5 = '**None** \\n **(n = {n})**'\n",
    "  ) %>%\n",
    "  bold_labels()\n",
    "\n",
    "pts_subset_stratified.kable  <- pts_subset_stratified  %>%\n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\", \n",
    "    caption=\"Final model including crude odds ratios (cOR) and adjusted odds ratios (aOR)\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )\n",
    "#     scroll_box(\n",
    "#   height = \"100%\",\n",
    "#   width = \"100%\",\n",
    "#   box_css = \"border: 1px solid #ddd; padding: 5px; \",\n",
    "#   extra_css = NULL,\n",
    "#   fixed_thead = TRUE\n",
    "# )\n",
    "\n",
    "pts_subset_stratified.kable "
   ],
   "id": "ac93d34d-2cb6-40ce-8113-28ccba3e40d1"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  -----------------------------------------------------------------------------------------------------------------------\n",
       "  Characteristic                             Overall\\   Methadone\\   Buprenorphine   Buprenorphine     Any\\      None\\\n",
       "                                            (n = 400)   (n = 216)        oral\\           LAIB\\       (n = 14)   (n = 34)\n",
       "                                                                       (n = 68)        (n = 68)                \n",
       "  ----------------------------------------- ---------- ------------ --------------- --------------- ---------- ----------\n",
       "  [Age, Median                               45 (39 -  46 (40 - 53)  43 (38 - 48)    46 (40 - 52)    39 (34 -   51 (41 -\n",
       "  (IQR)]{style=\" font-weight: bold;    \"}      53)                                                     49)        54)\n",
       "\n",
       "  [Age group, n                                                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  18 - 35 years                                 53       22 (42%)      12 (23%)         9 (17%)      4 (7.5%)   6 (11%)\n",
       "\n",
       "  36 - 45 years                                150       82 (55%)      31 (21%)        24 (16%)      6 (4.0%)   7 (4.7%)\n",
       "\n",
       "  \\>45 years                                   197      112 (57%)      25 (13%)        35 (18%)      4 (2.0%)   21 (11%)\n",
       "\n",
       "  [Gender, n                                                                                                   \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Male                                         237      128 (54%)      44 (19%)        37 (16%)      9 (3.8%)  19 (8.0%)\n",
       "\n",
       "  Female                                       162       87 (54%)      24 (15%)        31 (19%)      5 (3.1%)  15 (9.3%)\n",
       "\n",
       "  Transgender                                   1        1 (100%)       0 (0%)          0 (0%)        0 (0%)     0 (0%)\n",
       "\n",
       "  [Level of education, n                                                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Completed less than 10 years school          206      118 (57%)      31 (15%)        39 (19%)      7 (3.4%)  11 (5.3%)\n",
       "  education                                                                                                    \n",
       "\n",
       "  Completed more than 10 years school          194       98 (51%)      37 (19%)        29 (15%)      7 (3.6%)   23 (12%)\n",
       "  education                                                                                                    \n",
       "\n",
       "  [Income, n                                                                                                   \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Other                                        349      188 (54%)      59 (17%)        62 (18%)     13 (3.7%)  27 (7.7%)\n",
       "\n",
       "  Paid                                          51       28 (55%)       9 (18%)         6 (12%)      1 (2.0%)   7 (14%)\n",
       "\n",
       "  [Homelessness, n                                                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            26       15 (58%)      1 (3.8%)         4 (15%)      2 (7.7%)   4 (15%)\n",
       "\n",
       "  Yes                                          374      201 (54%)      67 (18%)        64 (17%)     12 (3.2%)  30 (8.0%)\n",
       "\n",
       "  [Incarceration, n                                                                                            \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           166       87 (52%)      30 (18%)        28 (17%)      4 (2.4%)   17 (10%)\n",
       "\n",
       "  Yes \\> 6 months                               41       21 (51%)       7 (17%)         7 (17%)      1 (2.4%)   5 (12%)\n",
       "\n",
       "  Yes \\< 6 months                              193      108 (56%)      31 (16%)        33 (17%)      9 (4.7%)  12 (6.2%)\n",
       "\n",
       "  [Chronic pain, n                                                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           231      123 (53%)      48 (21%)        35 (15%)     11 (4.8%)  14 (6.1%)\n",
       "\n",
       "  Yes                                          169       93 (55%)      20 (12%)        33 (20%)      3 (1.8%)   20 (12%)\n",
       "\n",
       "  [Heroin use, n                                                                                               \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           119       57 (48%)      31 (26%)        22 (18%)      3 (2.5%)   6 (5.0%)\n",
       "\n",
       "  Yes                                          281      159 (57%)      37 (13%)        46 (16%)     11 (3.9%)  28 (10.0%)\n",
       "\n",
       "  [Non-prescribed methadone use, n                                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           330      175 (53%)      62 (19%)        59 (18%)     10 (3.0%)  24 (7.3%)\n",
       "\n",
       "  Yes                                           70       41 (59%)      6 (8.6%)         9 (13%)      4 (5.7%)   10 (14%)\n",
       "\n",
       "  [Non-prescribed buprenorphine use, n                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           375      209 (56%)      61 (16%)        63 (17%)     12 (3.2%)  30 (8.0%)\n",
       "\n",
       "  Yes                                           25       7 (28%)        7 (28%)         5 (20%)      2 (8.0%)   4 (16%)\n",
       "\n",
       "  [Non-prescribed pharmaceutical opioid                                                                        \n",
       "  use, n                                                                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           333      174 (52%)      60 (18%)        61 (18%)     10 (3.0%)  28 (8.4%)\n",
       "\n",
       "  Yes                                           67       42 (63%)       8 (12%)         7 (10%)      4 (6.0%)   6 (9.0%)\n",
       "\n",
       "  [Cocaine use, n                                                                                              \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           365      198 (54%)      66 (18%)        59 (16%)     10 (2.7%)  32 (8.8%)\n",
       "\n",
       "  Yes                                           35       18 (51%)      2 (5.7%)         9 (26%)      4 (11%)    2 (5.7%)\n",
       "\n",
       "  [Methamphetamine use, n                                                                                      \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           219      125 (57%)      35 (16%)        38 (17%)      4 (1.8%)  17 (7.8%)\n",
       "\n",
       "  Yes                                          181       91 (50%)      33 (18%)        30 (17%)     10 (5.5%)  17 (9.4%)\n",
       "\n",
       "  [Recent benzodiazepine use, n                                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           207      108 (52%)      35 (17%)        36 (17%)      9 (4.3%)  19 (9.2%)\n",
       "\n",
       "  Yes                                          193      108 (56%)      33 (17%)        32 (17%)      5 (2.6%)  15 (7.8%)\n",
       "\n",
       "  [Drug injecting, n                                                                                           \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            90       40 (44%)      23 (26%)        19 (21%)      3 (3.3%)   5 (5.6%)\n",
       "\n",
       "  Yes                                          310      176 (57%)      45 (15%)        49 (16%)     11 (3.5%)  29 (9.4%)\n",
       "\n",
       "  [Drug injecting frequency, n                                                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Did not inject                                90       40 (44%)      23 (26%)        19 (21%)      3 (3.3%)   5 (5.6%)\n",
       "\n",
       "  Weekly or less                                64       36 (56%)      10 (16%)        12 (19%)      2 (3.1%)   4 (6.3%)\n",
       "\n",
       "  More than weekly, not daily                  105       64 (61%)      15 (14%)        13 (12%)      2 (1.9%)   11 (10%)\n",
       "\n",
       "  Once daily                                    64       40 (63%)      6 (9.4%)        11 (17%)      3 (4.7%)   4 (6.3%)\n",
       "\n",
       "  2 - 3 times a day                             54       24 (44%)       9 (17%)        13 (24%)      3 (5.6%)   5 (9.3%)\n",
       "\n",
       "  More than 3 times a day                       23       12 (52%)       5 (22%)         0 (0%)       1 (4.3%)   5 (22%)\n",
       "\n",
       "  [Heroin injecting, n                                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           131       62 (47%)      34 (26%)        26 (20%)      3 (2.3%)   6 (4.6%)\n",
       "\n",
       "  Yes                                          269      154 (57%)      34 (13%)        42 (16%)     11 (4.1%)   28 (10%)\n",
       "\n",
       "  [Non-prescribed methadone injecting, n                                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           359      185 (52%)      65 (18%)        65 (18%)     12 (3.3%)  32 (8.9%)\n",
       "\n",
       "  Yes                                           41       31 (76%)      3 (7.3%)        3 (7.3%)      2 (4.9%)   2 (4.9%)\n",
       "\n",
       "  [Recent non-prescribed suboxone                                                                              \n",
       "  injecting, n                                                                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           368      205 (56%)      59 (16%)        63 (17%)     13 (3.5%)  28 (7.6%)\n",
       "\n",
       "  Yes                                           32       11 (34%)       9 (28%)         5 (16%)      1 (3.1%)   6 (19%)\n",
       "\n",
       "  [Cocaine injecting, n                                                                                        \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           374      201 (54%)      67 (18%)        63 (17%)     10 (2.7%)  33 (8.8%)\n",
       "\n",
       "  Yes                                           26       15 (58%)      1 (3.8%)         5 (19%)      4 (15%)    1 (3.8%)\n",
       "\n",
       "  [Methamphetamine injecting, n                                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           256      139 (54%)      45 (18%)        45 (18%)      4 (1.6%)  23 (9.0%)\n",
       "\n",
       "  Yes                                          144       77 (53%)      23 (16%)        23 (16%)     10 (6.9%)  11 (7.6%)\n",
       "\n",
       "  [Ever received OAT with methadone, n                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            52       8 (15%)       17 (33%)         8 (15%)      6 (12%)    13 (25%)\n",
       "\n",
       "  Yes                                          348      208 (60%)      51 (15%)        60 (17%)      8 (2.3%)  21 (6.0%)\n",
       "\n",
       "  [Ever received OAT with buprenorphine, n                                                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           138       97 (70%)      5 (3.6%)        15 (11%)      5 (3.6%)   16 (12%)\n",
       "\n",
       "  Yes                                          262      119 (45%)      63 (24%)        53 (20%)      9 (3.4%)  18 (6.9%)\n",
       "  -----------------------------------------------------------------------------------------------------------------------\n"
      ]
     }
    }
   ],
   "source": [
    "pts_subset_stratified.kable"
   ],
   "id": "d4e1bcfe-6e5b-4a2a-b295-972088d36e67"
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Table S2"
   ],
   "id": "9b1d59bb-cf51-4798-b857-aaf72016a3a5"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "# oat <- p %>%\n",
    "#   filter(oat.yn.f == \"Yes\")%>% # By filtering for oat.yn.f = \"yes\" we are selecting on those participants currently receiving OAT\n",
    "#   dplyr::select(age, agegroup, edu.factor ,genderall.factor, gender.mf,\n",
    "#                 income.factor.yn, homeless.factor.yn, homeless.factor,        \n",
    "#                 prison.factor, chronicpain.factor.yn, prefer.factor,\n",
    "#                 heroin.month.factor, prescribedmethadone.month.f, \n",
    "#                 nonmethadone.month.factor, prescribedsuboxone.month.f,\n",
    "#                 nonbupe.month.factor, prescribedsuboxone.month.f, otheropi.month.factor, \n",
    "#                 cocaine.month.factor, meth.month.factor, benzo.month.factor, \n",
    "#                 anyinject.yn.f,otheropi1month,\n",
    "#                 injfreq.factor, injectingheroin.month.f,\n",
    "#                 injectingnonmethadone.month.f, \n",
    "#                 injectingprescribedmethadone.month.f,\n",
    "#                 injectingprescribedsuboxone.month.f, \n",
    "#                 injectingnonsuboxone.month.f, injectjngcocaine.month.f,\n",
    "#                 injectingmeth.month.f, injectingbenzo.month.f, methadoneever.yn, \n",
    "#                 bupeever.factor, oatcurrentmed.f, usedrugs.oat, paytx.yn.f, \n",
    "#                 paytx.factor.month,doselocation.factor, dose.km.factor, \n",
    "#                 timedose.factor, oatpref.all, kmdose, dosesite.sep1.factor, \n",
    "#                 clinic.attend.factor, lastdosesite, missd.month, missdose.factor, currentmed)"
   ],
   "id": "f5a9ae7c-859a-4411-8249-ccba234d3dc7"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "pts_oatfull_stratified <-  \n",
    "    p %>%\n",
    "  filter(lastdosesite != \"Not prescribed\")%>%\n",
    "   filter(prefertreat.yn == \"Prefers treatment\")%>%\n",
    "  # filter(prefer.factor == \"Methadone\" | prefer.factor == \"Buprenorphine\")%>%\n",
    "  # filter(pref_oat == \"Methadone\" | prefer.factor == \"Buprenorphine\")%>%\n",
    "  filter(oat.yn.f == \"Yes\")%>%\n",
    "  tbl_summary(by = oatpref.all, include = c(age,agegroup, genderall.factor, edu.factor, \n",
    "                                              \n",
    "                                              income.factor.yn, homeless.factor.yn,         \n",
    "                                              prison.factor, chronicpain.factor.yn, \n",
    "                                              heroin.month.factor,  \n",
    "                                              nonmethadone.month.factor,\n",
    "                                              nonbupe.month.factor,  \n",
    "                                              otheropi.month.factor, \n",
    "                                              cocaine.month.factor, \n",
    "                                              meth.month.factor, benzo.month.factor,\n",
    "                                              anyinject.yn.f,\n",
    "                                              injfreq.factor, injectingheroin.month.f,\n",
    "                                              injectingnonmethadone.month.f, \n",
    "                                              injectingnonsuboxone.month.f,\n",
    "                                            injectingnonopi.month,\n",
    "                                              injectjngcocaine.month.f,\n",
    "                                              injectingmeth.month.f,\n",
    "                                              methadoneever.yn, bupeever.factor,\n",
    "                                              oatcurrentmed.f, usedrugs.oat, missdose.factor, paytx.yn.f, \n",
    "                                              lastdosesite,clinic.attend.factor,  \n",
    "                                              kmdose, timedose.factor, oatpref.all),\n",
    "  # type = all_categorical() ~ \"categorical\",\n",
    "  label = \n",
    "    list(age ~ \"Age\",\n",
    "         agegroup ~ \"Age group\",\n",
    "         usedrugs.oat ~ \"Drugs used while on OAT\",\n",
    "         methadoneever.yn ~ \"Ever received OAT with methadone\", \n",
    "         bupeever.factor ~ \"Ever received OAT with buprenorphine\",\n",
    "         timedose.factor ~ \"Travel time to dosing site\",\n",
    "         clinic.attend.factor ~ \"Frequency of OAT dose collection\",\n",
    "         kmdose ~ \"Travel distance to OAT collection site (km)\", \n",
    "         injectingheroin.month.f ~ \"Heroin injecting\",\n",
    "         injectingnonmethadone.month.f ~ \"Non-prescribed methadone injecting\",\n",
    "         otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n",
    "         injectjngcocaine.month.f ~ \"Cocaine injecting\",\n",
    "         injectingmeth.month.f ~ \"Methamphetamine injecting\",\n",
    "         injectingnonopi.month ~ \"Non-prescribed pharmaceutical opioid injecting\",\n",
    "         injectingnonsuboxone.month.f ~ \"Non-precsribed buprenorphine injecting\",\n",
    "         lastdosesite ~ \"Site last dose collected\"), \n",
    "         # currentmed ~ \"Current OAT medication\"),\n",
    "  type = all_categorical()~\"categorical\",\n",
    "  missing = \"no\",\n",
    "  percent = \"row\",\n",
    "  statistic =(all_continuous()  ~ \"{median} ({p25} - {p75})\"))%>%\n",
    "  add_stat_label()%>%\n",
    "  add_overall(statistic = list(all_continuous()  ~ \"{median} ({p25} - {p75})\",\n",
    "                               all_categorical() ~ \"{n}\")) %>% \n",
    "  modify_footnote(update = everything() ~ NA, abbreviation = FALSE) %>%\n",
    "  modify_header(\n",
    "    stat_0 = '**Overall** \\n **(n = {n})**',\n",
    "    stat_1 = '**Methadone** \\n **(n = {n})**',\n",
    "    stat_2 = '**Buprenorphine oral** \\n **(n = {n})**', \n",
    "    stat_3 = '**Buprenorphine LAIB** \\n **(n = {n})**', \n",
    "    stat_4 = '**Any** \\n **(n = {n})**', \n",
    "    stat_5 = '**None** \\n **(n = {n})**'\n",
    "  ) %>%\n",
    "  bold_labels()%>%\n",
    "  remove_row_type(variable = oatcurrentmed.f, \n",
    "                  type = \"level\", level_value = \"None\")%>%\n",
    "  remove_row_type(variable = clinic.attend.factor, \n",
    "                  type = \"level\", level_value = \"0\")%>%\n",
    "  remove_row_type(variable = lastdosesite, \n",
    "                  type = \"level\", level_value = \"Not prescribed\")\n",
    "\n",
    "pts_oatfull_stratified.kable  <- pts_oatfull_stratified  %>%\n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\", \n",
    "    caption=\"Final model including crude odds ratios (cOR) and adjusted odds ratios (aOR)\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )"
   ],
   "id": "fdb44e46-f97a-4b06-9e7c-b821bb21dc0d"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  -----------------------------------------------------------------------------------------------------------------------\n",
       "  Characteristic                             Overall\\   Methadone\\   Buprenorphine   Buprenorphine     Any\\      None\\\n",
       "                                            (n = 301)   (n = 185)        oral\\           LAIB\\       (n = 5)    (n = 0)\n",
       "                                                                       (n = 56)        (n = 55)                \n",
       "  ----------------------------------------- ---------- ------------ --------------- --------------- ---------- ----------\n",
       "  [Age, Median                               45 (39 -  46 (40 - 54)  43 (37 - 48)    46 (40 - 53)    43 (42 -   NA (NA -\n",
       "  (IQR)]{style=\" font-weight: bold;    \"}      52)                                                     53)        NA)\n",
       "\n",
       "  [Age group, n                                                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  18 - 35 years                                 36       21 (58%)      10 (28%)         5 (14%)       0 (0%)     0 (0%)\n",
       "\n",
       "  36 - 45 years                                120       70 (58%)      25 (21%)        22 (18%)      3 (2.5%)    0 (0%)\n",
       "\n",
       "  \\>45 years                                   145       94 (65%)      21 (14%)        28 (19%)      2 (1.4%)    0 (0%)\n",
       "\n",
       "  [Gender, n                                                                                                   \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Male                                         172      106 (62%)      37 (22%)        26 (15%)      3 (1.7%)    0 (0%)\n",
       "\n",
       "  Female                                       128       78 (61%)      19 (15%)        29 (23%)      2 (1.6%)    0 (0%)\n",
       "\n",
       "  Transgender                                   1        1 (100%)       0 (0%)          0 (0%)        0 (0%)     0 (0%)\n",
       "\n",
       "  [Level of education, n                                                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Completed less than 10 years school          166      102 (61%)      26 (16%)        35 (21%)      3 (1.8%)    0 (0%)\n",
       "  education                                                                                                    \n",
       "\n",
       "  Completed more than 10 years school          135       83 (61%)      30 (22%)        20 (15%)      2 (1.5%)    0 (0%)\n",
       "  education                                                                                                    \n",
       "\n",
       "  [Income, n                                                                                                   \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Other                                        266      161 (61%)      49 (18%)        51 (19%)      5 (1.9%)    0 (0%)\n",
       "\n",
       "  Paid                                          35       24 (69%)       7 (20%)         4 (11%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Homelessness, n                                                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            15       10 (67%)      1 (6.7%)         4 (27%)       0 (0%)     0 (0%)\n",
       "\n",
       "  Yes                                          286      175 (61%)      55 (19%)        51 (18%)      5 (1.7%)    0 (0%)\n",
       "\n",
       "  [Incarceration, n                                                                                            \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           126       79 (63%)      24 (19%)        21 (17%)      2 (1.6%)    0 (0%)\n",
       "\n",
       "  Yes \\> 6 months                               29       16 (55%)       7 (24%)         6 (21%)       0 (0%)     0 (0%)\n",
       "\n",
       "  Yes \\< 6 months                              146       90 (62%)      25 (17%)        28 (19%)      3 (2.1%)    0 (0%)\n",
       "\n",
       "  [Chronic pain, n                                                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           182      110 (60%)      38 (21%)        29 (16%)      5 (2.7%)    0 (0%)\n",
       "\n",
       "  Yes                                          119       75 (63%)      18 (15%)        26 (22%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Heroin use, n                                                                                               \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           106       53 (50%)      31 (29%)        20 (19%)      2 (1.9%)    0 (0%)\n",
       "\n",
       "  Yes                                          195      132 (68%)      25 (13%)        35 (18%)      3 (1.5%)    0 (0%)\n",
       "\n",
       "  [Non-prescribed methadone use, n                                                                             \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           264      158 (60%)      53 (20%)        49 (19%)      4 (1.5%)    0 (0%)\n",
       "\n",
       "  Yes                                           37       27 (73%)      3 (8.1%)         6 (16%)      1 (2.7%)    0 (0%)\n",
       "\n",
       "  [Non-prescribed buprenorphine use, n                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           295      183 (62%)      53 (18%)        54 (18%)      5 (1.7%)    0 (0%)\n",
       "\n",
       "  Yes                                           6        2 (33%)        3 (50%)         1 (17%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Non-prescribed pharmaceutical opioid                                                                        \n",
       "  use, n                                                                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           266      160 (60%)      51 (19%)        50 (19%)      5 (1.9%)    0 (0%)\n",
       "\n",
       "  Yes                                           35       25 (71%)       5 (14%)         5 (14%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Cocaine use, n                                                                                              \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           280      172 (61%)      55 (20%)        50 (18%)      3 (1.1%)    0 (0%)\n",
       "\n",
       "  Yes                                           21       13 (62%)      1 (4.8%)         5 (24%)      2 (9.5%)    0 (0%)\n",
       "\n",
       "  [Methamphetamine use, n                                                                                      \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           180      115 (64%)      30 (17%)        32 (18%)      3 (1.7%)    0 (0%)\n",
       "\n",
       "  Yes                                          121       70 (58%)      26 (21%)        23 (19%)      2 (1.7%)    0 (0%)\n",
       "\n",
       "  [Recent benzodiazepine use, n                                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           158       95 (60%)      27 (17%)        31 (20%)      5 (3.2%)    0 (0%)\n",
       "\n",
       "  Yes                                          143       90 (63%)      29 (20%)        24 (17%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Drug injecting, n                                                                                           \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            79       38 (48%)      22 (28%)        17 (22%)      2 (2.5%)    0 (0%)\n",
       "\n",
       "  Yes                                          222      147 (66%)      34 (15%)        38 (17%)      3 (1.4%)    0 (0%)\n",
       "\n",
       "  [Drug injecting frequency, n                                                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Did not inject                                79       38 (48%)      22 (28%)        17 (22%)      2 (2.5%)    0 (0%)\n",
       "\n",
       "  Weekly or less                                57       36 (63%)      10 (18%)        10 (18%)      1 (1.8%)    0 (0%)\n",
       "\n",
       "  More than weekly, not daily                   80       56 (70%)      12 (15%)        11 (14%)      1 (1.3%)    0 (0%)\n",
       "\n",
       "  Once daily                                    37       28 (76%)      3 (8.1%)         6 (16%)       0 (0%)     0 (0%)\n",
       "\n",
       "  2 - 3 times a day                             35       18 (51%)       5 (14%)        11 (31%)      1 (2.9%)    0 (0%)\n",
       "\n",
       "  More than 3 times a day                       13       9 (69%)        4 (31%)         0 (0%)        0 (0%)     0 (0%)\n",
       "\n",
       "  [Heroin injecting, n                                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           115       57 (50%)      33 (29%)        23 (20%)      2 (1.7%)    0 (0%)\n",
       "\n",
       "  Yes                                          186      128 (69%)      23 (12%)        32 (17%)      3 (1.6%)    0 (0%)\n",
       "\n",
       "  [Non-prescribed methadone injecting, n                                                                       \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           279      165 (59%)      55 (20%)        54 (19%)      5 (1.8%)    0 (0%)\n",
       "\n",
       "  Yes                                           22       20 (91%)      1 (4.5%)        1 (4.5%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Non-precsribed buprenorphine injecting,                                                                     \n",
       "  n (%)]{style=\" font-weight: bold;    \"}                                                                      \n",
       "\n",
       "  No                                           290      180 (62%)      51 (18%)        54 (19%)      5 (1.7%)    0 (0%)\n",
       "\n",
       "  Yes                                           11       5 (45%)        5 (45%)        1 (9.1%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Non-prescribed pharmaceutical opioid                                                                        \n",
       "  injecting, n                                                                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           279      170 (61%)      52 (19%)        52 (19%)      5 (1.8%)    0 (0%)\n",
       "\n",
       "  Yes                                           22       15 (68%)       4 (18%)         3 (14%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Cocaine injecting, n                                                                                        \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           286      175 (61%)      56 (20%)        52 (18%)      3 (1.0%)    0 (0%)\n",
       "\n",
       "  Yes                                           15       10 (67%)       0 (0%)          3 (20%)      2 (13%)     0 (0%)\n",
       "\n",
       "  [Methamphetamine injecting, n                                                                                \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           208      128 (62%)      39 (19%)        38 (18%)      3 (1.4%)    0 (0%)\n",
       "\n",
       "  Yes                                           93       57 (61%)      17 (18%)        17 (18%)      2 (2.2%)    0 (0%)\n",
       "\n",
       "  [Ever received OAT with methadone, n                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            19       1 (5.3%)      12 (63%)         6 (32%)       0 (0%)     0 (0%)\n",
       "\n",
       "  Yes                                          282      184 (65%)      44 (16%)        49 (17%)      5 (1.8%)    0 (0%)\n",
       "\n",
       "  [Ever received OAT with buprenorphine, n                                                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            95       79 (83%)      2 (2.1%)        12 (13%)      2 (2.1%)    0 (0%)\n",
       "\n",
       "  Yes                                          206      106 (51%)      54 (26%)        43 (21%)      3 (1.5%)    0 (0%)\n",
       "\n",
       "  [Current OAT medication, n                                                                                   \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Methadone                                    235      180 (77%)      11 (4.7%)       39 (17%)      5 (2.1%)    0 (0%)\n",
       "\n",
       "  Suboxone                                      43       4 (9.3%)      36 (84%)        3 (7.0%)       0 (0%)     0 (0%)\n",
       "\n",
       "  Subutex                                       9        1 (11%)        7 (78%)         1 (11%)       0 (0%)     0 (0%)\n",
       "\n",
       "  Buvidal                                       14        0 (0%)        2 (14%)        12 (86%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Drugs used while on OAT, n                                                                                  \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                            57       31 (54%)      11 (19%)        11 (19%)      4 (7.0%)    0 (0%)\n",
       "\n",
       "  Heroin                                       167      113 (68%)      22 (13%)        31 (19%)      1 (0.6%)    0 (0%)\n",
       "\n",
       "  Pharmaceutical opioids                        10       7 (70%)        2 (20%)         1 (10%)       0 (0%)     0 (0%)\n",
       "\n",
       "  Methamphetamine                               26       11 (42%)       9 (35%)         6 (23%)       0 (0%)     0 (0%)\n",
       "\n",
       "  Benzodiazepines                               19       12 (63%)       5 (26%)         2 (11%)       0 (0%)     0 (0%)\n",
       "\n",
       "  Other                                         22       11 (50%)       7 (32%)         4 (18%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Average no. days OAT dose missed, n                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  None                                         170      109 (64%)      26 (15%)        32 (19%)      3 (1.8%)    0 (0%)\n",
       "\n",
       "  1 - 5 days                                    96       55 (57%)      25 (26%)        16 (17%)       0 (0%)     0 (0%)\n",
       "\n",
       "  \\> 5 days                                     35       21 (60%)       5 (14%)         7 (20%)      2 (5.7%)    0 (0%)\n",
       "\n",
       "  [Pay for OAT, n                                                                                              \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  No                                           109       63 (58%)      16 (15%)        29 (27%)      1 (0.9%)    0 (0%)\n",
       "\n",
       "  Yes                                          192      122 (64%)      40 (21%)        26 (14%)      4 (2.1%)    0 (0%)\n",
       "\n",
       "  [Site last dose collected, n                                                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Pharmacy                                     145       93 (64%)      30 (21%)        18 (12%)      4 (2.8%)    0 (0%)\n",
       "\n",
       "  Public clinic                                110       64 (58%)      15 (14%)        30 (27%)      1 (0.9%)    0 (0%)\n",
       "\n",
       "  Private clinic                                32       22 (69%)       5 (16%)         5 (16%)       0 (0%)     0 (0%)\n",
       "\n",
       "  At home                                       9        4 (44%)        5 (56%)         0 (0%)        0 (0%)     0 (0%)\n",
       "\n",
       "  Other                                         5        2 (40%)        1 (20%)         2 (40%)       0 (0%)     0 (0%)\n",
       "\n",
       "  [Frequency of OAT dose collection, n                                                                         \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Daily or several times per week              240      163 (68%)      37 (15%)        37 (15%)      3 (1.3%)    0 (0%)\n",
       "\n",
       "  Weekly or less frequently                     61       22 (36%)      19 (31%)        18 (30%)      2 (3.3%)    0 (0%)\n",
       "\n",
       "  [Travel distance to OAT collection site   3 (2 - 8)   3 (2 - 9)     5 (2 - 10)       3 (1 - 5)    2 (2 - 5)   NA (NA -\n",
       "  (km), Median                                                                                                    NA)\n",
       "  (IQR)]{style=\" font-weight: bold;    \"}                                                                      \n",
       "\n",
       "  [Travel time to dosing site, n                                                                               \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                                        \n",
       "\n",
       "  Less than 30 minutes                         214      132 (62%)      37 (17%)        42 (20%)      3 (1.4%)    0 (0%)\n",
       "\n",
       "  More than 30 minutes                          87       53 (61%)      19 (22%)        13 (15%)      2 (2.3%)    0 (0%)\n",
       "  -----------------------------------------------------------------------------------------------------------------------\n"
      ]
     }
    }
   ],
   "source": [
    "pts_oatfull_stratified.kable"
   ],
   "id": "27c330b3-fc44-4920-8ede-1addec6c9774"
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Table S3"
   ],
   "id": "3972efbd-6e74-4545-8c3d-02fed4c3f6f4"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "p <- p %>%\n",
    "mutate(prefer.factor = fct_relevel(prefer.factor,\"Methadone\", \"Buprenorphine\"))\n",
    "\n",
    "pts_oat_stratified <-  \n",
    "  p %>%\n",
    "  filter(lastdosesite != \"Not prescribed\")%>%\n",
    "  filter(prefertreat.yn == \"Prefers treatment\")%>%\n",
    "  filter(prefer.factor == \"Methadone\" | prefer.factor == \"Buprenorphine\")%>%\n",
    "  filter(pref_oat == \"Methadone\" | prefer.factor == \"Buprenorphine\")%>%\n",
    "  filter(oat.yn.f == \"Yes\")%>%\n",
    "  tbl_summary(by = prefer.factor, include = c(age, agegroup, \n",
    "                                              gender.mf, edu.factor,\n",
    "                                              income.factor.yn, homeless.factor.yn,         \n",
    "                                              prison.factor, chronicpain.factor.yn,\n",
    "                                              heroin.month.factor,  \n",
    "                                              nonmethadone.month.factor,\n",
    "                                              nonbupe.month.factor, \n",
    "                                              otheropi.month.factor, \n",
    "                                              cocaine.month.factor, meth.month.factor, \n",
    "                                              benzo.month.factor,\n",
    "                                              methadoneever.yn, bupeever.factor,\n",
    "                                              currentmed,\n",
    "                                              \n",
    "                                              usedrugs.oat, paytx.yn.f, \n",
    "                                              lastdosesite,clinic.attend.factor,  \n",
    "                                               kmdose, timedose.factor,\n",
    "                                              prefer.factor \n",
    "  ),\n",
    "  # type = all_categorical() ~ \"categorical\",\n",
    "  label = \n",
    "    list(age ~ \"Age\",\n",
    "         agegroup ~ \"Age group\",\n",
    "         gender.mf ~ \"Gender\",\n",
    "         usedrugs.oat ~ \"Drugs used while on OAT\",\n",
    "         methadoneever.yn ~ \"Ever received OAT with methadone\", \n",
    "         bupeever.factor ~ \"Ever received OAT with buprenorphine\",\n",
    "         timedose.factor ~ \"Travel time to dosing site\",\n",
    "         clinic.attend.factor ~ \"Frequency of OAT dose collection\",\n",
    "         kmdose ~ \"Travel distance to OAT collection site (km)\", \n",
    "         lastdosesite ~ \"Site last dose collected\",\n",
    "         otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n",
    "         currentmed ~ \"Current OAT medication\"), \n",
    "         # current_methadone ~ \"Currently receiving OAT with methadone\", \n",
    "         # current_buprenorphine ~ \"Currently receiving OAT with buprenorphine\"),\n",
    "  type = all_categorical()~\"categorical\",\n",
    "  missing = \"no\",\n",
    "  percent = \"row\",\n",
    "  statistic =(all_continuous()  ~ \"{median} ({p25} - {p75})\"),\n",
    "  digits = list(all_categorical() ~ c(0)))%>%\n",
    "  add_stat_label()%>%\n",
    "  add_overall(statistic = list(all_continuous()  ~ \"{median} ({p25} - {p75})\",\n",
    "                               all_categorical() ~ \"{n}\")) %>% \n",
    "  modify_footnote(update = everything() ~ NA, abbreviation = FALSE) %>%\n",
    "  add_n()%>%\n",
    "  modify_header(\n",
    "    stat_0 = '**Overall** \\n **(n = {n})**',\n",
    "    stat_1 = '**Methadone** \\n **(n = {n})**',\n",
    "    stat_2 = '**Buprenorphine** \\n **(n = {n})**'\n",
    "  ) %>%\n",
    "  bold_labels()%>%\n",
    "  # remove_row_type(variable = oatcurrentmed.f, \n",
    "  #                 type = \"level\", level_value = \"None\")%>%\n",
    "  remove_row_type(variable = clinic.attend.factor, \n",
    "                type = \"level\", level_value = \"0\")%>%\n",
    "  remove_row_type(variable = lastdosesite, \n",
    "                  type = \"level\", level_value = \"Not prescribed\")"
   ],
   "id": "729c0cfc-a3f5-4949-9b58-7a4e32aa2032"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "pts_oat_stratified.kable <- pts_oat_stratified %>% \n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\", \n",
    "    caption=\"Demographic and behavioural characteristics of people currently receiving OAT stratified by preference for methadone or buprenorphine\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )"
   ],
   "id": "5fee5da8-e325-4b85-83f0-2bb3aa46778f"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  -------------------------------------------------------------------------------------------------------\n",
       "  Characteristic                                  N           Overall\\      Methadone\\    Buprenorphine\\\n",
       "                                                             (n = 296)      (n = 185)       (n = 111)\n",
       "  ----------------------------------------- -------------- -------------- -------------- ----------------\n",
       "  [Age, Median                                   296        45 (39 - 52)   46 (40 - 54)    44 (39 - 51)\n",
       "  (IQR)]{style=\" font-weight: bold;    \"}                                                \n",
       "\n",
       "  [Age group, n                                  296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  18 - 35 years                                                  36          21 (58%)        15 (42%)\n",
       "\n",
       "  36 - 45 years                                                 117          70 (60%)        47 (40%)\n",
       "\n",
       "  \\>45 years                                                    143          94 (66%)        49 (34%)\n",
       "\n",
       "  [Gender, n                                     295                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  Female                                                        126          78 (62%)        48 (38%)\n",
       "\n",
       "  Male                                                          169         106 (63%)        63 (37%)\n",
       "\n",
       "  [Level of education, n                         296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  Completed less than 10 years school                           163         102 (63%)        61 (37%)\n",
       "  education                                                                              \n",
       "\n",
       "  Completed more than 10 years school                           133          83 (62%)        50 (38%)\n",
       "  education                                                                              \n",
       "\n",
       "  [Income, n                                     296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  Other                                                         261         161 (62%)       100 (38%)\n",
       "\n",
       "  Paid                                                           35          24 (69%)        11 (31%)\n",
       "\n",
       "  [Homelessness, n                               296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                             15          10 (67%)        5 (33%)\n",
       "\n",
       "  Yes                                                           281         175 (62%)       106 (38%)\n",
       "\n",
       "  [Incarceration, n                              296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            124          79 (64%)        45 (36%)\n",
       "\n",
       "  Yes \\> 6 months                                                29          16 (55%)        13 (45%)\n",
       "\n",
       "  Yes \\< 6 months                                               143          90 (63%)        53 (37%)\n",
       "\n",
       "  [Chronic pain, n                               296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            177         110 (62%)        67 (38%)\n",
       "\n",
       "  Yes                                                           119          75 (63%)        44 (37%)\n",
       "\n",
       "  [Heroin use, n                                 296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            104          53 (51%)        51 (49%)\n",
       "\n",
       "  Yes                                                           192         132 (69%)        60 (31%)\n",
       "\n",
       "  [Non-prescribed methadone use, n               296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            260         158 (61%)       102 (39%)\n",
       "\n",
       "  Yes                                                            36          27 (75%)        9 (25%)\n",
       "\n",
       "  [Non-prescribed buprenorphine use, n           296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            290         183 (63%)       107 (37%)\n",
       "\n",
       "  Yes                                                            6           2 (33%)         4 (67%)\n",
       "\n",
       "  [Non-prescribed pharmaceutical opioid          296                                     \n",
       "  use, n                                                                                 \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            261         160 (61%)       101 (39%)\n",
       "\n",
       "  Yes                                                            35          25 (71%)        10 (29%)\n",
       "\n",
       "  [Cocaine use, n                                296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            277         172 (62%)       105 (38%)\n",
       "\n",
       "  Yes                                                            19          13 (68%)        6 (32%)\n",
       "\n",
       "  [Methamphetamine use, n                        296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            177         115 (65%)        62 (35%)\n",
       "\n",
       "  Yes                                                           119          70 (59%)        49 (41%)\n",
       "\n",
       "  [Recent benzodiazepine use, n                  296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            153          95 (62%)        58 (38%)\n",
       "\n",
       "  Yes                                                           143          90 (63%)        53 (37%)\n",
       "\n",
       "  [Ever received OAT with methadone, n           296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                             19           1 (5%)         18 (95%)\n",
       "\n",
       "  Yes                                                           277         184 (66%)        93 (34%)\n",
       "\n",
       "  [Ever received OAT with buprenorphine, n       296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                             93          79 (85%)        14 (15%)\n",
       "\n",
       "  Yes                                                           203         106 (52%)        97 (48%)\n",
       "\n",
       "  [Current OAT medication, n                     296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  Methadone                                                     230         180 (78%)        50 (22%)\n",
       "\n",
       "  Buprenorphine                                                  66           5 (8%)         61 (92%)\n",
       "\n",
       "  [Drugs used while on OAT, n                    296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                             53          31 (58%)        22 (42%)\n",
       "\n",
       "  Heroin                                                        166         113 (68%)        53 (32%)\n",
       "\n",
       "  Pharmaceutical opioids                                         10          7 (70%)         3 (30%)\n",
       "\n",
       "  Methamphetamine                                                26          11 (42%)        15 (58%)\n",
       "\n",
       "  Benzodiazepines                                                19          12 (63%)        7 (37%)\n",
       "\n",
       "  Other                                                          22          11 (50%)        11 (50%)\n",
       "\n",
       "  [Pay for OAT, n                                296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  No                                                            108          63 (58%)        45 (42%)\n",
       "\n",
       "  Yes                                                           188         122 (65%)        66 (35%)\n",
       "\n",
       "  [Site last dose collected, n                   296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  Pharmacy                                                      141          93 (66%)        48 (34%)\n",
       "\n",
       "  Public clinic                                                 109          64 (59%)        45 (41%)\n",
       "\n",
       "  Private clinic                                                 32          22 (69%)        10 (31%)\n",
       "\n",
       "  At home                                                        9           4 (44%)         5 (56%)\n",
       "\n",
       "  Other                                                          5           2 (40%)         3 (60%)\n",
       "\n",
       "  [Frequency of OAT dose collection, n           296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  Daily or several times per week                               237         163 (69%)        74 (31%)\n",
       "\n",
       "  Weekly or less frequently                                      59          22 (37%)        37 (63%)\n",
       "\n",
       "  [Travel distance to OAT collection site        296         3 (2 - 8)      3 (2 - 9)       3 (2 - 8)\n",
       "  (km), Median                                                                           \n",
       "  (IQR)]{style=\" font-weight: bold;    \"}                                                \n",
       "\n",
       "  [Travel time to dosing site, n                 296                                     \n",
       "  (%)]{style=\" font-weight: bold;    \"}                                                  \n",
       "\n",
       "  Less than 30 minutes                                          211         132 (63%)        79 (37%)\n",
       "\n",
       "  More than 30 minutes                                           85          53 (62%)        32 (38%)\n",
       "  -------------------------------------------------------------------------------------------------------\n",
       "\n",
       "  : Demographic and behavioural characteristics of people currently\n",
       "  receiving OAT stratified by preference for methadone or buprenorphine\n"
      ]
     }
    }
   ],
   "source": [
    "pts_oat_stratified.kable"
   ],
   "id": "0302594d-3ed3-47b2-9ec5-07a9945bb134"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "p <- p %>%\n",
    "  mutate(prefer.factor = fct_relevel(prefer.factor, \"Buprenorphine\", \"Methadone\"))"
   ],
   "id": "8f70b40c-6473-4a72-a076-6007a43a747c"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    " oat_cor <-\n",
    "   p %>%\n",
    "  filter(lastdosesite != \"Not prescribed\")%>%\n",
    "  filter(prefertreat.yn == \"Prefers treatment\")%>%\n",
    "  filter(prefer.factor == \"Methadone\" | prefer.factor == \"Buprenorphine\")%>%\n",
    "  filter(pref_oat == \"Methadone\" | prefer.factor == \"Buprenorphine\")%>%\n",
    "  filter(oat.yn.f == \"Yes\")%>%\n",
    "  dplyr::select(age, gender.mf, nonmethadone.month.factor, \n",
    "                nonbupe.month.factor,heroin.month.factor,\n",
    "                methadoneever.yn, bupeever.factor, \n",
    "                currentmed,lastdosesite,\n",
    "                usedrugs.oat, paytx.yn.f,\n",
    "                clinic.attend.factor, kmdose,\n",
    "                timedose.factor, prefer.factor) %>%\n",
    "  tbl_uvregression(\n",
    "    method = glm,\n",
    "    y = prefer.factor, \n",
    "    label = list(age ~ \"Age\",\n",
    "         # agegroup ~ \"Age group\",\n",
    "         gender.mf ~ \"Gender\",\n",
    "         usedrugs.oat ~ \"Drugs used while on OAT\",\n",
    "         methadoneever.yn ~ \"Ever received OAT with methadone\", \n",
    "         bupeever.factor ~ \"Ever received OAT with buprenorphine\",\n",
    "         timedose.factor ~ \"Travel time to dosing site\",\n",
    "         clinic.attend.factor ~ \"Frequency of OAT dose collection\",\n",
    "         kmdose ~ \"Travel distance to OAT collection site (km)\", \n",
    "         lastdosesite ~ \"Site last dose collected\", \n",
    "         currentmed ~ \"Current OAT medication\"),\n",
    "                 # current_methadone ~ \"Currently receiving OAT with methadone\", \n",
    "                 # current_buprenorphine ~ \"Currently receiving OAT with buprenorphine\"),\n",
    "    method.args = list(family = binomial),\n",
    "    exponentiate = TRUE,\n",
    "    hide_n = TRUE,\n",
    "    pvalue_fun = function(x) style_pvalue(x, digits = 3)\n",
    "  ) %>%\n",
    "   modify_header(\n",
    "     label = \"**Variable**\",\n",
    "     estimate = '**cOR**',\n",
    "     ci = '**95% CI**',\n",
    "     p.value = '**p-value**'\n",
    "   ) %>%\n",
    "   modify_footnote(update = everything() ~ NA, abbreviation = TRUE) %>%\n",
    "   modify_table_styling(\n",
    "     column = estimate,\n",
    "     rows = !is.na(estimate),\n",
    "     cols_merge_pattern = \"{estimate} ({conf.low} - {conf.high})\"\n",
    "   ) %>%\n",
    "   modify_header(estimate = \"**cOR (95% CI)**\", \n",
    "                 all_stat_cols() ~ \"**{level}**, N = {n} ({style_percent(p)}%)\") %>%\n",
    "   modify_column_hide(c(ci)) %>% \n",
    "   # bold_p()%>% # bold p-values under a given threshold (default 0.05)\n",
    "   #bold_p(t = 0.10, q = TRUE) %>% # now bold q-values under the threshold of 0.10\n",
    "   bold_labels()%>%\n",
    "  remove_row_type(variable = clinic.attend.factor, \n",
    "                type = \"level\", level_value = \"0\")%>%\n",
    "  remove_row_type(variable = lastdosesite, \n",
    "                  type = \"level\", level_value = \"Not prescribed\")"
   ],
   "id": "76a87184-dc24-452c-a248-e53e5c322033"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "oat_cor.kable <- oat_cor %>% \n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\", \n",
    "    caption=\"Results of a univariate logistic regression with crude odds ratios and 95% confidence interval\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )"
   ],
   "id": "a1bd911f-51f5-4e08-91f1-7b3ae3e81672"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  Variable                                                                             cOR (95% CI)      p-value\n",
       "  -------------------------------------------------------------------------------- -------------------- ---------\n",
       "  [Age]{style=\" font-weight: bold;    \"}                                            1.01 (0.99 - 1.04)    0.367\n",
       "  [Gender]{style=\" font-weight: bold;    \"}                                                             \n",
       "  Female                                                                                   ---          \n",
       "  Male                                                                              1.04 (0.64 - 1.67)    0.886\n",
       "  [Non-prescribed methadone use]{style=\" font-weight: bold;    \"}                                       \n",
       "  No                                                                                       ---          \n",
       "  Yes                                                                               1.94 (0.91 - 4.52)    0.103\n",
       "  [Non-prescribed buprenorphine use]{style=\" font-weight: bold;    \"}                                   \n",
       "  No                                                                                       ---          \n",
       "  Yes                                                                               0.29 (0.04 - 1.52)    0.160\n",
       "  [Heroin use]{style=\" font-weight: bold;    \"}                                                         \n",
       "  No                                                                                       ---          \n",
       "  Yes                                                                               2.12 (1.30 - 3.47)    0.003\n",
       "  [Ever received OAT with methadone]{style=\" font-weight: bold;    \"}                                   \n",
       "  No                                                                                       ---          \n",
       "  Yes                                                                               35.6 (7.19 - 646)    \\<0.001\n",
       "  [Ever received OAT with buprenorphine]{style=\" font-weight: bold;    \"}                               \n",
       "  No                                                                                       ---          \n",
       "  Yes                                                                               0.19 (0.10 - 0.35)   \\<0.001\n",
       "  [Current OAT medication]{style=\" font-weight: bold;    \"}                                             \n",
       "  Methadone                                                                                ---          \n",
       "  Buprenorphine                                                                     0.02 (0.01 - 0.05)   \\<0.001\n",
       "  [Site last dose collected]{style=\" font-weight: bold;    \"}                                           \n",
       "  Pharmacy                                                                                 ---          \n",
       "  Public clinic                                                                     0.73 (0.44 - 1.23)    0.241\n",
       "  Private clinic                                                                    1.14 (0.51 - 2.68)    0.763\n",
       "  At home                                                                           0.41 (0.10 - 1.63)    0.202\n",
       "  Other                                                                             0.34 (0.04 - 2.14)    0.251\n",
       "  [Drugs used while on OAT]{style=\" font-weight: bold;    \"}                                            \n",
       "  No                                                                                       ---          \n",
       "  Heroin                                                                            1.51 (0.80 - 2.85)    0.202\n",
       "  Pharmaceutical opioids                                                            1.66 (0.41 - 8.34)    0.498\n",
       "  Methamphetamine                                                                   0.52 (0.20 - 1.34)    0.178\n",
       "  Benzodiazepines                                                                   1.22 (0.42 - 3.73)    0.722\n",
       "  Other                                                                             0.71 (0.26 - 1.94)    0.501\n",
       "  [Pay for OAT]{style=\" font-weight: bold;    \"}                                                        \n",
       "  No                                                                                       ---          \n",
       "  Yes                                                                               1.32 (0.81 - 2.15)    0.262\n",
       "  [Frequency of OAT dose collection]{style=\" font-weight: bold;    \"}                                   \n",
       "  Daily or several times per week                                                          ---          \n",
       "  Weekly or less frequently                                                         0.27 (0.15 - 0.49)   \\<0.001\n",
       "  [Travel distance to OAT collection site (km)]{style=\" font-weight: bold;    \"}    1.00 (0.98 - 1.02)    0.646\n",
       "  [Travel time to dosing site]{style=\" font-weight: bold;    \"}                                         \n",
       "  Less than 30 minutes                                                                     ---          \n",
       "  More than 30 minutes                                                              0.99 (0.59 - 1.68)    0.974\n",
       "\n",
       "  : Results of a univariate logistic regression with crude odds ratios\n",
       "  and 95% confidence interval\n"
      ]
     }
    }
   ],
   "source": [
    "oat_cor.kable"
   ],
   "id": "066a1d2c-c989-4988-9122-d22bb21bd7e1"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "<div id=\"pzxailjemu\" style=\"padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;\">\n",
       "<style>#pzxailjemu table {\n",
       "  font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\n",
       "  -webkit-font-smoothing: antialiased;\n",
       "  -moz-osx-font-smoothing: grayscale;\n",
       "}\n",
       "\n",
       "#pzxailjemu thead, #pzxailjemu tbody, #pzxailjemu tfoot, #pzxailjemu tr, #pzxailjemu td, #pzxailjemu th {\n",
       "  border-style: none;\n",
       "}\n",
       "\n",
       "#pzxailjemu p {\n",
       "  margin: 0;\n",
       "  padding: 0;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_table {\n",
       "  display: table;\n",
       "  border-collapse: collapse;\n",
       "  line-height: normal;\n",
       "  margin-left: auto;\n",
       "  margin-right: auto;\n",
       "  color: #333333;\n",
       "  font-size: 16px;\n",
       "  font-weight: normal;\n",
       "  font-style: normal;\n",
       "  background-color: #FFFFFF;\n",
       "  width: auto;\n",
       "  border-top-style: solid;\n",
       "  border-top-width: 2px;\n",
       "  border-top-color: #A8A8A8;\n",
       "  border-right-style: none;\n",
       "  border-right-width: 2px;\n",
       "  border-right-color: #D3D3D3;\n",
       "  border-bottom-style: solid;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #A8A8A8;\n",
       "  border-left-style: none;\n",
       "  border-left-width: 2px;\n",
       "  border-left-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_caption {\n",
       "  padding-top: 4px;\n",
       "  padding-bottom: 4px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_title {\n",
       "  color: #333333;\n",
       "  font-size: 125%;\n",
       "  font-weight: initial;\n",
       "  padding-top: 4px;\n",
       "  padding-bottom: 4px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "  border-bottom-color: #FFFFFF;\n",
       "  border-bottom-width: 0;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_subtitle {\n",
       "  color: #333333;\n",
       "  font-size: 85%;\n",
       "  font-weight: initial;\n",
       "  padding-top: 3px;\n",
       "  padding-bottom: 5px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "  border-top-color: #FFFFFF;\n",
       "  border-top-width: 0;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_heading {\n",
       "  background-color: #FFFFFF;\n",
       "  text-align: center;\n",
       "  border-bottom-color: #FFFFFF;\n",
       "  border-left-style: none;\n",
       "  border-left-width: 1px;\n",
       "  border-left-color: #D3D3D3;\n",
       "  border-right-style: none;\n",
       "  border-right-width: 1px;\n",
       "  border-right-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_bottom_border {\n",
       "  border-bottom-style: solid;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_col_headings {\n",
       "  border-top-style: solid;\n",
       "  border-top-width: 2px;\n",
       "  border-top-color: #D3D3D3;\n",
       "  border-bottom-style: solid;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "  border-left-style: none;\n",
       "  border-left-width: 1px;\n",
       "  border-left-color: #D3D3D3;\n",
       "  border-right-style: none;\n",
       "  border-right-width: 1px;\n",
       "  border-right-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_col_heading {\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  font-size: 100%;\n",
       "  font-weight: normal;\n",
       "  text-transform: inherit;\n",
       "  border-left-style: none;\n",
       "  border-left-width: 1px;\n",
       "  border-left-color: #D3D3D3;\n",
       "  border-right-style: none;\n",
       "  border-right-width: 1px;\n",
       "  border-right-color: #D3D3D3;\n",
       "  vertical-align: bottom;\n",
       "  padding-top: 5px;\n",
       "  padding-bottom: 6px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "  overflow-x: hidden;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_column_spanner_outer {\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  font-size: 100%;\n",
       "  font-weight: normal;\n",
       "  text-transform: inherit;\n",
       "  padding-top: 0;\n",
       "  padding-bottom: 0;\n",
       "  padding-left: 4px;\n",
       "  padding-right: 4px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_column_spanner_outer:first-child {\n",
       "  padding-left: 0;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_column_spanner_outer:last-child {\n",
       "  padding-right: 0;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_column_spanner {\n",
       "  border-bottom-style: solid;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "  vertical-align: bottom;\n",
       "  padding-top: 5px;\n",
       "  padding-bottom: 5px;\n",
       "  overflow-x: hidden;\n",
       "  display: inline-block;\n",
       "  width: 100%;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_spanner_row {\n",
       "  border-bottom-style: hidden;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_group_heading {\n",
       "  padding-top: 8px;\n",
       "  padding-bottom: 8px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  font-size: 100%;\n",
       "  font-weight: initial;\n",
       "  text-transform: inherit;\n",
       "  border-top-style: solid;\n",
       "  border-top-width: 2px;\n",
       "  border-top-color: #D3D3D3;\n",
       "  border-bottom-style: solid;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "  border-left-style: none;\n",
       "  border-left-width: 1px;\n",
       "  border-left-color: #D3D3D3;\n",
       "  border-right-style: none;\n",
       "  border-right-width: 1px;\n",
       "  border-right-color: #D3D3D3;\n",
       "  vertical-align: middle;\n",
       "  text-align: left;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_empty_group_heading {\n",
       "  padding: 0.5px;\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  font-size: 100%;\n",
       "  font-weight: initial;\n",
       "  border-top-style: solid;\n",
       "  border-top-width: 2px;\n",
       "  border-top-color: #D3D3D3;\n",
       "  border-bottom-style: solid;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "  vertical-align: middle;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_from_md > :first-child {\n",
       "  margin-top: 0;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_from_md > :last-child {\n",
       "  margin-bottom: 0;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_row {\n",
       "  padding-top: 8px;\n",
       "  padding-bottom: 8px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "  margin: 10px;\n",
       "  border-top-style: solid;\n",
       "  border-top-width: 1px;\n",
       "  border-top-color: #D3D3D3;\n",
       "  border-left-style: none;\n",
       "  border-left-width: 1px;\n",
       "  border-left-color: #D3D3D3;\n",
       "  border-right-style: none;\n",
       "  border-right-width: 1px;\n",
       "  border-right-color: #D3D3D3;\n",
       "  vertical-align: middle;\n",
       "  overflow-x: hidden;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_stub {\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  font-size: 100%;\n",
       "  font-weight: initial;\n",
       "  text-transform: inherit;\n",
       "  border-right-style: solid;\n",
       "  border-right-width: 2px;\n",
       "  border-right-color: #D3D3D3;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_stub_row_group {\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  font-size: 100%;\n",
       "  font-weight: initial;\n",
       "  text-transform: inherit;\n",
       "  border-right-style: solid;\n",
       "  border-right-width: 2px;\n",
       "  border-right-color: #D3D3D3;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "  vertical-align: top;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_row_group_first td {\n",
       "  border-top-width: 2px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_row_group_first th {\n",
       "  border-top-width: 2px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_summary_row {\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  text-transform: inherit;\n",
       "  padding-top: 8px;\n",
       "  padding-bottom: 8px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_first_summary_row {\n",
       "  border-top-style: solid;\n",
       "  border-top-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_first_summary_row.thick {\n",
       "  border-top-width: 2px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_last_summary_row {\n",
       "  padding-top: 8px;\n",
       "  padding-bottom: 8px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "  border-bottom-style: solid;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_grand_summary_row {\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  text-transform: inherit;\n",
       "  padding-top: 8px;\n",
       "  padding-bottom: 8px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_first_grand_summary_row {\n",
       "  padding-top: 8px;\n",
       "  padding-bottom: 8px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "  border-top-style: double;\n",
       "  border-top-width: 6px;\n",
       "  border-top-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_last_grand_summary_row_top {\n",
       "  padding-top: 8px;\n",
       "  padding-bottom: 8px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "  border-bottom-style: double;\n",
       "  border-bottom-width: 6px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_striped {\n",
       "  background-color: rgba(128, 128, 128, 0.05);\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_table_body {\n",
       "  border-top-style: solid;\n",
       "  border-top-width: 2px;\n",
       "  border-top-color: #D3D3D3;\n",
       "  border-bottom-style: solid;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_footnotes {\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  border-bottom-style: none;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "  border-left-style: none;\n",
       "  border-left-width: 2px;\n",
       "  border-left-color: #D3D3D3;\n",
       "  border-right-style: none;\n",
       "  border-right-width: 2px;\n",
       "  border-right-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_footnote {\n",
       "  margin: 0px;\n",
       "  font-size: 90%;\n",
       "  padding-top: 4px;\n",
       "  padding-bottom: 4px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_sourcenotes {\n",
       "  color: #333333;\n",
       "  background-color: #FFFFFF;\n",
       "  border-bottom-style: none;\n",
       "  border-bottom-width: 2px;\n",
       "  border-bottom-color: #D3D3D3;\n",
       "  border-left-style: none;\n",
       "  border-left-width: 2px;\n",
       "  border-left-color: #D3D3D3;\n",
       "  border-right-style: none;\n",
       "  border-right-width: 2px;\n",
       "  border-right-color: #D3D3D3;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_sourcenote {\n",
       "  font-size: 90%;\n",
       "  padding-top: 4px;\n",
       "  padding-bottom: 4px;\n",
       "  padding-left: 5px;\n",
       "  padding-right: 5px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_left {\n",
       "  text-align: left;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_center {\n",
       "  text-align: center;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_right {\n",
       "  text-align: right;\n",
       "  font-variant-numeric: tabular-nums;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_font_normal {\n",
       "  font-weight: normal;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_font_bold {\n",
       "  font-weight: bold;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_font_italic {\n",
       "  font-style: italic;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_super {\n",
       "  font-size: 65%;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_footnote_marks {\n",
       "  font-size: 75%;\n",
       "  vertical-align: 0.4em;\n",
       "  position: initial;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_asterisk {\n",
       "  font-size: 100%;\n",
       "  vertical-align: 0;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_indent_1 {\n",
       "  text-indent: 5px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_indent_2 {\n",
       "  text-indent: 10px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_indent_3 {\n",
       "  text-indent: 15px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_indent_4 {\n",
       "  text-indent: 20px;\n",
       "}\n",
       "\n",
       "#pzxailjemu .gt_indent_5 {\n",
       "  text-indent: 25px;\n",
       "}\n",
       "</style>\n",
       "<table class=\"gt_table\" data-quarto-postprocess=\"true\"\n",
       "data-quarto-disable-processing=\"false\" data-quarto-bootstrap=\"false\">\n",
       "<colgroup>\n",
       "<col style=\"width: 33%\" />\n",
       "<col style=\"width: 33%\" />\n",
       "<col style=\"width: 33%\" />\n",
       "</colgroup>\n",
       "<thead>\n",
       "<tr class=\"header gt_col_headings\">\n",
       "<th id=\"&lt;strong&gt;Variable&lt;/strong&gt;\"\n",
       "class=\"gt_col_heading gt_columns_bottom_border gt_left\"\n",
       "data-quarto-table-cell-role=\"th\"\n",
       "scope=\"col\"><strong>Variable</strong></th>\n",
       "<th id=\"&lt;strong&gt;cOR (95% CI)&lt;/strong&gt;\"\n",
       "class=\"gt_col_heading gt_columns_bottom_border gt_center\"\n",
       "data-quarto-table-cell-role=\"th\" scope=\"col\"><strong>cOR (95%\n",
       "CI)</strong></th>\n",
       "<th id=\"&lt;strong&gt;p-value&lt;/strong&gt;\"\n",
       "class=\"gt_col_heading gt_columns_bottom_border gt_center\"\n",
       "data-quarto-table-cell-role=\"th\"\n",
       "scope=\"col\"><strong>p-value</strong></th>\n",
       "</tr>\n",
       "</thead>\n",
       "<tbody class=\"gt_table_body\">\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Age</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.01 (0.99 - 1.04)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.367</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Gender</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Female</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Male</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.04 (0.64 - 1.67)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.886</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Level of education</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Completed less than 10\n",
       "years school education</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Completed more than 10\n",
       "years school education</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.99 (0.62 - 1.60)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.976</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Income</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Other</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Paid</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.36 (0.65 - 2.99)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.431</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Homelessness</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.83 (0.25 - 2.39)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.733</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Incarceration</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes &gt; 6 months</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.70 (0.31 - 1.61)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.395</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes &lt; 6 months</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.97 (0.59 - 1.59)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.896</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Chronic pain</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.04 (0.64 - 1.68)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.878</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Heroin use</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">2.12 (1.30 - 3.47)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.003</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Non-prescribed methadone use</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.94 (0.91 - 4.52)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.103</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Non-prescribed buprenorphine use</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.29 (0.04 - 1.52)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.160</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Non-prescribed pharmaceutical opioid use</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.58 (0.75 - 3.57)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.248</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Cocaine use</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.32 (0.51 - 3.86)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.583</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Methamphetamine use</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.77 (0.48 - 1.24)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.284</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Recent benzodiazepine use</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.04 (0.65 - 1.66)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.881</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Current OAT medication</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Methadone</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Buprenorphine</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.02 (0.01 - 0.05)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">&lt;0.001</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Drugs used while on OAT</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Heroin</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.51 (0.80 - 2.85)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.202</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Pharmaceutical\n",
       "opioids</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.66 (0.41 - 8.34)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.498</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Methamphetamine</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.52 (0.20 - 1.34)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.178</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Benzodiazepines</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.22 (0.42 - 3.73)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.722</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Other</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.71 (0.26 - 1.94)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.501</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\" style=\"font-weight: bold\">Pay\n",
       "for OAT</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    No</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Yes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.32 (0.81 - 2.15)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.262</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Frequency of OAT dose collection</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Daily or several times\n",
       "per week</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Weekly or less\n",
       "frequently</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.27 (0.15 - 0.49)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">&lt;0.001</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Travel distance to OAT collection site\n",
       "(km)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.00 (0.98 - 1.02)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.646</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Travel time to dosing site</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Less than 30 minutes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    More than 30 minutes</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.99 (0.59 - 1.68)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.974</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\"\n",
       "style=\"font-weight: bold\">Site last dose collected</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\"><br />\n",
       "</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Pharmacy</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">—</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\"><br />\n",
       "</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Public clinic</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.73 (0.44 - 1.23)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.241</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Private clinic</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">1.14 (0.51 - 2.68)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.763</td>\n",
       "</tr>\n",
       "<tr class=\"even\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    At home</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.41 (0.10 - 1.63)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.202</td>\n",
       "</tr>\n",
       "<tr class=\"odd\">\n",
       "<td class=\"gt_row gt_left\" headers=\"label\">    Other</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"estimate\">0.34 (0.04 - 2.14)</td>\n",
       "<td class=\"gt_row gt_center\" headers=\"p.value\">0.251</td>\n",
       "</tr>\n",
       "</tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/markdown": [
       "  -----------------------------------------------------------------------\n",
       "  **Variable**            **cOR (95% CI)**        **p-value**\n",
       "  ----------------------- ----------------------- -----------------------\n",
       "  Age                     1.01 (0.99 - 1.04)      0.367\n",
       "\n",
       "  Gender                  \\                       \\\n",
       "\n",
       "      Female              ---                     \\\n",
       "\n",
       "      Male                1.04 (0.64 - 1.67)      0.886\n",
       "\n",
       "  Level of education      \\                       \\\n",
       "\n",
       "      Completed less than ---                     \\\n",
       "  10 years school                                 \n",
       "  education                                       \n",
       "\n",
       "      Completed more than 0.99 (0.62 - 1.60)      0.976\n",
       "  10 years school                                 \n",
       "  education                                       \n",
       "\n",
       "  Income                  \\                       \\\n",
       "\n",
       "      Other               ---                     \\\n",
       "\n",
       "      Paid                1.36 (0.65 - 2.99)      0.431\n",
       "\n",
       "  Homelessness            \\                       \\\n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 0.83 (0.25 - 2.39)      0.733\n",
       "\n",
       "  Incarceration           \\                       \\\n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes \\> 6 months     0.70 (0.31 - 1.61)      0.395\n",
       "\n",
       "      Yes \\< 6 months     0.97 (0.59 - 1.59)      0.896\n",
       "\n",
       "  Chronic pain            \\                       \\\n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 1.04 (0.64 - 1.68)      0.878\n",
       "\n",
       "  Heroin use              \\                       \\\n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 2.12 (1.30 - 3.47)      0.003\n",
       "\n",
       "  Non-prescribed          \\                       \\\n",
       "  methadone use                                   \n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 1.94 (0.91 - 4.52)      0.103\n",
       "\n",
       "  Non-prescribed          \\                       \\\n",
       "  buprenorphine use                               \n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 0.29 (0.04 - 1.52)      0.160\n",
       "\n",
       "  Non-prescribed          \\                       \\\n",
       "  pharmaceutical opioid                           \n",
       "  use                                             \n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 1.58 (0.75 - 3.57)      0.248\n",
       "\n",
       "  Cocaine use             \\                       \\\n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 1.32 (0.51 - 3.86)      0.583\n",
       "\n",
       "  Methamphetamine use     \\                       \\\n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 0.77 (0.48 - 1.24)      0.284\n",
       "\n",
       "  Recent benzodiazepine   \\                       \\\n",
       "  use                                             \n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 1.04 (0.65 - 1.66)      0.881\n",
       "\n",
       "  Current OAT medication  \\                       \\\n",
       "\n",
       "      Methadone           ---                     \\\n",
       "\n",
       "      Buprenorphine       0.02 (0.01 - 0.05)      \\<0.001\n",
       "\n",
       "  Drugs used while on OAT \\                       \\\n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Heroin              1.51 (0.80 - 2.85)      0.202\n",
       "\n",
       "      Pharmaceutical      1.66 (0.41 - 8.34)      0.498\n",
       "  opioids                                         \n",
       "\n",
       "      Methamphetamine     0.52 (0.20 - 1.34)      0.178\n",
       "\n",
       "      Benzodiazepines     1.22 (0.42 - 3.73)      0.722\n",
       "\n",
       "      Other               0.71 (0.26 - 1.94)      0.501\n",
       "\n",
       "  Pay for OAT             \\                       \\\n",
       "\n",
       "      No                  ---                     \\\n",
       "\n",
       "      Yes                 1.32 (0.81 - 2.15)      0.262\n",
       "\n",
       "  Frequency of OAT dose   \\                       \\\n",
       "  collection                                      \n",
       "\n",
       "      Daily or several    ---                     \\\n",
       "  times per week                                  \n",
       "\n",
       "      Weekly or less      0.27 (0.15 - 0.49)      \\<0.001\n",
       "  frequently                                      \n",
       "\n",
       "  Travel distance to OAT  1.00 (0.98 - 1.02)      0.646\n",
       "  collection site (km)                            \n",
       "\n",
       "  Travel time to dosing   \\                       \\\n",
       "  site                                            \n",
       "\n",
       "      Less than 30        ---                     \\\n",
       "  minutes                                         \n",
       "\n",
       "      More than 30        0.99 (0.59 - 1.68)      0.974\n",
       "  minutes                                         \n",
       "\n",
       "  Site last dose          \\                       \\\n",
       "  collected                                       \n",
       "\n",
       "      Pharmacy            ---                     \\\n",
       "\n",
       "      Public clinic       0.73 (0.44 - 1.23)      0.241\n",
       "\n",
       "      Private clinic      1.14 (0.51 - 2.68)      0.763\n",
       "\n",
       "      At home             0.41 (0.10 - 1.63)      0.202\n",
       "\n",
       "      Other               0.34 (0.04 - 2.14)      0.251\n",
       "  -----------------------------------------------------------------------\n"
      ]
     }
    }
   ],
   "source": [
    "p <- p %>%\n",
    "  mutate(prefer.factor = fct_relevel(prefer.factor, \"Buprenorphine\", \"Methadone\"))\n",
    "\n",
    "\n",
    "oatcurrent_cor <-\n",
    "  p %>%\n",
    "  filter(lastdosesite != \"Not prescribed\")%>%\n",
    "  filter(prefertreat.yn == \"Prefers treatment\")%>%\n",
    "  filter(prefer.factor == \"Methadone\" | prefer.factor == \"Buprenorphine\")%>%\n",
    "  filter(pref_oat == \"Methadone\" | prefer.factor == \"Buprenorphine\")%>%\n",
    "  filter(oat.yn.f == \"Yes\")%>%\n",
    "  dplyr::select(age, gender.mf,edu.factor, income.factor.yn, homeless.factor.yn,  \n",
    "                prison.factor, chronicpain.factor.yn, heroin.month.factor, \n",
    "                nonmethadone.month.factor,\n",
    "                nonbupe.month.factor, otheropi.month.factor, \n",
    "                cocaine.month.factor, meth.month.factor, benzo.month.factor,\n",
    "                currentmed,\n",
    "                usedrugs.oat, paytx.yn.f,\n",
    "                clinic.attend.factor, kmdose,\n",
    "                timedose.factor, prefer.factor, lastdosesite) %>%\n",
    "  tbl_uvregression(\n",
    "    method = glm,\n",
    "    y = prefer.factor, \n",
    "    label = list(age ~ \"Age\",\n",
    "                 gender.mf ~ \"Gender\",\n",
    "                 otheropi.month.factor ~ \"Non-prescribed pharmaceutical opioid use\",\n",
    "                 usedrugs.oat ~ \"Drugs used while on OAT\",\n",
    "                 # methadoneever.yn ~ \"Ever received OAT with methadone\",\n",
    "                 # bupeever.factor ~ \"Ever received OAT with buprenorphine\", \n",
    "                 # gender.mf ~ \"Gender\", \n",
    "                 clinic.attend.factor ~ \"Frequency of OAT dose collection\", \n",
    "                 kmdose ~ \"Travel distance to OAT collection site (km)\", \n",
    "                 timedose.factor ~ \"Travel time to dosing site\",\n",
    "                 lastdosesite ~ \"Site last dose collected\",\n",
    "                 currentmed ~ \"Current OAT medication\"),\n",
    "    method.args = list(family = binomial),\n",
    "    exponentiate = TRUE,\n",
    "    hide_n = TRUE,\n",
    "    pvalue_fun = function(x) style_pvalue(x, digits = 3)\n",
    "  ) %>%\n",
    "  modify_header(\n",
    "    label = \"**Variable**\",\n",
    "    estimate = '**cOR**',\n",
    "    ci = '**95% CI**',\n",
    "    p.value = '**p-value**'\n",
    "  ) %>%\n",
    "  modify_footnote(update = everything() ~ NA, abbreviation = TRUE) %>%\n",
    "  modify_table_styling(\n",
    "    column = estimate,\n",
    "    rows = !is.na(estimate),\n",
    "    cols_merge_pattern = \"{estimate} ({conf.low} - {conf.high})\"\n",
    "  ) %>%\n",
    "  modify_header(estimate = \"**cOR (95% CI)**\", \n",
    "                all_stat_cols() ~ \"**{level}**, N = {n} ({style_percent(p)}%)\") %>%\n",
    "  modify_column_hide(c(ci)) %>% \n",
    "  # add_n()%>%\n",
    "  # bold_p()%>% # bold p-values under a given threshold (default 0.05)\n",
    "  #bold_p(t = 0.10, q = TRUE) %>% # now bold q-values under the threshold of 0.10\n",
    "  bold_labels()%>%\n",
    "  remove_row_type(variable = clinic.attend.factor, \n",
    "                type = \"level\", level_value = \"0\")%>%\n",
    "  remove_row_type(variable = lastdosesite, \n",
    "                  type = \"level\", level_value = \"Not prescribed\")%>%\n",
    " modify_table_styling(label = \"**Overall (n = {n})**\")\n",
    " \n",
    " oatcurrent_cor"
   ],
   "id": "435c65f8-a3cf-40e0-9af7-4a7ccb069a94"
  },
  {
   "cell_type": "raw",
   "metadata": {
    "raw_mimetype": "text/html"
   },
   "source": [
    "<!-- #### Variable selection -->"
   ],
   "id": "b4984fba-230a-4e4f-b345-b56945a7abd2"
  },
  {
   "cell_type": "raw",
   "metadata": {
    "raw_mimetype": "text/html"
   },
   "source": [
    "<!-- In univariate regression, variables that return a p-value \\< 0.20 are -->"
   ],
   "id": "cfa3b0aa-3d72-473b-be98-c34f506bd245"
  },
  {
   "cell_type": "raw",
   "metadata": {
    "raw_mimetype": "text/html"
   },
   "source": [
    "<!-- purposefully selected for inclusion in the final model. -->"
   ],
   "id": "ff8cd41f-1613-4802-b325-7f2bc5565fa7"
  },
  {
   "cell_type": "raw",
   "metadata": {
    "raw_mimetype": "text/html"
   },
   "source": [
    "<!-- The following variables had a p-value \\< 0.05 in the univariate -->"
   ],
   "id": "1aea0fde-e2b8-4d5c-990b-1b16e9e38f4d"
  },
  {
   "cell_type": "raw",
   "metadata": {
    "raw_mimetype": "text/html"
   },
   "source": [
    "<!-- regression: -->"
   ],
   "id": "fc79f4bc-decf-4e80-927d-c0a4e87a6d13"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "# aOR_var_oat <- p %>%\n",
    "# \n",
    "#   dplyr::select(age, gender.mf,  homeless.factor.yn, heroin.month.factor,\n",
    "#                 nonmethadone.month.factor,\n",
    "#                  currentmed,paytx.yn.f, lastdosesite,\n",
    "#                 doselocation.factor, clinic.attend, timedose.factor)"
   ],
   "id": "10e78514-0426-4c7e-9c60-291f03efc575"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "# aOR_var_oat <- map_df(aOR_variables_var, function(x) attributes(x)$label) %>% \n",
    "#   gather(key = Code, value = Label)"
   ],
   "id": "8b2385b9-53b9-4d0c-8db3-cbe447d62bcd"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "## View the codebook\n",
    "# library(kableExtra)\n",
    "# aOR_var_oat %>%\n",
    "#       kable(caption=\"Codebook of variables selected for the unadjusted odds ratios from a multivariable logistic regression among participants currently receiving OAT\", col.names = c(\"Variable\", \"Description\"),  booktabs = TRUE) %>%\n",
    "#   kable_styling(bootstrap_options = \"striped\", row_label_position = c(2, 5),  full_width = TRUE, position = \"center\", fixed_thead = list(enabled = T, background = \"anycolor\")) "
   ],
   "id": "49089412-8876-4c53-a037-021fa857c553"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "oat_model_final <- glm(prefer.factor ~ age + gender.mf + heroin.month.factor +  nonmethadone.month.factor + currentmed + paytx.yn.f + lastdosesite+  \n",
    "                         kmdose + clinic.attend.factor\n",
    "                       , data=p, family=binomial)"
   ],
   "id": "b028a50d-3d74-4b5e-968f-1be0ef889438"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stderr",
     "text": [
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred\n",
      "\n",
      "Warning: glm.fit: fitted probabilities numerically 0 or 1 occurred"
     ]
    }
   ],
   "source": [
    "oat_mod_final <- tbl_regression(oat_model_final, exponentiate = TRUE,  \n",
    "                                label = \n",
    "                                  list(age ~ \"Age\",\n",
    "        \n",
    "         gender.mf ~ \"Gender\",\n",
    "         # usedrugs.oat ~ \"Drugs used while on OAT\",\n",
    "         # methadoneever.yn ~ \"Ever received OAT with methadone\", \n",
    "         # bupeever.factor ~ \"Ever received OAT with buprenorphine\",\n",
    "         # timedose.factor ~ \"Travel time to dosing site\",\n",
    "         clinic.attend.factor ~ \"Frequency of OAT dose collection\",\n",
    "         kmdose ~ \"Travel distance to OAT collection site (km)\", \n",
    "         lastdosesite ~ \"Site last dose collected\", \n",
    "         currentmed ~ \"Current OAT medication\"),\n",
    "                                add_estimate_to_reference_rows = FALSE,\n",
    "                                # show_single_row = c(age, gender.mf, heroin.month.factor),\n",
    "                                pvalue_fun = function(x) style_pvalue(x, digits = 3))%>%\n",
    "  # pvalue_fun = ~style_sigfig(., digits = 4)                              )%>%\n",
    "  modify_header(\n",
    "    label = '**Variable**',\n",
    "    estimate = '**aOR**',\n",
    "    ci = '**95% CI**',\n",
    "    p.value = '**p-value**'\n",
    "  ) %>%\n",
    "  modify_footnote(update = everything() ~ NA, abbreviation = TRUE) %>%\n",
    "  modify_table_styling(\n",
    "    column = estimate,\n",
    "    rows = !is.na(estimate),\n",
    "    cols_merge_pattern = \"{estimate} ({conf.low} - {conf.high})\"\n",
    "  ) %>%\n",
    "  modify_header(estimate ~ \"**aOR (95% CI)**\") %>%\n",
    "  modify_column_hide(c(ci)) %>% \n",
    "  bold_labels() %>%\n",
    "  modify_footnote(everything() ~ NA, abbreviation = TRUE)%>%\n",
    "   remove_row_type(variable = clinic.attend.factor, \n",
    "                type = \"level\", level_value = \"0\")%>%\n",
    "  remove_row_type(variable = lastdosesite, \n",
    "                  type = \"level\", level_value = \"Not prescribed\")"
   ],
   "id": "1fd7027c-e86f-4255-aca9-26ac311b22f0"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "oat_mod_final.kable <- oat_mod_final%>% \n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\", \n",
    "    caption=\"Results of a multivariable logistic regression with adjusted odds ratios and 95% confidence interval among participants currently receiving OAT\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )"
   ],
   "id": "72e09d0b-92be-4e61-b11e-e6905a33aea3"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "  Variable                                                                             aOR (95% CI)      p-value\n",
       "  -------------------------------------------------------------------------------- -------------------- ---------\n",
       "  [Age]{style=\" font-weight: bold;    \"}                                            1.01 (0.98 - 1.05)    0.431\n",
       "  [Gender]{style=\" font-weight: bold;    \"}                                                             \n",
       "  Female                                                                                   ---          \n",
       "  Male                                                                              1.54 (0.82 - 2.90)    0.178\n",
       "  [Heroin use]{style=\" font-weight: bold;    \"}                                                         \n",
       "  No                                                                                       ---          \n",
       "  Yes                                                                               1.08 (0.54 - 2.09)    0.830\n",
       "  [Non-prescribed methadone use]{style=\" font-weight: bold;    \"}                                       \n",
       "  No                                                                                       ---          \n",
       "  Yes                                                                               1.12 (0.46 - 3.05)    0.819\n",
       "  [Current OAT medication]{style=\" font-weight: bold;    \"}                                             \n",
       "  Methadone                                                                                ---          \n",
       "  Buprenorphine                                                                     0.02 (0.01 - 0.06)   \\<0.001\n",
       "  [Pay for OAT]{style=\" font-weight: bold;    \"}                                                        \n",
       "  No                                                                                       ---          \n",
       "  Yes                                                                               1.24 (0.38 - 4.03)    0.725\n",
       "  [Site last dose collected]{style=\" font-weight: bold;    \"}                                           \n",
       "  Pharmacy                                                                                 ---          \n",
       "  Public clinic                                                                     0.88 (0.26 - 3.03)    0.843\n",
       "  Private clinic                                                                    0.96 (0.36 - 2.75)    0.930\n",
       "  At home                                                                           1.93 (0.20 - 18.5)    0.572\n",
       "  Other                                                                             0.21 (0.02 - 2.05)    0.159\n",
       "  [Travel distance to OAT collection site (km)]{style=\" font-weight: bold;    \"}    1.01 (0.98 - 1.04)    0.536\n",
       "  [Frequency of OAT dose collection]{style=\" font-weight: bold;    \"}                                   \n",
       "  Daily or several times per week                                                          ---          \n",
       "  Weekly or less frequently                                                         0.43 (0.17 - 1.08)    0.067\n",
       "\n",
       "  : Results of a multivariable logistic regression with adjusted odds\n",
       "  ratios and 95% confidence interval among participants currently\n",
       "  receiving OAT\n"
      ]
     }
    }
   ],
   "source": [
    "oat_mod_final.kable"
   ],
   "id": "b572c202-7609-43a1-8fb8-a7d8d2220b0a"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "table_merged_oat <-\n",
    "  tbl_merge(\n",
    "    tbls = list(pts_oat_stratified, oatcurrent_cor,oat_mod_final),\n",
    "    tab_spanner = c(\"** **\", \"**Unadjusted model**\", \"**Adjusted model**\")) %>%\n",
    "  modify_header(label = \"**Variable**\") %>% # update the column header\n",
    "  modify_footnote(everything() ~ NA)"
   ],
   "id": "9aabf2c4-e1fa-46ce-b2a6-b208095f4ab3"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [],
   "source": [
    "table_merged_oat.kable <- table_merged_oat %>% \n",
    "   gtsummary::as_kable_extra(\n",
    "    format = \"html\",\n",
    "    booktabs = TRUE,\n",
    "    longtable = TRUE,\n",
    "    linesep = \"\", \n",
    "    caption=\"Demographic and behavioral characteristics stratified by OAT medication preference and sesults of a multivariable logistic regression with adjusted odds ratios and 95% confidence interval among participants currently receiving OAT\")%>%\n",
    "  kableExtra::kable_styling(\n",
    "      position = \"left\",\n",
    "      latex_options = c(\"striped\", \"repeat_header\"),\n",
    "      stripe_color = \"gray!15\"\n",
    "    )\n",
    "#       scroll_box(\n",
    "#   height = \"100%\",\n",
    "#   width = \"100%\",\n",
    "#   box_css = \"border: 1px solid #ddd; padding: 5px; \",\n",
    "#   extra_css = NULL,\n",
    "#   fixed_thead = TRUE\n",
    "# )"
   ],
   "id": "57ace989-e995-433e-9737-7c35be5647a0"
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "layout-align": "center"
   },
   "outputs": [
    {
     "output_type": "display_data",
     "metadata": {},
     "data": {
      "text/html": [
       "\n"
      ],
      "text/markdown": [
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "|       |       |       |       |       | :     |       | :     |       |\n",
       "|       |       |       |       |       | :: {s |       | :: {s |       |\n",
       "|       |       |       |       |       | tyle= |       | tyle= |       |\n",
       "|       |       |       |       |       | \"bord |       | \"bord |       |\n",
       "|       |       |       |       |       | er-bo |       | er-bo |       |\n",
       "|       |       |       |       |       | ttom: |       | ttom: |       |\n",
       "|       |       |       |       |       |  1px  |       |  1px  |       |\n",
       "|       |       |       |       |       | solid |       | solid |       |\n",
       "|       |       |       |       |       |  #ddd |       |  #ddd |       |\n",
       "|       |       |       |       |       | ; pad |       | ; pad |       |\n",
       "|       |       |       |       |       | ding- |       | ding- |       |\n",
       "|       |       |       |       |       | botto |       | botto |       |\n",
       "|       |       |       |       |       | m: 5p |       | m: 5p |       |\n",
       "|       |       |       |       |       | x; \"} |       | x; \"} |       |\n",
       "|       |       |       |       |       | Unadj |       | Adj   |       |\n",
       "|       |       |       |       |       | usted |       | usted |       |\n",
       "|       |       |       |       |       | model |       | model |       |\n",
       "|       |       |       |       |       | :::   |       | :::   |       |\n",
       "+:======+:=====:+:=====:+:=====:+:=====:+:=====:+:=====:+:=====:+:=====:+\n",
       "| Var   | N     | Ove   | Metha | Bupr  | cOR   | p-    | aOR   | p-    |\n",
       "| iable |       | rall\\ | done\\ | enorp | (95%  | value | (95%  | value |\n",
       "|       |       | (n =  | (n =  | hine\\ | CI)   |       | CI)   |       |\n",
       "|       |       | 296)  | 185)  | (n =  |       |       |       |       |\n",
       "|       |       |       |       | 111)  |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Age, | 296   | 45    | 46    | 44    | 1.01  | 0.367 | 1.01  | 0.431 |\n",
       "| M     |       | (39 - | (40 - | (39 - | (0    |       | (0    |       |\n",
       "| edian |       | 52)   | 54)   | 51)   | .99 - |       | .98 - |       |\n",
       "| (IQR  |       |       |       |       | 1.04) |       | 1.05) |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Age  | 296   |       |       |       |       |       |       |       |\n",
       "| g     |       |       |       |       |       |       |       |       |\n",
       "| roup, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| 18 -  |       | 36    | 21    | 15    |       |       |       |       |\n",
       "| 35    |       |       | (58%) | (42%) |       |       |       |       |\n",
       "| years |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| 36 -  |       | 117   | 70    | 47    |       |       |       |       |\n",
       "| 45    |       |       | (60%) | (40%) |       |       |       |       |\n",
       "| years |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| \\>45  |       | 143   | 94    | 49    |       |       |       |       |\n",
       "| years |       |       | (66%) | (34%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Ge   | 295   |       |       |       |       |       |       |       |\n",
       "| nder, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| F     |       | 126   | 78    | 48    | ---   |       | ---   |       |\n",
       "| emale |       |       | (62%) | (38%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Male  |       | 169   | 106   | 63    | 1.04  | 0.886 | 1.54  | 0.178 |\n",
       "|       |       |       | (63%) | (37%) | (0    |       | (0    |       |\n",
       "|       |       |       |       |       | .64 - |       | .82 - |       |\n",
       "|       |       |       |       |       | 1.67) |       | 2.90) |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [     | 296   |       |       |       |       |       |       |       |\n",
       "| Level |       |       |       |       |       |       |       |       |\n",
       "| of    |       |       |       |       |       |       |       |       |\n",
       "| educa |       |       |       |       |       |       |       |       |\n",
       "| tion, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Comp  |       | 163   | 102   | 61    | ---   |       |       |       |\n",
       "| leted |       |       | (63%) | (37%) |       |       |       |       |\n",
       "| less  |       |       |       |       |       |       |       |       |\n",
       "| than  |       |       |       |       |       |       |       |       |\n",
       "| 10    |       |       |       |       |       |       |       |       |\n",
       "| years |       |       |       |       |       |       |       |       |\n",
       "| s     |       |       |       |       |       |       |       |       |\n",
       "| chool |       |       |       |       |       |       |       |       |\n",
       "| educ  |       |       |       |       |       |       |       |       |\n",
       "| ation |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Comp  |       | 133   | 83    | 50    | 0.99  | 0.976 |       |       |\n",
       "| leted |       |       | (62%) | (38%) | (0    |       |       |       |\n",
       "| more  |       |       |       |       | .62 - |       |       |       |\n",
       "| than  |       |       |       |       | 1.60) |       |       |       |\n",
       "| 10    |       |       |       |       |       |       |       |       |\n",
       "| years |       |       |       |       |       |       |       |       |\n",
       "| s     |       |       |       |       |       |       |       |       |\n",
       "| chool |       |       |       |       |       |       |       |       |\n",
       "| educ  |       |       |       |       |       |       |       |       |\n",
       "| ation |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [In   | 296   |       |       |       |       |       |       |       |\n",
       "| come, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Other |       | 261   | 161   | 100   | ---   |       |       |       |\n",
       "|       |       |       | (62%) | (38%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Paid  |       | 35    | 24    | 11    | 1.36  | 0.431 |       |       |\n",
       "|       |       |       | (69%) | (31%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .65 - |       |       |       |\n",
       "|       |       |       |       |       | 2.99) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Hom  | 296   |       |       |       |       |       |       |       |\n",
       "| eless |       |       |       |       |       |       |       |       |\n",
       "| ness, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 15    | 10    | 5     | ---   |       |       |       |\n",
       "|       |       |       | (67%) | (33%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 281   | 175   | 106   | 0.83  | 0.733 |       |       |\n",
       "|       |       |       | (62%) | (38%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .25 - |       |       |       |\n",
       "|       |       |       |       |       | 2.39) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Inca | 296   |       |       |       |       |       |       |       |\n",
       "| rcera |       |       |       |       |       |       |       |       |\n",
       "| tion, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 124   | 79    | 45    | ---   |       |       |       |\n",
       "|       |       |       | (64%) | (36%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 29    | 16    | 13    | 0.70  | 0.395 |       |       |\n",
       "| \\> 6  |       |       | (55%) | (45%) | (0    |       |       |       |\n",
       "| m     |       |       |       |       | .31 - |       |       |       |\n",
       "| onths |       |       |       |       | 1.61) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 143   | 90    | 53    | 0.97  | 0.896 |       |       |\n",
       "| \\< 6  |       |       | (63%) | (37%) | (0    |       |       |       |\n",
       "| m     |       |       |       |       | .59 - |       |       |       |\n",
       "| onths |       |       |       |       | 1.59) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Ch   | 296   |       |       |       |       |       |       |       |\n",
       "| ronic |       |       |       |       |       |       |       |       |\n",
       "| pain, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 177   | 110   | 67    | ---   |       |       |       |\n",
       "|       |       |       | (62%) | (38%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 119   | 75    | 44    | 1.04  | 0.878 |       |       |\n",
       "|       |       |       | (63%) | (37%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .64 - |       |       |       |\n",
       "|       |       |       |       |       | 1.68) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [H    | 296   |       |       |       |       |       |       |       |\n",
       "| eroin |       |       |       |       |       |       |       |       |\n",
       "| use,  |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 104   | 53    | 51    | ---   |       | ---   |       |\n",
       "|       |       |       | (51%) | (49%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 192   | 132   | 60    | 2.12  | 0.003 | 1.08  | 0.830 |\n",
       "|       |       |       | (69%) | (31%) | (1    |       | (0    |       |\n",
       "|       |       |       |       |       | .30 - |       | .54 - |       |\n",
       "|       |       |       |       |       | 3.47) |       | 2.09) |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Non- | 296   |       |       |       |       |       |       |       |\n",
       "| presc |       |       |       |       |       |       |       |       |\n",
       "| ribed |       |       |       |       |       |       |       |       |\n",
       "| meth  |       |       |       |       |       |       |       |       |\n",
       "| adone |       |       |       |       |       |       |       |       |\n",
       "| use,  |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 260   | 158   | 102   | ---   |       | ---   |       |\n",
       "|       |       |       | (61%) | (39%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 36    | 27    | 9     | 1.94  | 0.103 | 1.12  | 0.819 |\n",
       "|       |       |       | (75%) | (25%) | (0    |       | (0    |       |\n",
       "|       |       |       |       |       | .91 - |       | .46 - |       |\n",
       "|       |       |       |       |       | 4.52) |       | 3.05) |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Non- | 296   |       |       |       |       |       |       |       |\n",
       "| presc |       |       |       |       |       |       |       |       |\n",
       "| ribed |       |       |       |       |       |       |       |       |\n",
       "| bup   |       |       |       |       |       |       |       |       |\n",
       "| renor |       |       |       |       |       |       |       |       |\n",
       "| phine |       |       |       |       |       |       |       |       |\n",
       "| use,  |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 290   | 183   | 107   | ---   |       |       |       |\n",
       "|       |       |       | (63%) | (37%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 6     | 2     | 4     | 0.29  | 0.160 |       |       |\n",
       "|       |       |       | (33%) | (67%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .04 - |       |       |       |\n",
       "|       |       |       |       |       | 1.52) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Non- | 296   |       |       |       |       |       |       |       |\n",
       "| presc |       |       |       |       |       |       |       |       |\n",
       "| ribed |       |       |       |       |       |       |       |       |\n",
       "| phar  |       |       |       |       |       |       |       |       |\n",
       "| maceu |       |       |       |       |       |       |       |       |\n",
       "| tical |       |       |       |       |       |       |       |       |\n",
       "| o     |       |       |       |       |       |       |       |       |\n",
       "| pioid |       |       |       |       |       |       |       |       |\n",
       "| use,  |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 261   | 160   | 101   | ---   |       |       |       |\n",
       "|       |       |       | (61%) | (39%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 35    | 25    | 10    | 1.58  | 0.248 |       |       |\n",
       "|       |       |       | (71%) | (29%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .75 - |       |       |       |\n",
       "|       |       |       |       |       | 3.57) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Co   | 296   |       |       |       |       |       |       |       |\n",
       "| caine |       |       |       |       |       |       |       |       |\n",
       "| use,  |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 277   | 172   | 105   | ---   |       |       |       |\n",
       "|       |       |       | (62%) | (38%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 19    | 13    | 6     | 1.32  | 0.583 |       |       |\n",
       "|       |       |       | (68%) | (32%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .51 - |       |       |       |\n",
       "|       |       |       |       |       | 3.86) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [     | 296   |       |       |       |       |       |       |       |\n",
       "| Metha |       |       |       |       |       |       |       |       |\n",
       "| mphet |       |       |       |       |       |       |       |       |\n",
       "| amine |       |       |       |       |       |       |       |       |\n",
       "| use,  |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 177   | 115   | 62    | ---   |       |       |       |\n",
       "|       |       |       | (65%) | (35%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 119   | 70    | 49    | 0.77  | 0.284 |       |       |\n",
       "|       |       |       | (59%) | (41%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .48 - |       |       |       |\n",
       "|       |       |       |       |       | 1.24) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [R    | 296   |       |       |       |       |       |       |       |\n",
       "| ecent |       |       |       |       |       |       |       |       |\n",
       "| benz  |       |       |       |       |       |       |       |       |\n",
       "| odiaz |       |       |       |       |       |       |       |       |\n",
       "| epine |       |       |       |       |       |       |       |       |\n",
       "| use,  |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 153   | 95    | 58    | ---   |       |       |       |\n",
       "|       |       |       | (62%) | (38%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 143   | 90    | 53    | 1.04  | 0.881 |       |       |\n",
       "|       |       |       | (63%) | (37%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .65 - |       |       |       |\n",
       "|       |       |       |       |       | 1.66) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Ever | 296   |       |       |       |       |       |       |       |\n",
       "| rec   |       |       |       |       |       |       |       |       |\n",
       "| eived |       |       |       |       |       |       |       |       |\n",
       "| OAT   |       |       |       |       |       |       |       |       |\n",
       "| with  |       |       |       |       |       |       |       |       |\n",
       "| metha |       |       |       |       |       |       |       |       |\n",
       "| done, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 19    | 1     | 18    |       |       |       |       |\n",
       "|       |       |       | (5%)  | (95%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 277   | 184   | 93    |       |       |       |       |\n",
       "|       |       |       | (66%) | (34%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Ever | 296   |       |       |       |       |       |       |       |\n",
       "| rec   |       |       |       |       |       |       |       |       |\n",
       "| eived |       |       |       |       |       |       |       |       |\n",
       "| OAT   |       |       |       |       |       |       |       |       |\n",
       "| with  |       |       |       |       |       |       |       |       |\n",
       "| bupr  |       |       |       |       |       |       |       |       |\n",
       "| enorp |       |       |       |       |       |       |       |       |\n",
       "| hine, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 93    | 79    | 14    |       |       |       |       |\n",
       "|       |       |       | (85%) | (15%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 203   | 106   | 97    |       |       |       |       |\n",
       "|       |       |       | (52%) | (48%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Cu   | 296   |       |       |       |       |       |       |       |\n",
       "| rrent |       |       |       |       |       |       |       |       |\n",
       "| OAT   |       |       |       |       |       |       |       |       |\n",
       "| m     |       |       |       |       |       |       |       |       |\n",
       "| edica |       |       |       |       |       |       |       |       |\n",
       "| tion, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Meth  |       | 230   | 180   | 50    | ---   |       | ---   |       |\n",
       "| adone |       |       | (78%) | (22%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Bup   |       | 66    | 5     | 61    | 0.02  | \\<    | 0.02  | \\<    |\n",
       "| renor |       |       | (8%)  | (92%) | (0    | 0.001 | (0    | 0.001 |\n",
       "| phine |       |       |       |       | .01 - |       | .01 - |       |\n",
       "|       |       |       |       |       | 0.05) |       | 0.06) |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [     | 296   |       |       |       |       |       |       |       |\n",
       "| Drugs |       |       |       |       |       |       |       |       |\n",
       "| used  |       |       |       |       |       |       |       |       |\n",
       "| while |       |       |       |       |       |       |       |       |\n",
       "| on    |       |       |       |       |       |       |       |       |\n",
       "| OAT,  |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 53    | 31    | 22    | ---   |       |       |       |\n",
       "|       |       |       | (58%) | (42%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| H     |       | 166   | 113   | 53    | 1.51  | 0.202 |       |       |\n",
       "| eroin |       |       | (68%) | (32%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .80 - |       |       |       |\n",
       "|       |       |       |       |       | 2.85) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Phar  |       | 10    | 7     | 3     | 1.66  | 0.498 |       |       |\n",
       "| maceu |       |       | (70%) | (30%) | (0    |       |       |       |\n",
       "| tical |       |       |       |       | .41 - |       |       |       |\n",
       "| op    |       |       |       |       | 8.34) |       |       |       |\n",
       "| ioids |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Metha |       | 26    | 11    | 15    | 0.52  | 0.178 |       |       |\n",
       "| mphet |       |       | (42%) | (58%) | (0    |       |       |       |\n",
       "| amine |       |       |       |       | .20 - |       |       |       |\n",
       "|       |       |       |       |       | 1.34) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Benzo |       | 19    | 12    | 7     | 1.22  | 0.722 |       |       |\n",
       "| diaze |       |       | (63%) | (37%) | (0    |       |       |       |\n",
       "| pines |       |       |       |       | .42 - |       |       |       |\n",
       "|       |       |       |       |       | 3.73) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Other |       | 22    | 11    | 11    | 0.71  | 0.501 |       |       |\n",
       "|       |       |       | (50%) | (50%) | (0    |       |       |       |\n",
       "|       |       |       |       |       | .26 - |       |       |       |\n",
       "|       |       |       |       |       | 1.94) |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Pay  | 296   |       |       |       |       |       |       |       |\n",
       "| for   |       |       |       |       |       |       |       |       |\n",
       "| OAT,  |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| No    |       | 108   | 63    | 45    | ---   |       | ---   |       |\n",
       "|       |       |       | (58%) | (42%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Yes   |       | 188   | 122   | 66    | 1.32  | 0.262 | 1.24  | 0.725 |\n",
       "|       |       |       | (65%) | (35%) | (0    |       | (0    |       |\n",
       "|       |       |       |       |       | .81 - |       | .38 - |       |\n",
       "|       |       |       |       |       | 2.15) |       | 4.03) |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Site | 296   |       |       |       |       |       |       |       |\n",
       "| last  |       |       |       |       |       |       |       |       |\n",
       "| dose  |       |       |       |       |       |       |       |       |\n",
       "| colle |       |       |       |       |       |       |       |       |\n",
       "| cted, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Pha   |       | 141   | 93    | 48    | ---   |       | ---   |       |\n",
       "| rmacy |       |       | (66%) | (34%) |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| P     |       | 109   | 64    | 45    | 0.73  | 0.241 | 0.88  | 0.843 |\n",
       "| ublic |       |       | (59%) | (41%) | (0    |       | (0    |       |\n",
       "| c     |       |       |       |       | .44 - |       | .26 - |       |\n",
       "| linic |       |       |       |       | 1.23) |       | 3.03) |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Pr    |       | 32    | 22    | 10    | 1.14  | 0.763 | 0.96  | 0.930 |\n",
       "| ivate |       |       | (69%) | (31%) | (0    |       | (0    |       |\n",
       "| c     |       |       |       |       | .51 - |       | .36 - |       |\n",
       "| linic |       |       |       |       | 2.68) |       | 2.75) |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| At    |       | 9     | 4     | 5     | 0.41  | 0.202 | 1.93  | 0.572 |\n",
       "| home  |       |       | (44%) | (56%) | (0    |       | (0    |       |\n",
       "|       |       |       |       |       | .10 - |       | .20 - |       |\n",
       "|       |       |       |       |       | 1.63) |       | 18.5) |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Other |       | 5     | 2     | 3     | 0.34  | 0.251 | 0.21  | 0.159 |\n",
       "|       |       |       | (40%) | (60%) | (0    |       | (0    |       |\n",
       "|       |       |       |       |       | .04 - |       | .02 - |       |\n",
       "|       |       |       |       |       | 2.14) |       | 2.05) |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [Freq | 296   |       |       |       |       |       |       |       |\n",
       "| uency |       |       |       |       |       |       |       |       |\n",
       "| of    |       |       |       |       |       |       |       |       |\n",
       "| OAT   |       |       |       |       |       |       |       |       |\n",
       "| dose  |       |       |       |       |       |       |       |       |\n",
       "| c     |       |       |       |       |       |       |       |       |\n",
       "| ollec |       |       |       |       |       |       |       |       |\n",
       "| tion, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Daily |       | 237   | 163   | 74    | ---   |       | ---   |       |\n",
       "| or    |       |       | (69%) | (31%) |       |       |       |       |\n",
       "| se    |       |       |       |       |       |       |       |       |\n",
       "| veral |       |       |       |       |       |       |       |       |\n",
       "| times |       |       |       |       |       |       |       |       |\n",
       "| per   |       |       |       |       |       |       |       |       |\n",
       "| week  |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| W     |       | 59    | 22    | 37    | 0.27  | \\<    | 0.43  | 0.067 |\n",
       "| eekly |       |       | (37%) | (63%) | (0    | 0.001 | (0    |       |\n",
       "| or    |       |       |       |       | .15 - |       | .17 - |       |\n",
       "| less  |       |       |       |       | 0.49) |       | 1.08) |       |\n",
       "| frequ |       |       |       |       |       |       |       |       |\n",
       "| ently |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [T    | 296   | 3     | 3     | 3     | 1.00  | 0.646 | 1.01  | 0.536 |\n",
       "| ravel |       | (2 -  | (2 -  | (2 -  | (0    |       | (0    |       |\n",
       "| dis   |       | 8)    | 9)    | 8)    | .98 - |       | .98 - |       |\n",
       "| tance |       |       |       |       | 1.02) |       | 1.04) |       |\n",
       "| to    |       |       |       |       |       |       |       |       |\n",
       "| OAT   |       |       |       |       |       |       |       |       |\n",
       "| colle |       |       |       |       |       |       |       |       |\n",
       "| ction |       |       |       |       |       |       |       |       |\n",
       "| site  |       |       |       |       |       |       |       |       |\n",
       "| (km), |       |       |       |       |       |       |       |       |\n",
       "| M     |       |       |       |       |       |       |       |       |\n",
       "| edian |       |       |       |       |       |       |       |       |\n",
       "| (IQR  |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| [T    | 296   |       |       |       |       |       |       |       |\n",
       "| ravel |       |       |       |       |       |       |       |       |\n",
       "| time  |       |       |       |       |       |       |       |       |\n",
       "| to    |       |       |       |       |       |       |       |       |\n",
       "| d     |       |       |       |       |       |       |       |       |\n",
       "| osing |       |       |       |       |       |       |       |       |\n",
       "| site, |       |       |       |       |       |       |       |       |\n",
       "| n     |       |       |       |       |       |       |       |       |\n",
       "| (%    |       |       |       |       |       |       |       |       |\n",
       "| )]{st |       |       |       |       |       |       |       |       |\n",
       "| yle=\" |       |       |       |       |       |       |       |       |\n",
       "|  font |       |       |       |       |       |       |       |       |\n",
       "| -weig |       |       |       |       |       |       |       |       |\n",
       "| ht: b |       |       |       |       |       |       |       |       |\n",
       "| old;  |       |       |       |       |       |       |       |       |\n",
       "|    \"} |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| Less  |       | 211   | 132   | 79    | ---   |       |       |       |\n",
       "| than  |       |       | (63%) | (37%) |       |       |       |       |\n",
       "| 30    |       |       |       |       |       |       |       |       |\n",
       "| mi    |       |       |       |       |       |       |       |       |\n",
       "| nutes |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "| More  |       | 85    | 53    | 32    | 0.99  | 0.974 |       |       |\n",
       "| than  |       |       | (62%) | (38%) | (0    |       |       |       |\n",
       "| 30    |       |       |       |       | .59 - |       |       |       |\n",
       "| mi    |       |       |       |       | 1.68) |       |       |       |\n",
       "| nutes |       |       |       |       |       |       |       |       |\n",
       "+-------+-------+-------+-------+-------+-------+-------+-------+-------+\n",
       "\n",
       ": Demographic and behavioral characteristics stratified by OAT\n",
       "medication preference and sesults of a multivariable logistic regression\n",
       "with adjusted odds ratios and 95% confidence interval among participants\n",
       "currently receiving OAT\n"
      ]
     }
    }
   ],
   "source": [
    "table_merged_oat.kable"
   ],
   "id": "99f10f08-96fd-4ec7-a91e-d4a4ba395eba"
  }
 ],
 "nbformat": 4,
 "nbformat_minor": 5,
 "metadata": {}
}
